ISSUE 13 19 • AUTUMN SPRING 2019 2018

NSW Govt response

to ‘Cosmetic

Complaints’ Inquiry






Research shows good

looking people make

more money


On top of

their game

Australian females

grab the sporting


PAGE 128

ISSN 2204-0633



772204 063006

Trust in our experience 2,9

Extensively researched with a unique

manufacturing process 2,10–13

Trust in our performance 6,7,14

Rapid, noticeable results 6,7,15 that last

up to 4 months 16–18

Trust in our patient satisfaction 1,19–23

Patient satisfaction proven over time 1,19–23

Before prescribing, please review approved Product Information and

PBS information in the primary advertisement of this publication.

REFERENCES: 1. Carruthers A et al. Dermatol Surg 2015;41(6):693–701. 2. Carruthers J and Carruthers A. J Cosmet Laser Ther 2007;9(3):186–92. 3. Sundaram H et al. Plast Reconstr

Surg 2016;137(3):518e–29e. 4. Allergan, Data on File. INT/0827/2017. 5. Medical Insight Market Study. The Global Aesthetic Market Study: Version XV. May 2017. 6. Allergan, BOTOX ®

Approved Product Information. 7. Allergan, BOTOX ® Approved Data Sheet. 8. Kantar Health. BOTOX ® marketing survey. June 2018. 9. Naumann M and Jankovic J. Curr Med Res Opin

2004;20(7):981–90. 10. Brin MF et al. Biologics 2014;8:227–41. 11. Wenzel R et al. J Clin Pharm Ther 2007;32:387–402. 12. Cohen JL et al. Botulinum Toxins: Cosmetic and Clinical

Applications. New Jersey: Wiley-Blackwell; 2018. Chapter 3, Botulinum Toxin: From Molecule to Medicine; 37–51. 13. Benedetto AV. Botulinum Toxins in Clinical Aesthetic Practice. Volume

1: Clinical Adaptations. Third Edition. Boca Raton: CRC Press 2018. Chapter 2, Botulinum Toxins: Pharmacology, Immunology and Current Developments; 6–19. 14. De Boulle K et al.

Dermatol Surg 2018;44(11):1437–48. 15. Beer KR et al. J Drugs Dermatol 2011;10(1):39–44. 16. Lowe NJ et al. Dermatol Surg 2005;31(3):257–62. 17. Glogau R et al. Dermatol Surg

2012;38(11):1794–803. 18. Flynn TC. Am J Clin Dermatol 2010;11(3):183–99. 19. Stotland MA et al. Plast Reconstr Surg 2007;120(5):1386–93. 20. Trindade de Almeida A. et al.

Dermatol Surg 2015;41 (Suppl 1):S19–28. 21. Dayan S et al. Dermatol Surg 2015;41 (Suppl 1):S67–74. 22. De Boulle K. J Cosmet Laser Ther 2008;10(2):87–92. 23. Dailey RA et al.

Dermatol Surg 2011;37(7):918–28. ® Trademark(s) and registered trademark(s) of Allergan, Inc. Allergan Australia Pty Ltd, 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831.

© 2019 Allergan. All rights reserved. ANZ/0161/2019. ALBC16419W. Date of preparation: May 2019. Ward6.

You know it.1–7

You trust it.8

50+ thread

lifting methods

& 30 different


Now available

on 5 continents

& 51 countries

Anti-Aging &

Beauty Trophy

2018 – 2019

Presented by


& Wosiam

Your Focus. Our Passion.

Why is Aptos the world leader in thread lifting

methods and solutions?

Since 1996, Aptos has been the pioneer

of modern thread lifting methods

and solutions. Founded by Dr Marlen

Sulamanidze and further developed

by Doctors George and Constantin

Sulamanidze, Aptos is now the world

leader in thread lifting methods and

the recipient of numerous International

awards for thread lifting excellence.

Key to Aptos success has been the

focus on developing thread lifting

methods to support Doctors achieve

exceptional patient results. This focus

combined with a passion for developing

thread lifting solutions continues

to inspire and drive Aptos to new

breakthroughs in aesthetic medicine.

Dr Marlen Sulamanidze

To discover your passion for thread lifting Contact:

Mara Aesthetics Pty Ltd. P.O. Box 4132, Mosman NSW 2088 |

Scott Ross | | Phone 02 9056 5035 or 0410 640 437




Lighter, ergonomic handpiece

with multi-directional



Optimised treatment

algorithm with site specific

real-time tuning


Up to 25% faster treatment

time with the new

Total Tip 4.0*.


One handpiece to treat the

face, eyes and body.


Vibration available for both

face and body treatments.


Large touchscreen with

user friendly interface.

All comparisons are to the Thermage CPT system and its components.*With 33% larger surface area as compared to Total Tip 3.0.

A radio-frequency, skin tightening device indicated to treat the face, eyes and body.


Up to 25% faster treatment time with

new treatment tip (Total Tip 4.0) which

covers 33% larger surface area.


AccuREP TM technology offers real-time

tuning with each pulse to account for

variations in local impedance and deliver

consistent energy from one treatment

site to the next.


Patient comfort and enhanced

user experience with ergonomically

designed handpiece that uses vibration

for both face and body treatments.


INDICATION: The Thermage System is indicated for use in dermatologic procedures to address skin laxity, including: non-invasive

treatment of wrinkles and rhytids; non-invasive treatment of wrinkles and rhytids around the eyes, including upper and lower


© 2019 Thermage is a registered trademark of Valeant Pharmaceuticals North America LLC and its subsidiaries.

Distributed in Australia by Bausch & Lomb (Australia) Pty Limited A.B.N. 88 000 222 408,

Level 2, 12 Help Street, Chatswood, NSW 2067. Ph 1800 251 150.

THR.0015.AU.19 G247-84825



Venus Concept is a leader in the global

medical aesthetic market, pairing best-inclass

technology with the fi rst and only true

subscription model in the industry. Our goal

is to help both new and established practices

succeed in this growing industry.

In partnering with Venus Concept, aesthetic

professionals worldwide gain access to

never-before-seen business features such as

the most comprehensive warranty program,

unmatched marketing support, continuous

clinical education and more.








For more information contact Venus Concept on

0423 505 931 or




Winner of the 2018 MyFaceMyBody Awards.

cutting edge sun protection for all skin types

The new mesoprotech ® technology provides complete protection from a broad

solar spectrum. Innovative formulas combining UVA and UVB filters with biological

filters to protect from oxidation. Textures suited to the needs of every skin type.

Dermatologically tested.


Advanced Cosmeceuticals

1800 242 011 |

H Y A L U R O N I C A C I D + A N T I O X I D A N T S


Brought to you by Envogue Skin

For more info or 0452 104 365



Designed by leading dermatologists to offer

the widest spot size range in vascular and

pigmentation treatments, excel V+ offers

unmatched precision in 1/2 the time of any

device in its class.

It's the power, speed and flexibility you need

to put your practice ahead of the rest.

excel ® t/4


© 2019, Cutera, Inc. All rights reserved. AP002542 rA

Innovative solutions

for face and body

The Nordlys system features three

foundational technologies for your practice:

Ellipse IPL for exceptional photorejuvenation and vascular

treatments, as well as hair removal, 1,2 Frax 1550 for skin

resurfacing and treatment of acne scars, surgical scars, and

striae, 1 and Nd:YAG 1064 for treatment of a wide range of

vascular lesions.

The Nordlys Advantage:

Powerful sub-millisecond IPL pulses 1,2

Quiet and ergonomic operation 2

Guided treatments for a short learning curve

Patient database for ease of use

Remote assistance for service support 2

Dr John Sullivan

Kingsway Dermatology

MBBS (Hons), MSc (Pharm), FACD | Dermatologist

Nordlys is a versatile platform and is our most highly utilised laser and energy-based device. It not only treats

a wide range of both medical, surgical, skin cancer and cosmetic dermatologic indications but does this in a class

leading way. It’s Danish origins are reflected in its design, safety, ease of use, guiding menu and expert adjustability.

Photorejuvenation Photos by Guillermo Simón, M.D. Rosacea Photos by Michael Drosner, M.D. Telangiectasia

Photos by Guillermo Simón, M.D.







Visit or call 1300 (CANDELA) 226 335

References. 1. Ellipse Nordlys CE Mark clearance. 2. Nordlys system instructions for use, 2018. Candela, data on file.

© 2019 Candela Corporation. This material contains registered and unregistered trademarks, trade-names, service marks and brand names of

Candela Corporation and its affiliates. All other trademarks are the property of their respective owners. All rights reserved.

Disclaimer: All contents of this material are for informational purposes only and provided by Candela without warranties of any kind. Healthcare professionals are solely

responsible for making their own independent evaluation as to the suitability of any product for any particular purpose and in accordance with country specific regulations.

The availability of products and the indications mentioned in this material is subject to the regulatory requirements and product registration status in each country.

Refer to the User Manual for country specific indications. Products and technical specifications may change without notice. Please contact Candela for more details.

Beauty true to

every side of you.

Help your patients stay true to themselves with BELOTERO ® Volume. Its rheology helps you create the round and

natural facial shapes that respect your patients‘ features and expressions. 1

• Combines powerful volumising with modelling capacity, which allows you

to achieve a natural aesthetic enhancement 2

• Lasts up to 18 months 2

Enabling your patients to look their best from every angle.


Prager W et al. J Drugs Dermatol. 2017; 16(4): 351-357


Micheels P et al. J Clin Aesth Derm. 2015; 8(3): 28-34


BELOTERO ® Volume Lidocaine is an injectable resorbable implant indicated to restore facial volumes, as for example to enhance the cheeks or the chin.

BELOTERO ® Volume Lidocaine should not be used on patients: with known hypersensitivity to any of the components or amide anesthetics; presenting with a general infection; prone to

hypertrophic scars/keloids or streptococcal diseases; in an area with permanent dermal filler or inflamed/infected skin; into blood vessels, superficial dermis, lips, glabellar or tear-trough

region; under 18 years of age; in pregnancy or lactation; others.

BELOTERO ® Volume Lidocaine is precautioned in patients: with history of severe multiple allergies or anaphylactic shock; with active autoimmune disease, epilepsy, impaired cardiac

conditions, severely impaired hepatic function or severe renal dysfunction or porphyria, congenital methemoglobinemia, with glucose-6-phosphate dehydrogenase deficiencies; with

unhealed aesthetic treatments; on antithrombotic medications; into the periorbital area; others – see full Instructions for Use before prescribing for full safety information, available from

Copyright ©2019. Merz Australia Pty Ltd. All rights reserved. Belotero ® and Merz Aesthetics are registered trademarks of Merz Pharma GMbH & Co. KGaA.

This medical device must be administered by a Healthcare Professional. ANZ_BEL_BEAUTYTRUE_V1:JUN19 8349MER.

Merz Australia Pty Ltd (ACN 151 073 559), Level 3, 244 Coward St, Mascot, NSW, 2020. For more information please phone 1800 268 820.


16 Botox may relieve endometriosis pelvic pain

16 3 interventions could prevent millions of

cardio deaths

17 edited ‘selfies’ linked to plastic surgery acceptance

17 crushed eggshells could help repair bones

18 new paths for ALS therapy

18 air pollution may raise heart disease risk

18 skin cancer surgery complications for smokers

21 new urine test for advanced prostate cancer

21 cancer proton therapy has fewer side effects

22 global alcohol consumption up 70%

22 appendix removal triples Parkinson’s risk

22 fasting may prevent diabetes




24 Justice served

Sydney plastic surgeon Dr Kourosh Tavakoli wins $530,000

damages for false Google review

28 nsw Govt Response To ‘Cosmetic Complaints’ Inquiry

The NSW Government has formally responded to the 16

recommendations contained in the report of the NSW Parliamentary

Health Care Complaints Committee Inquiry into ‘Cosmetic health

service complaints in NSW’.

34 good Looking People Make More Money

Pulchronomics is the study of the financial and career advantages

of ‘looking good’ – and the researchers agree those advantages

are significant.

128 aussie women on top of their game

A series of sensational performances by Australian females grabbed

the sporting spotlight across 2019’s northern hemisphere summer.



32 SkinCeuticals Est Clinic launch

Coverage of Dr Frank Lin’s EST Clinic launch in Emporium

Melbourne, the global first SkinCeuticals collaboration with a

plastic surgeon.




50 One plus one equals success

Hanya Oversby, Director of Specialist Consulting, interviews

her clients Dr Belinda Welsh and Dr Cara Mcdonald about their

business venture.

54 the Four Step program

Your reception person plays a major and highly valued role in your

clinic. Lizzy Boots explains the importance of providing an effective

training program.



Kerry Bielik explains why ‘Don’t ask, Don’t tell’ couldn’t be

further from the mark if you want to ensure your patients have

a great experience.

58 teamWORK – Hard to get, easy to lose

Roanne Innes, Business Coach and Leadership Consultant,

explains the importance of good teamwork and maintaining

optimal cohesiveness.

61 a step by step guide to setting up a YouTube channel

Alfie Lombardi from Trusted Surgeons explains how to capitalise

on video content by setting up a YouTube channel of your own.


A regular feature, shining the spotlight on an international

destination through the eyes of a local medico.

136 spotlight on Toulouse, France

Plastic and Aesthetic Surgeon, Dr Lakhdar Belhaouari, gives

us a tour of his city in the south west of France.




70 Read about the latest technologies, products and

services available to make the modern aesthetic practice

more successful.


Letter from the editor



David Hickie

Debbie Pilarinos

Shonagh Walker

Maria Leahy

Catherine Hale

Harriet Hickson

Welcome to the

spring edition of

Aesthetic Medical

Practitioner. In this issue we

have a fascinating article on the

economic advantages of ‘looking

good’ and being perceived as

‘attractive’ or ‘beautiful’. While this

may not sit well with modern attitudes that individuals,

and in particular females, should be valued for more

than just their looks, the reality is that attractiveness

does have an effect on career earning potential as

well as happiness. And it’s backed by research.

‘Pulchronomics’ is the study of the financial and career

advantages of ‘looking good’, so turn to page 34 to

read this article and judge for yourself.

Australian women have been in the headlines over

the last few months for a very different reason – their

sporting talent and success. On page 128 we have an

article that showcases the elite Aussie female sports

stars who have taken the world by storm and ‘done our

nation proud’ with their achievements.

We also have a wrap of the NSW Government

response to the ‘Cosmetic Complaints’ Inquiry,

which was held in February. Turn to page 28 to read

its response to the16 recommendations contained

in the report of the NSW Parliamentary Health Care

Complaints Committee Inquiry into ‘Cosmetic health

service complaints in NSW’.

Plus, in our Best Practice section from page 50,

we bring you articles on: achieving teamwork in your

practice by avoiding five natural pitfalls; the importance

of providing an effective training program for your

reception person; and how to set up your own YouTube


A recent study published in the Journal of Medical

Practice Management analysed 35,000 online reviews

of medical practices. It revealed 96% of complaints

found fault with the customer service – not the quality

of care, so our story on page 56 on the reasons patient

satisfaction surveys are so valuable in your practice is

very pertinent.

With the upcoming months usually the busiest of the

year, from page 80 we bring you all the latest devices

and treatments available for your patients.

I trust you will enjoy reading this issue and take

advantage of the beautiful spring weather just around

the corner.

Michelle Kearney


Michelle Kearney


Catherine Hale, Harriet Hickson,

Maria Leahy, Shonagh Walker


David Hickie

Art Director

Debbie Pilarinos


Debbie Pilarinos, ShutterStock

Distribution &

Subscription Enquiries

Bill Dunk

Phone 02 8095 6265


Advertising Enquiries

Michelle Kearney,

Phone 02 8095 6265 Mob 0419 624 246


Editorial Enquiries

Michelle Kearney

Phone 02 8095 6265 Mob 0419 624 246


Produced & Published

by Bella Media

ABN 86 082 157 695

Managing Director

Michelle Kearney

Chief Operating Officer

Bill Dunk

Public Relations, Marketing

& Event Organisation

Phone 02 8095 6265

Office address

Suite 2201, Level 22 Westfield Tower 2

101 Grafton St Bondi Junction NSW 2022

Ph +61 2 8095 6265

All 'before and after' photographs in Aesthetic Medical

Practitioner articles are of genuine patients. It is important

to understand that they represent one person's experience

and there is no guarantee that any other patient will

experience similar results.

Advertising Policy AMP follows and upholds the Australian

Competition and Consumer Commission (ACCC) Guidelines

to Advertising Medical Services, the Therapeutic Goods

Administration (TGA) advertising regulations for therapeutic

goods and services, and individual state Medical Board

guidelines. All reasonable effort is made by AMP to ensure

that all advertisements accepted for publication follow

these guidelines. Copies of these guidelines are available

from the individual agencies and boards. AMP reserves

the right to reject advertising that is in breach of these

guidelines. All AMP advertisers assume sole responsibility

and liability for statements contained in their advertising

copy, and hold harmless and indemnify AMP, Bella Media,

and officers, directors and employees from and against all

liability, loss, claim, damages, costs or expenses arising out

of matter contained in the advertising. Advertisers accept

these terms and responsibilities when signing an advertising

contract with AMP.





What is Radiesse®?

Radiesse® (+) Lidocaine is one of the most well studied

fillers worldwide and has a longstanding history of efficacy

and tolerability for correction of moderate to severe

facial lines. 1 Its principal component is synthetic calcium

hydroxylapatite (CaHA) microspheres suspended in a gel

carrier. CaHA provides the benefits of initial volume

replacement and a longer term reconstructive process due

to collagen biostimulation at the injection site. 2

What is the Radiesse® Academy?

• The Radiesse® Academy is a unique training experience with up to three

workshops covering select areas using Radiesse® and Radiesse® (+) Lidocaine

• Training incorporates online learning modules followed by 2 to 3 theoretical

and hands-on injecting sessions with nationally recognised Merz training

doctors and Merz nurse injector trainers

• Each injecting session will have 1 expert trainer to 4 trainees

• After each injecting session, individual follow-up training with Merz nurse

injector trainers will be offered to attendees

Please contact for more information

and to express interest in the next available academy in your area.

Radiesse® (+) Lidocaine injectable implant is indicated for plastic / reconstructive procedures in adults, including deep dermal

and subdermal soft tissue augmentation of the facial area and is also intended for restoration and correction of fat or volume loss

(lipoatrophy) in the facial area and for rejuvenation of the hands. Radiesse® (+) Lidocaine should not be used on patients: with

known hypersensitivity to any of the components or amide anesthetics; prone to inflammatory skin conditions, hypertrophic scars/

keloids or poor wound healing; with bleeding disorders or inflamed/infected skin; in the presence of foreign bodies/implants; in

the epidermis, glabellar or lip mucosa; taking anti-coagulants; in pregnancy or lactation; others. If you are a Healthcare Professional,

please review the Radiesse® (+) Lidocaine Instructions for Use before prescribing for full safety information, available from www.

References: 1. Loghem JV, Yutskovskaya YA, PhilipWerschler WM. Calcium Hydroxylapatite: Over a Decade of Clinical Experience.The Journal of Clinical and Aesthetic Dermatology. 2015;8:38-49. 2. “Yutskovskaya MD,

Kogan E, Leshunov E. J Drugs Dermatol, 2014;13(9) 47-52

Merz Australia Pty Ltd (ACN: 151 073 559) Sydney, Australia. Radiesse® and Merz Aesthetics are registered trademarks of Merz Pharma GmbH & Co. KGaA. All rights reserved. Ph: 1800 268

820. AU_RAD+_RADACDAD_V1_AUG19 Date of Preparation: August 2019.


Botox may relieve endometriosis pelvic pain

Many women with endometriosis

(a chronic inflammatory condition in

which endometrial-like tissue grows

outside the uterus on other organs)

suffer from pain due to pelvic floor

spasms, even after surgical and

hormonal treatment.

But a study by the US National

Institute of Neurological Disorders

and Stroke ‘has discovered

that treating these spasms with

injections of botulinum toxin at the

site can help ease the pain, in part

by relaxing the muscles’ reported

Importantly the study, reported

in Regional Anesthesia & Pain

Medicine, focused on women ‘who

had pain that persisted despite

receiving the best standard-of-care

treatment for endometriosis’ and

the injections ‘were intended to

alleviate pain symptoms only, not

treat the disease’.

Women who received the

injections were followed for 4

months. By 2 months after injections

‘all reported decreased pain,

including some who said their pain

was now mild to non-existent.

Half reported reduced use of pain


Botulinum toxin works by blocking

the release of a chemical messenger

molecule (acetylcholine) from the

nerve cells that tells the muscle to

contract; it blocks the action of the

nerve, not the muscle. If the nerve

can’t communicate with the muscle,

the muscle relaxes.

Lead author Dr Barbara Karp

commented: ‘Relaxing the muscle is

probably not the only way it works.

Botulinum toxin also blocks the

release of other chemical messages

involved in sending pain signals to

the brain.’

The effects of botulinum toxin

typically last three months, but Karp

added: ‘The benefit can be longer

in some patients and for some pain

conditions, as seen in some of the

patients we reported.’

And she warned: ‘More research

is needed on how to select the

dose, muscles for injection, and

approach to injection.’

Sources: Regional Anesthesia &

Pain Medicine,, and bodyandsoul.

3 interventions could prevent millions of cardio deaths

New research from the Harvard

School of Public Health ‘suggests

3 tried and tested interventions,

if implemented through global

policies, could prevent many of

the 17.9 million deaths worldwide

each year’ which the World Health

Organisation says are due to

cardiovascular disease (31% of

yearly global deaths).

In the study, reported in the journal

Circulation, US researchers examined

data from populations in different

countries, and found three ‘wellknown

interventions’ — lowering

blood pressure, reducing sodium

intake, and eliminating trans fat from

one’s diet — ‘could have an important

beneficial effect in terms of preventing

millions of premature, cardiovascular

event-related deaths worldwide’


The researchers believe ‘boosting

the reach of treatments for high

blood pressure to 70% of the

world’s population’ and ‘reducing

salt consumption by 30%’ could

save tens of millions of lives over the

next decade, especially in East Asia,

the Pacific, South Asia, and some

countries in sub-Saharan Africa.

Lead author Professor Goodarz

Danaei emphasised: ‘These

interventions have enormous

potential to save lives. However,

scaling them up to global

populations is a huge challenge.’

Countries across the world would

have to dedicate extra resources to

providing antihypertensive (blood

pressure-lowering) medication,

promote education about the risks

associated with too much sodium

intake, and update and push out

new and better health policies.

However the researchers

declared ‘these goals are entirely

achievable’. Other programs

have already demonstrated this:

for example, one program in

Northern California was able to

increase blood pressure control

to 90% among patients between


Professor Danaei commented:

‘These are realistic goals that

have been shown to be attainable

on smaller scales. We need the

commitment to scale up the

programs to achieve them globally.’

Sources: Circulation and





could help

repair bones

Edited ‘selfies’ linked to

plastic surgery acceptance

A US study has found ‘increased

acceptance of cosmetic facial surgery

is associated with the use of certain

social media and photo-editing


In the study published in JAMA

Facial Plastic Surgery, participants

reported ‘using photo-editing

applications to make changes in

photo lighting’ and ‘using these

applications to make changes in body

or face shape’ noted

The overall results found

‘participants who reported using

specific applications, such as

YouTube, Tinder and Snapchat

photograph filters, had an increased

acceptance of cosmetic surgery;

use of other applications, including

WhatsApp and Photoshop, was

associated with significantly lower

self-esteem scores’—something

the researchers say ‘may help guide

future patient-physician discussions

regarding cosmetic surgery


California facial plastic surgeon

Dr Jill Hessler said she’s recently

seen ‘an uptick in patients coming in

using filters or adjusting their photos

so she can see exactly what they

want’ — and she’s a fan. ‘In most

instances, I actually find it helpful so

we can have a realistic discussion

of what is possible and what is not

possible with surgical or minimally

invasive treatments. It can be used

as a version of the morphing software

that is often used by facial plastic

surgeons and plastic surgeons to

give patients an idea of what surgical

changes can provide.

‘I find it helpful to look at these

photos patients bring to the office

because it gives me a greater

understanding of their concerns

and their goals. Sometimes,

patients can’t articulate their

concerns, but a photo can really

help illustrate this to doctors.’

Fellow California plastic surgeon

Dr Robert Singer agreed a picture

really is ‘worth a thousand words’

when it comes to cosmetic surgery,

but he looks at the patient-selfie

connection as more suited for

communication — not a concrete

indicator of results — and

emphasised: ‘There are certainly

great advantages to technology,

but it’s not a secret there is a

growing demographic that has

become addicted to selfies to the

point of obsession.’

He warns selfies can produce

distorted views, something most

selfie-centric users fail to realise.

‘Because of the angles they are taken

at, the closeness of the subject and

the lighting, they can actually create

asymmetries and distortion.’

Sources:JAMA Facial Plastic Surgery, and

US researchers at the University

of Massachusetts have found an

innovative way of using crushed

eggshells to support new bone

tissue growth.

Eggshells are made entirely of

calcium carbonate – crucial for

maintaining bone growth – and the

researchers used finely crushed

eggshells to create a biomaterial

(described as a ‘hydrogel mixture’) that

helps bones regenerate after having

sustained damage by ‘allowing them

to form a frame in which new bone

can form from bone cells’ explained

‘Because the eggshells are made up

of calcium, this allows the bone cells

to both develop into bone tissue and

harden faster. This could also speed up

healing in the context of a bone graft ...

where specialists transplant new bone

tissue at the site of a damaged bone to

allow it to heal’.

The study is reported in the journal

Biomaterial Sciences, and Professor

Gulden Camci-Unal noted: ‘We

anticipate the process can be adapted

for use in many significant ways’. She

said the same process could apply, in

theory, to grow other types of tissue,

including cartilage, teeth, and tendons.

In their paper, the investigators also

noted: ‘Global waste of discarded

eggshells typically amounts to millions

of tons annually from household

and commercial cooking. Innovative

repurposing of eggshells can directly

impact the economy and environment,

while providing enhanced solutions to

unmet clinical needs.’

Sources: Biomaterial Sciences and



New paths for

ALS therapy

New US research has revealed

previously unknown ‘subtypes of

motor neurons’ in people with ALS

(amyotrophic lateral sclerosis, also

known as Lou Gehrig’s disease).

ALS – a progressive

neurodegenerative disease that leads

to the death of nerve cells which control

movement, leaving people unable to

move and, eventually, to breathe – is fatal

and, so far, incurable.

Currently, no one test can provide

a definitive diagnosis of ALS and

eventually diagnosis is based on its

symptoms. Hence most victims receive

their diagnosis when the condition has

already progressed to a visible extent.

But new research from the University

of Illinois, reported in Neurobiology

of Disease, ‘has identified a set of

biomarkers that sets people with

ALS apart from those without a

neurodegenerative disease. These

findings could help doctors diagnose

the condition earlier and also open up

new avenues for targeted therapy’,


The scientists analysed samples of

motor neurons and associated cells

from the spinal cords of individuals who

had died from ALS and from those of

healthy people.

They found people who had died from

focal-onset ALS had different types of

motor neurons, compared with healthy

individuals, and these differences ‘were

associated with microglia and astrocytes,

two types of specialised neural cells that

did not make an appearance in samples

collected from the same regions of the

spinal cord in healthy participants.

Lead researcher Dr Fei Song

commented: ‘We found a novel and

unique subtype of motor neurons in

these patients never before reported.

Now that we have identified new

subtypes of motor neurons and microglia

present in ALS patients, we can begin to

further study their roles in contributing to

disease progression.’

Sources: Neurobiology Of Disease


Air pollution may raise

heart disease risk

A new study which examines the link

between exposure to air pollution and

risk of coronary artery calcification among

Chinese adults ‘provides additional

evidence that pollution may affect our

cardiovascular health’.

The researchers set out to examine

whether ‘air pollution and proximity

to traffic’ correlate with coronary

artery calcium score, a key marker of

atherosclerosis (the build-up of plaque

inside artery walls which, over time, may

lead to serious cardiovascular conditions,

such as high blood pressure, heart

disease and heart attacks) using data on

8,867 Chinese people aged between 25

and 92 who all had suspected

coronary heart disease, reported

The team estimated annual levels

of pollution at the participants’ residences

‘by calculating their nitrogen dioxide,

ozone, and fine particulate matter levels

(a mixture of solid particles and liquid

droplets, including dust, dirt, soot, or

smoke present in the air that a person

Skin cancer surgery

complications for smokers

Complications after skin cancer

surgery ‘may be more common in

smokers and former smokers’, reported

US researchers at the University of

Minnesota examined outcomes after

‘Mohs reconstruction’ (a procedure to

remove a skin cancer lesion).

Compared to people who never

smoked, current smokers were

‘more than 9 times as likely to have

complications like infections, clots known

as hematomas, uncontrolled bleeding

or dead skin tissue’. Ex-smokers were

‘more than 3 times as likely to have these

acute complications’.

The study was reported in JAMA

Facial Plastic Surgery and senior author

Professor Ian Maher explained: ‘Smoking

having an adverse effect on healing and

outcomes has been documented for

other procedures, but not previously for

cannot see with the naked eye) using a

standard geostatistical prediction model’.

The research, reported in the journal

JAMA Network Open, revealed that for

each nitrogen dioxide increase of 20

micrograms per cubic meter, risk of a

high coronary artery calcium score rose

by 24.5%. And for each increase of 30

micrograms participants had exposure

to in their apartments, there was an

increase of 27.2% in the coronary artery

calcium score.

Lead author Meng Wang commented:

‘This finding should contribute to

an understanding of air pollutant

effects worldwide, providing both

much-needed, locally generated data

and supportive evidence to inform

the air pollution standard-setting

process on a global scale.

‘And atherosclerosis is a lifelong

process. As such, the effects of air

pollution exposure on atherosclerosis are

likely to be chronic.’

Sources: JAMA Network Open and

the repair of wounds with flaps and grafts

after skin cancer removal.

‘Good circulation is necessary for good

healing. Smoking damages small blood

vessels in many organs including the skin.

Having worse circulation slows healing

and sets patients up for complications

such as infection.’

Professor James Dinulos from Geisel

School of Medicine at Dartmouth

commented: ‘Smoking adversely impacts

the early phases of wound healing,

leading to increased complications that

were outlined in the study. It is likely

chemicals in smoke impact the integrity

of the skin over the long-term, especially

if the patient is a high pack-year smoker,

and some of the physiological changes

may not be reversible.’

Sources: JAMA Facial Plastic Surgery




• XEOMIN ® is the only ARTG registered

(AUST R 205508) Botulinum toxin that

is free from complexing proteins 1,2

• Higher foreign protein content is

a risk factor for secondary therapy

failure 1

• IncobotulinumtoxinA and OnabotulinumtoxinA

are clinically equivalent in the treatment of GFL

for up to 3 months as established by primary

and secondary endpoints 3

• XEOMIN ® can be stored at room


Please review Product Information before prescribing, available from

Merz Australia Pty Ltd on 1800 268 820.

PBS Information: This product is not listed on the PBS for the treatment of

Glabellar Frown Lines, Horizontal Forehead Lines and Crow’s Feet

Minimum Product Information

Xeomin ® (incobotulinumtoxinA). 50, 100 Units. Indications: In adults, for the treatment of cervical dystonia;

blepharospasm; spasticity of the upper limb; upper facial lines: glabellar frown lines, lateral periorbital lines

(crow’s feet), horizontal forehead lines. Contraindications: Hypersensitivity to ingredients; generalised

disorders of muscle activity (e.g. myasthenia gravis, Lambert-Eaton Syndrome); Infection or inflammation at

the proposed injection sites. Precautions: bleeding disorders; local and distant spread of toxin effect; preexisting

neuromuscular disorders; hypersensitivity reactions; antibody formation; lack of interchangeability

between botulinum toxin products; mild to severe dysphagia, aspiration and dyspnea; muscle weakness (neck);

swallowing, speech or respiratory disorders; avoid injection near levator palpebrae superioris, inferior oblique

and medial injections into the lower lid, pen marks, into blood vessels; ptosis; diplopia; reduced blinking; seizures;

contains albumin (human); pregnancy (Cat B3); lactation; children (not recommended); driving/using machines;

others, see full PI. Interactions with other medicines: Aminoglycoside antibiotics; anticoagulants or those

with similar effect; other agents interfering with neuromuscular transmission, e.g., tubocurarine-type muscle

relaxants. Adverse effects: Cervical Dystonia: dysphagia, dry mouth, nausea, injection site pain, asthenia, neck

pain, muscular weakness, myalgia, musculoskeletal stiffness, muscle spasms, headache, presyncope, dizziness,

upper respiratory tract infection, hyperhidrosis; Blepharospasm: dry eyes, eyelid ptosis, headache, facial paresis,

vision blurred, visual impairment, diplopia, lacrimation increased, dry mouth, dysphagia, injection site pain, fatigue,

muscular weakness; Spasticity of the upper limb: dry mouth; Glabellar frown lines: headache, Mephisto sign; Lateral

periorbital lines: injection site haematoma, eyelid oedema, dry eye; Upper facial lines: injection site haematoma,

pain and erythema, heavy feeling of frontal area, eyelid ptosis, dry eye, headache, hypoaesthesia, bown ptosis,

facial asymmetry, Mephisto sign, nausea; Others, see full PI. Dosage and Administration: For intramuscular

injection, single use in one patient only. Unit doses recommended for Xeomin are not interchangeable with those

for other preparations of botulinum toxin. Reconstitute with sodium chloride 9 mg/mL (0.9%) solution for injection

(see full PI for dilutions). The optimum dose and number of injection sites in the treated muscle(s) should be

individualised for each patient and determined by the treating doctor. Treatment intervals should be determined

based on the actual clinical need of the individual patient. Cervical dystonia: 0.1 to 0.5 mL/site; max 50 U/site; max

300 U/treatment session; no more frequent than every 6 weeks. Blepharospasm: 0.05-0.1 mL/site; max 25 U/eye;

max 100 U/treatment session; no more frequent than every 6 weeks. Spasticity: max 500 U/treatment session;

max 250 U in shoulder muscles; generally no more frequent than every 12 weeks. Glabellar frown lines: max 30 U/

treatment session; generally no more frequent than every 3 months. Lateral periorbital lines: max 24 U/treatment

session. Horizontal forehead lines: max 20 U/treatment session; see full PI. TGA-approved 14 February 2019.

REFERENCES: 1. XEOMIN Product Information February 2019. 2. XEOMIN Consumer Medicine Information February 2019.

3. Kane M et al, Dermatol Surg November 2015; 1310-1319.

Merz Australia Pty Ltd (ACN: 151 073 559) Sydney, Australia. Ph: 1800 268 820. Web: The Merz

Aesthetics and Xeomin logos are registered trademarks of Merz Pharma GmbH & Co. KGaA. Copyright ©2019. Merz Australia Pty

Ltd. All rights reserved. AU_XEOMIN_AMP_V2_AUG2019. Date of preparation: August 2019. 8525MER


New urine test for

advanced prostate cancer

A new urine test can detect aggressive

prostate cancer up to 5 years sooner

than other diagnostic methods.

UK researchers from the University of

East Anglia reported in the journal BJU

International that the Prostate Urine

Risk (PUR) test can distinguish ‘who

will and who will not require treatment

within the first 5 years of diagnosis’.

The researchers ‘looked at

gene expression in the urine

samples of 535 men and . . .

established a combination of 36

different genes considered risk

signatures, or biomarkers, that the

PUR test could look for,’ noted

The test ‘is unique in that it

can sort people into different risk

groups, thereby demonstrating

the aggressiveness of the cancer’.

Researcher Dr Jeremy Clark

commented: ‘Our urine test could be

used to not only diagnose prostate

cancer without the need for an invasive

needle biopsy, but to identify a person’s

level of risk. This means we could

predict whether or not prostate cancer

patients already on active surveillance

would require treatment.

‘The really exciting thing is

the test predicted disease

progression up to 5 years before it

was detected by standard clinical

methods. Furthermore, it was able

to identify men up to eight times

less likely to need treatment within

5 years of diagnosis.’

The PUR test not only identifies

the presence of cancer earlier, it

can also help put people into

different risk groups so doctors can

more accurately determine the

course of care: whether to watch

and wait, take a biopsy or start

treatment immediately.

Dr Clark summed up: ‘If this

test was to be used in the clinic,

large numbers of men could avoid

an unnecessary initial biopsy and

the repeated, invasive follow-up of

men with low-risk disease could be

drastically reduced.’

Sources: BJU International and

Cancer proton therapy has fewer side effects

The American Society Of Clinical

Oncology’s annual meeting has

been told that while cure rates for

X-ray therapy and proton beam

therapy ‘are the same in the

treatment of cancer, the risk of

severe side effects is much lower

with proton therapy’.

New research by doctors at

Washington University noted that,

although effective, radiation therapy

‘has a wide range’ of potential side

effects — including fatigue, skin

irritation, fever, nausea, vomiting

and diarrhea, as well as changes

in appetite or difficulty eating and

swallowing — while proton therapy

‘may have fewer and less severe

side effects than X-ray radiation’,


The research team examined

1,500 people with various forms

of cancer — lung, brain, head and

neck, as well as gastrointestinal

and gynecological cancers —

and compared the experiences

of patients who received proton

chemo-radiotherapy with those

who received photon (X-ray)


They found the relative risk

of severe side effects within 90

treatment days was two-thirds

lower for people who received

proton therapy, compared with

those who received X-ray radiation.

Lead researcher Dr Brian

Baumann noted: ‘Proton therapy

was associated with a substantial

reduction in the rates of severe,

acute side effects — those that

cause unplanned hospitalisations

or trips to the emergency room

— compared with conventional

photon, or X-ray, radiation for

patients treated with concurrent

radiation and chemotherapy.’

Sources: American Society

of Clinical Oncology and



Global alcohol consumption up 70%

A major international study has warned

‘across the globe, rates of individual

alcohol consumption have soared’ – a

‘dangerous pattern that policymakers

must address’.

The research by scientists at Canada’s

Centre for Addiction and Mental Health

in Toronto and Germany’s Universitat

Dresden and published in The Lancet,

analyses alcohol intake in 189 countries

from 1990–2017 and estimates rates

through to 2030.

The team found while patterns of alcohol

consumption have not changed much in

high-income countries, low and middleincome

regions ‘are seeing a staggering

increase’ reported

Globally, total volume of alcohol consumed

per year increased by as much as 70%

between 1990 and 2017 — from 20,999

million litres to 35,676 million litres per year.

Lead author Jakob Manthey explained:

‘Before 1990, most alcohol was

consumed in high-income countries, with

highest use levels recorded in Europe.

However, this pattern has changed

substantially, with large reductions across

Eastern Europe and vast increases in

several middle-income countries, such as

China, India, and Vietnam.

‘This trend is forecast to continue up

to 2030.’ By that point, ‘half of all adults

around the world will consume alcohol and

23% will engage in binge drinking at least

once every month’.

Manthey emphasised: ‘Based on our

data, the World Health Organisation aim of

reducing harmful use of alcohol by 10% by

2025 will not be reached globally. Instead,

alcohol use will remain one of the leading

risk factors for the burden of disease for

the foreseeable future, and its impact will

probably increase, relative to other risk

factors. Implementation of effective alcohol

policies is warranted, especially in rapidly

developing countries with growing rates of

alcohol use.’

Sources: The Lancet and

Appendix removal triples Parkinson’s risk

A huge study of 62.2 million health records

across 26 US health systems has found

patients who underwent appendix removal

were over ‘three times more likely to

develop Parkinson’s disease later on’.

The findings, reported in journal

Gastroenterology, are further evidence

of a ‘connection between the gut and

the brain in Parkinson’s disease’, noted

No current cure or treatment slows

Parkinson’s disease; but an avenue

scientists are pursuing concerns the

protein alpha-synuclein which features

in the development of Parkinson’s and

‘forms toxic lumps in the brains of people

with the disease’.

Recent research has also found

clumps of alpha-synuclein in the digestive

tract of people in the early stages of

Parkinson’s disease and lead study

author Dr Mohammed Sheriff, from

University Hospitals Cleveland Medical

Center, explained: ‘This is why scientists

around the world have been looking

into the gastrointestinal tract, including

the appendix, for evidence about the

development of Parkinson’s.’

Of the 62.2 million patient records

analysed, his team identified 488,190

people who had undergone an

appendectomy; of these 4,470 individuals

(0.92%) went on to receive a diagnosis of

Parkinson’s disease.

Of the remaining 61.7 million, only

177,230 (0.29%) received a Parkinson’s

diagnosis. The team also found the

more than three times higher likelihood

of developing Parkinson’s following an

appendectomy was not dependent on

age, sex or race.

Dr Sheriff added: ‘This research shows

a clear relationship between the appendix,

or appendix removal, and Parkinson’s.

Additional research is needed to confirm

this connection and better understand the

mechanisms involved.’

Sources: Gastroenterology and


may prevent


A new study suggests fasting

from dawn to sunset for 30 days

could help treat conditions relating

to obesity.

US researchers at Baylor

College of Medicine in Texas

‘used the Islamic spiritual practice

of Ramadan to study the benefits

of fasting from dawn to sunset’

(15 hours each day) and found

practicing this type of fasting

for 30 days ‘raised the levels of

certain proteins that can improve

insulin resistance and stave off

the adverse effects of a diet rich

in fats and sugar’.

The study, presented at

the Digestive Disease Week

conference in California, found ‘by

increasing certain proteins, fasting

may protect against metabolic

syndrome, diabetes, and liver

disease, but the ‘timing of and

duration between meals’ is key’


Participants provided blood

samples before the start of

the fast, again after 4 weeks of

fasting and finally 1 week after

fasting ended.

Lead researcher Professor Ayse

Leyla Mindikoglu noted: ‘Feeding

and fasting can significantly impact

how the body makes and uses

proteins (called tropomyosin or

TPM 1, 3, and 4) that are critical to

decreasing insulin resistance and

maintaining a healthy body weight.

‘Therefore the timing of and

duration between meals could be

important factors to consider for

people struggling with obesityrelated


‘Based on our initial research,

we believe dawn-to-sunset fasting

may provide a cost-effective

intervention for those struggling

with obesity-related conditions.’

Sources: Digestive Disease

Week and


World No.1

Ultrasound Lift

Tightening and Contouring

Exclusively Distributed in Australia & New Zealand by Cryomed | | T. 1300 346 448







The NSW Supreme Court has

ordered a woman to pay

$530,000 damages – plus

substantial costs and interest since

September 2017 – to Double Bay

plastic surgeon Dr Kourosh Tavakoli

following her malicious publication of

a ‘plainly untrue’ review on Google.

Justice Stephen Rothman found

defamatory imputations arose from

the review which alleged Dr Tavakoli

charged Cynthia Imisides ‘for a

buccal fat procedure that he did not

perform’ and that he acted both

‘improperly’ and ‘incompetently’ in

relation to that procedure. The judge

ruled ‘those allegations have been

shown to be plainly untrue’.

The judge explained the ‘claim in

defamation and injurious falsehood’

against Imisides ‘relates to the

publication of a Google review from

which the ordinary reasonable reader

would accept that the following

imputations arose’:

1. Dr Tavakoli ‘is an incompetent

plastic surgeon, in that the

rhinoplasty he performed’ on

Imisides was unsuccessful;

2. Dr Tavakoli ‘is cruel in his dealings

as a doctor, in that he does not

provide assistance to his patients

who are unhappy with their results

post-surgery’; and

3. Dr Tavakoli ‘is a bully in that he

intimidates patients that raise a

legitimate complaint about his

work by using his lawyers to

threaten them’.

The judge noted Dr Tavakoli was

born in Iran in 1969, moved as a

teenager with his family to London

and in 1986 moved to Sydney,

where he completed his education

and obtained a Bachelor of Science

(Medicine) and a Bachelor of

Medicine in 1993 and a Bachelor of

Surgery in 1994 at the University of

New South Wales. He is a Full Fellow

of the Royal Australasian College of

Surgeons (FRACS) in the division of

plastic and reconstructive surgery, as

well as a member of the Australian

Society of Plastic Surgeons, the

Australian Society of Aesthetic Plastic

Surgeons and the International

Society of Aesthetic Plastic Surgery.

The judge also noted Dr Tavakoli

holds visiting medical offi cer rights

at St Vincent’s Private Hospital and

East Sydney Private Hospital and

consults from rooms in Double

Bay. He ‘performs cosmetic

and reconstructive surgeries,

including breast augmentation,

abdominoplasty, rhinoplasty, breast

reduction and breast lifts, as well

as a range of facial procedures.

He has also worked with victims of

serious burns, of maxillofacial and

hand trauma and has performed

microsurgery for cancer patients.’

The judge said that between

December 2016 and January 2017

Cynthia Imisides made a number

of enquiries ‘regarding rhinoplasty,

breast augmentation and a facelift’.

When Dr Tavakoli fi rst saw her on 24

January 2017, she ‘was recovering

from plastic surgery performed by

another surgeon’.

Dr Tavakoli saw Imisides

again on 27 January and 7

February. At the second visit (27

January) ‘a fi nal quotation for the

three proposed procedures was

provided’ to Imisides.

On 9 February 2017,

Dr Tavakoli performed three

procedures on Imisides at East

Sydney Private Hospital:

• Rhinoplasty ‘involving the revision



of a former rhinoplasty on the

reconstruction of the nasal

septum. The previous rhinoplasty

had been performed by a West

Australian surgeon’;

• Buccal fat procedure ‘involving

removing the fat pads that

augment the lower part of the

cheeks, to which (Dr Tavakoli)

gained access through the inside

of (Imisides’s) mouth and used

dissolvable stitches on the inside of

her cheeks’;

• Fascia graft ‘being a procedure

involving the removal of fat from

one part of the body to fill another

part of the body, and, in this

case, the fat was removed from

(Imisides’s) abdomen and injected

into her bilateral tear trough. During

recovery, (Imisides) was observed

by her anaesthetist as she had

developed lockjaw from clenching

her teeth as a result of the pain

from the buccal fat procedure.’

An Operation Report for the buccal

fat procedure was dictated by Dr

Tavakoli on the day following the

operation. In May 2017, Imisides

agreed to come in for a postconsultation

visit ‘to have steroid

injections in order to reduce swelling

in her nose’. That procedure was

performed on 22 May 2017.

Justice Rothman noted ‘the

evidence before the Court

establishes that at the time that the

steroids were injected’, Dr Tavakoli

and Imisides had a conversation ‘to

the following effect’:

Tavakoli: ‘Your nose swelling will

take at least 18 months to settle.

During that time you just need a

number of steroid injections to

reduce the swelling. You can see as

The judge emphasised the statement in the

first Google review was untrue . . . and the

second Google review statements were

untrue’. Further, those statements ‘were

made for a purpose to harm the plaintiff and

the publication was actuated by that

purpose. Malice has been disclosed.

many surgeons as you want, but it is

widely accepted you cannot perform

surgery on a revision surgeon within

18 months. If you shop around, you

will eventually find someone who will

tell you differently.’

Imisides responded with words

to the following effect: ‘I know, I

just get so emotional and make

appointments. I now understand

and I will come and get the injections

whenever I travel to Sydney.’

The judge added there ‘was a

series of exchanges in relation to

appointments’ for Imisides in which

she was advised that ‘as per the

discussion with Dr Tavakoli, it is

extremely important for your healing

and results that you stick to your

appointment schedule’.

However an appointment she

could not attend on 21 July was

re-scheduled, but she ‘did not attend

that re-scheduled appointment’.

Soon after Imisides’s husband

Mark Imisides became involved in

telephone calls and emails to Dr

Tavakoli, resulting in formal written

correspondence on 8 August from

Tavakoli’s solicitors to both husband

and wife ‘seeking undertakings

relating to threatened publication’.

On 9 August, Mark Imisides

‘addressed three emails’ to

Tavakoli’s solicitors; one email

‘threatened (Dr Tavakoli) that the

information, previously threatened,

would be passed to A Current Affair

or Today Tonight’.

As a result interlocutory injunctions

were issued from the Court on 11

August and were ‘served, personally,

on Mark Imisides on that day and by

email’ on both he and his wife.

Nevertheless on 1 or 2 September,

Cynthia Imisides ‘published the

first Google review’ of which Dr

Tavakoli ‘became aware on 2

September. He attests to the fact

that he was extremely distressed and

embarrassed when he read it and by

its publication.’

On 7 September Andrew Murphy

(software developer and Dr Tavakoli’s

webmaster) conducted a review of

data, concerning Dr Tavakoli’s local

business listing on Google and ‘since

the posting of the first Google review,

the rate of visitors to (Dr Tavakoli’s)

website had dropped by 23.61% in

less than one week’.

Meanwhile Dr Tavakoli’s solicitors

‘sent emails to the defendants

throughout September, informing

them of Court orders’. Cynthia

Imisides left the review up for three

weeks, refused to apologise, and

‘threw out court documents’ served

upon her.

Eventually on 24 September,

Mark Imisides ‘was served personally

with the Statement of Claim and

other documents and, on the same

date, the first Google review was

finally removed’.

However on 26 November 2018

(a week before a trial was due to

begin) Cynthia Imisides published a



second Google review ‘on its face,

contravening the orders of the Court’.

On the same day, Dr Tavakoli’s

lawyers wrote to her ‘putting her

on notice of her contempt and

requesting that the second Google

review be removed’.

To that notice, Cynthia Imisides

‘responded in the following terms:

Piss off. I don’t have any money to

give you greedy people.’

Justice Rothman summed up:

‘Plainly, the publication is defamatory

of the plaintiff and goes to his

reputation as a surgeon. Further, as

earlier indicated, it has affected the

number of enquiries made of his

professional website.’

The judge also noted that the ‘tort

of injurious falsehood is the malicious

publication of a false statement that

causes damage to the plaintiff’ and

‘generally, it requires the Court to find

that there has been:

1. a false statement of or concerning

the plaintiff’s goods or business;

2. publication of that statement by

the defendant to a third person;

3. malice on the part of the

defendant; and

4. proof by the plaintiff of actual

damage (which may include a

general loss of business) suffered

as a result of the statement.’

The judge emphasised that

Cynthia Imisides ‘knew the statement

in the first Google review was untrue

. . . and she knew that the second

Google review statements were

untrue’. Further, those statements

‘were made for a purpose to harm

the plaintiff and the publication was

actuated by that purpose. Malice has

been disclosed.’

In assessing damages, Justice

Rothman noted the ‘significant

decline’ in the rate of visitors to

the plaintiff’s website – ‘this had

dropped by 23.61% by 7 September

2017’ – and added: ‘On the basis

of the statistical and/or commonsense

proposition that patients

are obtained, at least in part, from

persons who gain access to the

website of the plaintiff, it can be

inferred that there is actual damage

to the plaintiff’s business, if not

immediately, then, if the reviews are

not withdrawn and/or prevented from

further publication, into the future.’

And the judge added that, in this

case, Cynthia Imisides – and ‘to a

lesser extent’ Mark Imisides – ‘has

disclosed a willingness to defy

orders of the Court and, without

seeking to defend the publication,

re-publish in or to the same effect

as the earlier publication’. He also

noted ‘the circumstances of this

case, particularly the repeated

publication of imputations and

the threats to continue to repeat

defamatory imputations’.

In assessing aggravated damages,

the judge added ‘the harm suffered

by the plaintiff is, in this case, the

hurt to his feelings and the damage

to his reputation, including business

reputation. . . . . Where, as here, the

damage to the plaintiff is, in part, to

his business reputation on which

he depends for his whole life, the

damage is significant. Dr Tavakoli’s

whole life depends upon his honesty

and his competence as a surgeon.

The Court should place a high value

upon damage to his reputation in

each of those respects.’

The judge added that ‘the

evidence before the Court is that the

plaintiff had an exemplary reputation,

amongst his patients, within his

social circle and in the profession.

The evidence of John Flood, a

Plastic Surgeon, who has known the

plaintiff for many years, attests to the

plaintiff’s reputation of being caring,

kind and compassionate; and a

skilled surgeon.’

And the judge emphasised:

‘The allegations contained in

the publication are extremely

serious and go to the heart of the

reputation of the plaintiff in his

profession.’ Nevertheless Cynthia

Imisides ‘published the material in

order to punish the plaintiff. She

did so in circumstances where

she knew, at the time of the

publication, that the imputations in

the publication were untrue.

‘Further, during the ensuing period,

notwithstanding an appropriate and

proper approach by the plaintiff

through his solicitors’, she ‘has

refused to apologise; refused to

withdraw the imputations or, at least

initially, withdraw the publication from

the Internet; then, once the initial

publication was withdrawn, sought to

publish another set of imputations in

or to the same effect.’

Justice Rothman ruled: ‘The Court

is satisfied that the defamatory

material, and the conduct of (Cynthia

Imisides) are such as to warrant an

award of aggravated damages. . . .

In all the circumstances, the Court

assesses the damage at $530,000.’

He also noted Imisides ‘has

completely ignored the proceedings

and, by doing so, added significantly

to the costs of proving the plaintiff’s

case and effecting and proving

service’ and subsequently ‘ignored

orders of the Court, of which she

was aware, thereby necessitating

further costs’.

Hence in addition to the $530,000

damages, the judge ordered

Imisides to ‘pay the plaintiff’s costs’,

plus ‘interest at 4% per annum on

$530,000 from 1 September 2017

until the date of judgment’ plus

‘interest on the costs’. AMP


Spectra XTTM

Brilliant Versatility —

Industry Leading



• High power (1600mj), 4 Wavelengths, Large Spot (8mm)

• Multiple Pulse Durations (5ns & Spectra mode)

• Proprietary Hollywood Laser Peel Mode


• First FDA Cleared Q-Switched Device for Melasma

• Clinically Proven Worldwide

• Uniform Beam Profile


• Auto-sensing Handpiece & Spot-size Parameters

• User-programmable Parameters

• Smooth Function Arm Reduces Operator Strain


• Auto-calibration and self restoring

• Workhorse — Robust and Durable


• Melasma

• Nevi

• Pigmented Lesions

• Vascular Lesions

• Telangiectasias

• Wrinkles

• Acne scars

• Multi-color Tattoo


• Skin Resurfacing

• Hollywood Laser Peel®





Courtesy of J. Shieh, MD

Courtesy of Matthew Werner, MD, USA


Advanced Cosmeceuticals Medical

1800 242 011 |

NSW Govt

Response To




The NSW Government has

formally responded to

the 16 recommendations

contained in the report

of the NSW Parliamentary

Health Care Complaints

Committee Inquiry into

‘Cosmetic health service

complaints in NSW’.



In February 2018 the

Parliamentary Committee of the

NSW Health Care Complaints

Commission (HCCC) resolved to

conduct an Inquiry into cosmetic

health service complaints in NSW

‘in response to concerns raised by

the Minister for Health, the HCCC,

the media and the community’ to

investigate whether ‘the HCCC

and other Government regulatory

frameworks could improve

outcomes for the public who use

cosmetic health services’.

The Committee received 25

formal submissions and held two

days of public hearings in August

2018, before delivering its Report

– including 16 Recommendations

– in November 2018.

The NSW Government tabled

its formal response to those 16

Recommendations in June 2019

(see accompanying box) including

details surrounding three particularly

controversial issues:

• Title ‘Cosmetic Surgeon’:

whether the use of the title

‘cosmetic surgeon’ should

be restricted – the COAG

Health Council ‘will be considering

any needed legislative action’

arising out of a consultation

paper on this subject in the

second half of 2019, and

‘depending on the outcome

of the COAG Health Council

processes, the Minister for

Health and Medical Research

will consider whether any

changes should be made to

NSW specific legislation’.

• IPL and Laser Devices: in

respect of the regulation of the

use of IPL devices and laser

devices for cosmetic and beauty

services, in NSW the regulation

of radiation (which would include

IPL) ‘is generally administered

by environmental authorities’

and in December 2018 the

Australian Health Ministers’

Advisory Council ‘agreed to refer

the issue of the regulation of IPL

and laser devices to the Australian

Radiation Protection and Nuclear

Safety Agency’.

• Non-Registered Practitioners:

the NSW Ministry of Health and

NSW Fair Trading ‘will consider

whether cosmetic health services

provided by non-registered health

practitioners should be subject to

a ‘cooling off’ period’.

Terms Of Reference

The Inquiry’s ‘Terms of Reference’


That the Committee on the Health

Care Complaints Commission

inquire into and report on the

regulatory framework for complaints

concerning cosmetic health service

providers in NSW, with particular

reference to:

• The roles and responsibilities

of the HCCC relative to the

roles and responsibilities of

Commonwealth and other state

regulatory agencies;

• The adequacy of the powers and

functions of the HCCC to improve

outcomes for the public in the

cosmetic health services sector;

• The opportunities for collaboration

with other agencies, organisations

and levels of Government to

improve outcomes for the public

in the cosmetic health services

sector; and

• Any other related matters.



Submissions &


The Committee received 25 formal

submissions, which were published

on the NSW Parliament website



Subsequently the Committee

held two days of public hearings in

August 2018, where representatives

of 18 groups gave formal evidence:

Australian Society of Plastic

Surgeons, Australasian Society

of Aesthetic Plastic Surgeons,

Royal Australasian College of

Surgeons, Australasian College of

Dermatologists, Australian Medical

Association, Australian Lawyers

Alliance, Law Society of NSW,

Australian College of Nursing,

Trusted Surgeons, Cosmetic

Physicians College of Australasia,

Australasian College of Cosmetic

Surgery, Nursing and Midwifery

Council of NSW, Medical Council of

NSW, Australian Health Practitioner

Regulatory Agency, Australian

Department of Health, NSW Health,

NSW Fair Trading, NSW Health Care

Complaints Commission.

Final Report &


The Committee tabled its

final Report, including 16

formal Recommendations,

in November 2018.

Committee Chair Adam

Crouch summed up: ‘The Inquiry

considered whether the HCCC

and other government regulatory

frameworks could improve

outcomes for the public who use

cosmetic health services.

‘The Inquiry was also a response

to a growing public concern with

regards to this industry.’

Crouch noted the key findings

included Committee gaining an

understanding that ‘the regulatory

environment relating to cosmetic

health services is incredibly

complex, but also dynamic.

There are a number of state

and commonwealth laws and

organisations with regulatory and

complaint-handling functions, but

there is no set definition of cosmetic

health service – so both registered

and unregistered practitioners work

in this area.’

He said the Committee ‘was also

very concerned to hear that there

were many instances of underreporting

of complaints about

cosmetic health services for various

reasons. We know this is a growth

industry and there are concerns

about the ‘corporate model’ of

practice versus the traditional model

of patient-centred care.’

Crouch said the Committee

was particularly concerned about

‘instances of profits being put before

patients by some providers’.

He said the Committee also

found ‘collaboration between

the HCCC and other state and

commonwealth organisations is

important to inform and protect the

public’ and equally important that

‘this collaboration continues in the

strongest possible way.’

Crouch added that while the

Committee ‘mostly received

evidence from and about registered

practitioners’, it considered

the ‘regulation of unregistered

practitioners could be the subject of

a separate Inquiry’.



In highlighting what he described

as the major recommendations,

Committee Chair Adam Crouch

commented: ‘The Committee

recommended a review of the

HCCC’s powers and functions

to ensure that the HCCC is able

to protect patients using health

services, and assist in resolving

their concerns.’

Of particular focus, he highlighted

that the Committee recommended

‘the title ‘cosmetic surgeon’ be

restricted or protected nationally,

or at the very least in NSW, so

doctors using this title meet certain

minimum criteria in terms of

education, training and experience.

Crouch explained the Committee

‘heard that at present a range of

doctors may use this title – from

GPs to plastic surgeons – and this

can potentially mislead the public’.

Crouch added the Committee

also heard that the public ‘needs

to be better informed about

cosmetic health services

procedures and practitioners, and

the complaints process itself. The

Committee has recommended a

public awareness campaign and

a ‘one-shop-stop’ website and

advice service to ensure the main

demographics using these services

are very well informed.’



In summing up the Committee’s

‘anticipated outcomes’,

Crouch said it hoped the

recommendations ‘will ensure the

HCCC’s powers and functions

are robust enough to adequately

address the complexities

associated with the cosmetic

health services industry and assist

patients in resolving their concerns.

In addition, the Committee

sought ‘a stronger legislative and

regulatory framework to better

protect the public from potential

harm and, of course, a public that

is better informed about the risks

of cosmetic procedures, the types

of practitioners performing them

and ‘where and how’ to make a

complaint if they are dissatisfied.’

Crouch concluded his summary:

‘The one thing that’s come out

of this Inquiry is the fact that

the HCCC is there to help the

public.’ AMP



Cosmetic Health Services Complaints in NSW – Final report



Reforming the HCCC’s powers

Recommendation 1

The Committee recommends that the Minister for Health reviews the

powers and functions of the Health Care Complaints Commission to

ensure the Commission is able to sufficiently protect patients using

health services. In particular, the Committee recommends the

Commission should have the powers:

a) to issue public warnings about specific health service providers and

health organisations;

b) to issue prohibition orders in relation to specific health

organisations; and

c) for search and entry to apply to all complaints and allow authorised

persons to enter if the premises is a public place and the entry is

made when the place is open to the public.

Supported in principle

The Government supports the Health Care Complaints Commission

(HCCC) having the legislative tools to enable it to properly investigate

complaints and take appropriate action to protect the public. The

Ministry of Health has begun consultation with the HCCC to determine

whether any changes to the Health Care Complaints Act, or other

legislation, are required to enable the HCCC to effectively exercise

its functions.

Titles of medical practitioners

Recommendation 2

The Committee recommends that the Minister for Health continues to

make representations to the COAG Health Council to protect or otherwise

restrict the title ‘cosmetic surgeon’ at a national level under the Health

Practitioner Regulation National Law.

Supported in principle

The COAG Health Council released a consultation paper on the future of

the regulation of health practitioners earlier in 2018. The paper, among

other matters, sought submissions on whether the use of the titles

‘cosmetic surgeon’ should be restricted. It is expected that the COAG

Health Council will be considering any needed legislative action arising

out of the consultation paper in the second half of 2019.

Recommendation 3

The Committee recommends that, if the COAG Health Council does

not protect or otherwise restrict the title ‘cosmetic surgeon’ within a

reasonable timeframe, the Minister for Health considers whether

separate legislation should be introduced in the NSW Parliament to

place restrictions on the use of the title ‘cosmetic surgeon’ in relation

to doctors practising in New South Wales.

Supported in principle

Depending on the outcome of the COAG Health Council processes,

the Minister for Health and Medical Research will consider whether

any changes should be made to NSW specific legislation.

Recommendation 4

The Committee recommends that the Minister for Health considers

whether it is in the public interest to support protections and restrictions

on the use of the title ‘surgeon’ either at a national level or for doctors

practising in New South Wales.

Supported in principle

The COAG Health Council consultation paper also sought submissions

on whether the use of the titles and “surgeon” should be restricted.

It is expected that the COAG Health Council will be considering any

needed legislative action arising out of the consultation paper in the

second half of 2019.

Informing the public

Recommendation 5

The Committee recommends that the Minister for Health and the

Minister for Innovation and Better Regulation develop a targeted public

education campaign to raise awareness about cosmetic health services,

the risks involved in procedures and where to get relevant information.


NSW Fair Trading, in consultation with the Ministry of Health and the

HCCC, has already developed tools and educational materials to assist

consumers of cosmetic and beauty services.



Final report – continued


Recommendation 6

The Committee recommends that the public awareness campaign use

various forms of advertising, media (especially social media) and other

resources to target the main demographics seeking cosmetic health

services in terms of age, gender and cultural background.



NSW Fair Trading, in consultation with the Ministry of Health and the

HCCC, has already developed tools and educational materials to assist

consumers of cosmetic and beauty services.

Recommendation 7

The Committee recommends that the Minister for Health pursues with

the COAG Health Council the establishment of a national one-stop shop

website and advice service relating to cosmetic health services to:

a) provide relevant information about procedures, practitioners and facilities

to individuals seeking these services, and

b) direct individuals who are dissatisfied with a service or provider to

appropriate complaint pathways including, for New South Wales, the Health

Care Complaints Commission, NSW Fair Trading and NSW Health.

Supported in principle

The Government supports consumers being properly informed of the risks

of cosmetic health procedures prior to undertaking such procedures.

The Government does not support a national one-stop shop at this time.

However, the Ministry of Health and NSW Fair Trading will continue to work

together to consider how best to ensure that consumers can be properly

informed of the risks of cosmetic and beauty services. The Ministry will

also consult with the Australian Health Practitioner Regulation Agency,

which is responsible for the regulation of registered health practitioners

nationally, about these matters.

Recommendation 8

The Committee recommends that, if the COAG Health Council does

not agree to establishing a one-stop-shop website and advice service

for cosmetic health services, the Minister for Health looks at the NSW

Government establishing the service.

Supported in principle

While the Government does not support a national one-stop shop at this

time, the Ministry of Health and NSW Fair Trading will continue to work

together to consider how best to ensure that consumers can be properly

informed of the risks of cosmetic and beauty services.

Recommendation 9

The Committee recommends that NSW Health research behaviours of,

and influences on, consumers seeking cosmetic health services to inform

future policy, regulation and education programs in this area. The Minister

for Health could recommend to the COAG Health Council that it consider

this as a priority for research funded through the National Health and

Medical Research Council (NHMRC).

Supported in principle

In relation to undertaking research into the behaviours of, and influences

on consumers seeking cosmetic health services, this is an area best

considered nationally as consumers pursue treatment and services

interstate and overseas. As such, the Ministry of Health will work with

the Commonwealth and other jurisdictions regarding the prioritisation of

research in this area.

Protecting the public

Recommendation 10

The Committee recommends that the Minister for Health pursues

the issue of national regulation of the use of intense pulsed light

devices and laser devices for cosmetic health service procedures

with the COAG Health Council.

Supported in principle

In respect of the regulation of the use of IPL devices and laser devices for

cosmetic and beauty services, in NSW the regulation of radiation (which

would include IPL) is generally administered by environmental authorities.

In December 2018 the Australian Health Ministers’ Advisory Council agreed

to refer the issue of the regulation of IPL and laser devices to the Australian

Radiation Protection and Nuclear Safety Agency.

Recommendation 11

The Committee recommends that the Minister for Health examines

whether legislation should be introduced in New South Wales to regulate

the use of intense pulsed light devices and laser devices used for

cosmetic health services.

Supported in principle

The issue of the regulation of IPL and laser devices has been referred

to the Australian Radiation Protection and Nuclear Safety Agency.



Final report – continued


Recommendation 12

The Committee recommends that the Minister for Health and the Minister

for Innovation and Better Regulation consider whether individuals providing

cosmetic health services, and employees of those persons, should be

required to disclose any commissions, incentives or other payments they

receive for encouraging patients to agree to procedures, more of the same

procedure or additional procedures.


Supported in principle

In respect of incentives and commissions, the Better Business Reforms

package passed NSW Parliament on 24 October 2018. These reforms

include a general requirement for traders to disclose the existence of

financial incentives for providing or referring goods or services. The new

laws will require traders to take reasonable steps to ensure the consumer

is aware of the existence of these fees and commissions before the

consumer engages with the trader. While not specifically aimed at cosmetic

health service providers, the Minister for Health and Medical Research

and Minister for Better Regulation and Innovation will consider this

recommendation in implementing the Better Business Reform package.

Recommendation 13

The Committee recommends that the Minister for Health raises with

the COAG Health Council the issue of whether patients seeking invasive

cosmetic surgery be required to consult their General Practitioner and

pursue national consultation on this issue.

Supported in principle

In considering how best to ensure that consumers can be properly

informed of the risks, the Ministry of Health will consider how to

ensure patients and consumers receive appropriate advice from

general practitioners, or other relevant professionals, prior to receiving

a cosmetic health service.

Recommendation 14

The Committee recommends that, as part of the New South Wales

public education campaign about cosmetic health services, the Minister

for Health encourages patients considering invasive cosmetic surgery to

seek advice from a General Practitioner.

Supported in principle

The Ministry of Health and NSW Fair Trading will consider the Medical

Board of Australia’s Guidelines for registered medical practitioners who

perform cosmetic medical and surgical procedures to determine if they

remain suitable or whether the Medical Board of Australia should be

asked to review the guidelines.

Recommendation 15

The Committee recommends that the Minister for Health and the

Minster for Innovation and Better Regulation review whether the cooling

off periods provided for in the Medical Board of Australia’s Guidelines

for registered medical practitioners who perform cosmetic medical and

surgical procedures, 1 October 2016, are sufficient to protect consumers

in New South Wales.The Ministers should also consider whether it would

be appropriate to require and regulate cooling off periods for some

cosmetic health services provided by non-registered practitioners.

Supported in principle

The Ministry of Health and NSW Fair Trading will consider whether

cosmetic health services provided by non-registered health practitioners

should be subject to a cooling off period.

Recommendation 16

The Committee recommends that the Minister for Health considers

the feasibility of collecting data on revision surgery in the public health

system, to correct cosmetic health procedures, to inform future policy

and decision-making in this area.

Supported in principle

In relation to the collection of data on revision surgery in the public

system to correct cosmetic health procedures, the Ministry of Health will

investigate whether this information can be accurately captured

and reported to inform policy.








Make More


Pulchronomics is the study of the financial and career

advantages of ‘looking good’ – and the researchers agree

those advantages are significant.

As human resources

professionals around the

globe continually research

the latest competitive advantages,

increasingly entering the zeitgeist

– the defining spirit or mood of a

particular period of history as shown

by the ideas and beliefs of the time

– is ‘pulchronomics’: the economic

study of beauty (pulchritude) from the

Latin for beauty pulchritudito.

In the US, when the Huffington Post

asked its readers ‘To what extent do

good looks matter in the workplace?’

and ‘What physical characteristics are

most rewarded?’ the bible of trendy

topics declared bluntly: ‘You might be

amazed by the answers.’

Among a wide series of examples,

author Martha Laham noted:

• Research by prominent labour

economist Daniel Hamermesh (see

accompanying box ‘Why Attractive

People Are More Successful’)

showed attractive workers, during

their lifetime, earn US$230,000

more than those with average

looks (based on an average wage

of US$20 per hour) and for men

that figure rises to US$250,000

– explained by evidence showing

attractive workers attract more

business (so it makes good sense

to hire them).

• Another study reported people

rated ‘low’ in physical attractiveness

earned 5-10% less than ‘averagelooking’

people, who in turn earned

3-8% less than ‘good-looking’’

people, according to

• Similarly on the sporting field,

‘homely NFL quarterbacks earn less

than their comelier counterparts,

despite identical yards passed and

years in the league’ according to

The Economist.



Beauty Path To


– Via Money

When Time Magazine examined Daniel

Hamermesh’s landmark research into

‘pulchronomics’ it began with the

headline: ‘Why are Beautiful People

Happier? Mainly Because Good Looks

Help Them Get Rich’.

The magazine summed up:

‘Beauty is the path to happiness –

by way of money.’

The report noted: ‘A new series of

studies shows that attractive people

earn more money and marry betterlooking

spouses, and that the economic

benefits of being good looking make

them happier than their homely


Time reported researchers found

‘a big reason’ why beautiful people

are happier ‘is that they have more

money’ and quoted Hamermesh telling

USA Today: ‘Personal beauty raises

happiness. The majority of beauty’s

affect on happiness works through its

impact on economic outcomes.’

Why Attractive People Are More Successful

The term ‘pulchronomics’ was initially

popularised by the University of Texas

labour economist Daniel Hamermesh,

who spent a career studying the

economics of physical attractiveness

and how it affected employability and

earning potential.

In his landmark book ‘Beauty Pays:

Why Attractive People Are More

Successful’ Hamermesh described

numerous empirical studies to

demonstrate that physically attractive

people enjoy advantages over

average-looking people in terms of

both employment and earnings.

Extrapolating from data collected as

far back as the 1970s, and factoring

in 12 other categories (education,

age, race, marital status, etc) he

summarised that below-averagelooking

males earned 17% less than

those considered good-looking,

while below-average-looking females

earned 12% less than their attractive


In assessing the relationship

between beauty, self-esteem

and earning power, Hamermesh

considered the question: ‘Do good

looks make people more confident

and thus more desirable, boosting their

wages?’ He noted a Canadian study

showed a correlation between looks

and self-esteem.

Among numerous individual

studies across many levels of society,

Hamermesh included:

• A study of over 400 Canadian

economics professors where

students rated them with ‘hotness’

chili peppers signifying physical

attractiveness on ratemyprofessors.

com – and those considered

‘hot’ earned at least 6% more

than their otherwise identical


• A US study found NFL quarterbacks

with good-looking facial features

earned 12% more than their

less attractive but equally skilled


• A British study of a Dutch TV game

show found unattractive team

members were consistently voted

off, even though they were just as

good at answering questions.

In summary Hamermesh concluded

beautiful people not only earn more

income than unattractive people, but

society significantly favours them.

Specifically, better-looking people

are more likely to become employed,

receive substantially higher pay,

negotiate better loans, and attract

beautiful and better educated spouses.



Looks Affect Your Work,

Career, Life

Similarly a Newsweek Magazine

analysis of ‘The Beauty Advantage’

examined ‘how looks affect your

work, your career, your life’.

The detailed investigation

concluded that, in western society

we have reached the stage were ‘it’s

no secret we are a culture consumed

by image. Economists have long

recognised what’s been dubbed

the ‘beauty premium’ – the idea

that pretty people, whatever their

aspirations, tend to do better in, well,

almost everything’.

It noted research studies


• handsome men earned, on

average, 5% more than less

attractive counterparts and goodlooking

women earned 4 % more;

• pretty people get more attention

from teachers, bosses and mentors;

• even babies stare longer at goodlooking

faces (and we stare longer

at good-looking babies).

The magazine commented bluntly:

‘A couple of decades ago – when it

was a makeup-less Kate Moss, not a

plastic-surgery-plumped Paris Hilton,

who was considered the beauty ideal

– we might have brushed off those

statistics as superficial.’

But since 2010, when ‘Heidi

Montag’s bloated lips plastered every

magazine in town, when little girls

lust after an airbrushed, unattainable

body ideal, there’s a growing bundle

of research to show that our bias

against the unattractive (a book by

Stanford University law professor

Deborah Rhode brands it our ‘Beauty

Bias – see accompanying box

‘Discrimination On The Basis

of Looks’) is more pervasive than

ever. And when it comes to the

workplace, it’s looks, not merit, that

all too often rule.’

As a result, 13% of women

according to the American Society

of Plastic Surgeons and 10% of men

according to a Newsweek survey,

said ‘they’d consider cosmetic

surgery if it made them more

competitive at work’.

The magazine added that ‘in the

current economy, when employers

have more hiring options than ever,

looks, it seems, aren’t just important;

they’re critical.’

To that end, Newsweek surveyed

202 corporate hiring managers,

from human resources staff to

senior-level vice presidents, as well

as a thousand members of the

public ‘only to confirm what no

qualified (or unqualified) employee

wants to admit: from hiring to office

politics to promotions, looking good

is no longer something we can

dismiss as frivolous or vain’.

Among hiring managers, 57% said

qualified but unattractive candidates

‘are likely to have a harder time

landing a job’, while more than half

advised ‘spending as much time and

money on making sure they look

attractive as on perfecting a resume’.

And ‘when it comes to women,

flaunting your assets works: 61% of

managers (the majority of them men)

said it would be an advantage for a

woman to wear clothing showing off

her figure at work’.

Asked to rank employee attributes

in order of importance, managers

placed ‘looks’ above ‘education’

– indeed among nine character

traits, ‘looks’ came third (after only

‘experience’ and ‘confidence’) and

above where a candidate went to


One female New York recruiter

commented: ‘This is the new reality

of the job market. It’s better to be

average and good-looking, than

brilliant and unattractive.’

Beauty Has ‘More

influence Than Ever’

Newsweek concluded that ‘a

confluence of cultural forces has left

us clutching, desperately, to an everevolving

beauty ideal.

‘Today’s young workers were

reared on the kind of reality TV and

pop culture that screams, again and

The ‘Prettiness


There are times when ‘being too

attractive could work against

you in the workplace,’ reported

the Huffington Post.

Noting the role of ‘a gender

divide’, the publication said that

while ‘very good-looking men

invariably make out in salary and

hiring’, a study in ScienceDaily

showed that ‘highly attractive

women face hiring discrimination

when applying for maledominated


Elsewhere researchers in

a Rice University study found

higher expectations tend to

be set for beautiful people and,

if they fail to meet expectations,

they are ostracised in the


However a Smithsonian

Magazine report noted the

reverse is true of less attractive

people – because less is

expected of them, if they exceed

expectations they’re rewarded.


Easy &



Fast and Easy Applicator Exchange

With a simple press-and-release mechanism, the CLATUU Alpha

allows maximum convenience and makes switching cooling

cups as simple as possible. Detaching cables or turning

the system off is not required even during treatments.

1300 346 448 |


Are Height, Weight, Hair

Colour Important?

Numerous studies over the past decade have

attempted to quantify the financial influence of

key appearance factors such as height, weight

and hair colour.

On height, the Huffington Post summed up

bluntly: ‘If you’re tall, chances are that you

could be getting paid more than your shorter

cohorts.’ One study revealed every inch of

height equaled a salary increase of about

US$789 per year. Based on this figure ‘a 6-foot

tall (182.88cm) person earns US$5,525 more

annually, compared to a person who stands at

5 feet 6 inches (167.64cm)’.

On weight, US law Professor Deborah Rhode

(who has extensively studied appearancebased

discrimination in the workplace) said

about 60% of overweight women and 40%

of overweight men claim they’ve experienced

employment discrimination.

And Forbes magazine reported research

showing heavy women earn US$8,666 less

annually, and heavy men US$4,772 less

annually, than their trimmer colleagues.

The Huffington Post also reported a study

where participants were shown resumes and

photographs of a group of job applicants,

and then asked to ‘score the applicants on

the basis of their job suitability, starting salary

and employability’.

But the participants were not told the

photos were of the same person before

and after bariatric weight loss surgery. To a

‘significant degree, the thinner candidates

were selected for the job and assigned higher

starting salaries’.

On hair colour, Forbes magazine reported a

study which found blondes get paid 7% more

than female workers wearing another hair

colour – and the ‘boost in pay is equal to the

pay bump that a worker would realise from an

extra year of education’.

On general fitness, Time magazine reported

a study which found workers who exercise

routinely earn 9% more than their sedentary

peers. And workers who exercise three or

more times a week ‘can beef up their weekly

pay by US$80, compared to their deskbound’

colleagues. Even weekend warriors made

slightly more than 5% in additional pay.

workers who exercise three

or more times a week ‘can

beef up their weekly pay by

US$80, compared to their

deskbound’ colleagues.



again, that everything is a candidate

for upgrade.

‘We’ve watched bodies transformed

on Extreme Makeover, faces taken

apart and pieced back together on I

Want A Famous Face. We compare

ourselves with the airbrushed images

in advertisements and magazines,

and read surveys that confirm our

worst fears.

‘We are a culture more sexualised

than ever with technology that’s

made it easier than ever to ‘better’

ourselves, warping our standards for

what’s normal. Where that leads us

is ‘running-to-stand-still’: taught that

good looks are no longer a gift but a

ceaseless pursuit.’

Harvard University psychologist

Nancy Etcoff commented: ‘All of this

is happening against a backdrop of

more women in the workplace, in all

kinds of jobs, striving toward wage

equality. So we’re surprised – but we

shouldn’t be – how this beauty curse

continues to haunt us.’

Finally to add an extra layer of

complexity, there’s the conundrum

of ageing in a culture where

younger workers are more tech-savvy,

cheaper and ‘nicer on the eyes’.

In the Newsweek survey, 84% of

managers said a qualified but

visibly older candidate ‘would

make some employers hesitate’

– particularly for women.

Newsweek author Jessica Bennett

summed up: ‘The quest for beauty

may be a centuries-old obsession, but

in the present day the reality is ugly.

Beauty has more influence than ever

– not just over who we work with, but

whether we work at all.’

7 Ways Looks Affect

Your Wealth

In an overview of pulchronomics

for, Danielle Kurtzleben

assessed ‘seven ways your looks

affect your economic well-being’.

She summed up: ‘Being pretty

already has all sorts of benefits, but

it’s not just the joy of having gorgeous

cheekbones or finding super-attractive

people to mate with. Having it going

on also means a fatter bank account

and better career prospects.’

Beginning with ‘Bigger Lifetime

Earnings’, Kurtzleben notes both

Daniel Hamermesh’s research

(above) as well as another study from

the University of Wisconsin which

confirmed ‘strong correlation between

looks and earning among men’.

However she also reports other

research from the University of

Miami which ‘suggests grooming

and personality account for some of

the beauty premium, not just facial


Under the heading ‘Better

Performance In The Corner office’,

Kurtzleben reported an attractive CEO

‘makes a company a more attractive

investment’ citing as confirmation

a study on ‘beauty and earnings’

complied by The Atlantic Magazine.

In addition, research from the

University of Wisconsin found CEOs

‘with more attractive faces tended to

have better stock market performance

in their first days on the job and also

after merger and acquisitions’. Not

only that, but those CEOs’ company

stocks performed better after the

CEOs appeared on TV, ‘an effect that

did not repeat when the CEOs’ quotes

appeared in newspapers, further

convincing researchers that the effect

was due to looks’.

Under the heading ‘A ‘Meh’

Attitude Toward Inequality’,

Kurtzleben reported a study

which found people who consider

themselves more attractive ‘also

tend to both think inequality is less

of a problem and care less about

remedying it’. Instead, people who

think they are prettier ‘tend to believe

more in the idea that people can pull

themselves up by their bootstraps

and less in the idea that some groups,

like women and minorities, are

systematically paid less’.

Under the heading ‘A Lower

Likelihood Of Being Behind Bars’,

Kurtzleben reported that ‘the prettier

the person, the less likely they are to

resort to a life of crime’. She noted

a study which examined pre-labour

market (high school) looks and found

people who were more attractive in

their youth ‘were less likely to commit

all sorts of crimes several years after

high school’.

Under the heading ‘A Premium For

Skinny People’, Kurtzleben reported

that several studies have shown

obesity hurts people’s earnings,

particularly women’s earnings.

However she noted ‘it may not

just be obesity that hurts; even

having a few extra pounds can be

bad for women, and particularly

white women’. One study found that

earnings ‘fall off as women’s body

mass indexes go beyond 23 – which

falls within a normal weight range’. For

men, it was higher, at around 27.



Discrimination On The

Basis Of Looks

In her provocative book ‘The Beauty Bias’,

Stanford University law Professor Deborah

Rhode lays out the case for an America in which

appearance discrimination is no longer allowed.

Instead Rhode ‘proposes a legal regime

in which discrimination on the basis of looks

is as serious as discrimination based on

gender or race’.

Newsweek Magazine commented

that means:

• Hooters (topless waitress restaurants)

‘can’t fire its servers for being too heavy’,

as allegedly happened to a waitress in

Michigan who said she received nothing

but excellent reviews but weighed 132

pounds (59.87kg); and

• Abercrombie & Fitch couldn’t hold alleged

weekly meetings ‘at which photos of its

sales associates were reviewed and purged

for any sign of breakouts, weight gain or

unacceptable quantities of ethnicity’.

CEO ‘Pulchronomics’ and Appearance


Given the importance of

Chief Executive Officers in

wealth creation and corporate

profitability, one US study

assessed CEO pulchronomics

by examining:

• firstly ‘whether a beauty

premium exists in CEO

compensation’; and

• then ‘whether CEO

pulchritude has any effect on


The study, by researchers

from both Rutgers State

University of New Jersey and the

University of Cincinnati, identified

three CEO tasks (accounting,

operations, and corporate social

responsibility) which require

‘a true skill uncorrelated with

physical attractiveness’.

And they measured CEO

pulchritude ‘via the AnaFace

facial beauty analysis, which

uses facial symmetry, facial

structure and the golden ratio

to calculate a person’s beauty’

– noting this symmetry-based

methodology ‘is well supported

by research in evolutionary

biology and computer science’.

The researchers found

attractive CEOs earn higher

salaries (but not incentives) than

unattractive CEOs.

Nevertheless CEO pulchritude

‘bears no effect on firms’

accounting, operating and social


They concluded that since

the CEO beauty premium ‘is

not supported by the superior

productivity of those attractive

CEOs, we provide evidence that

appearance discrimination in

CEO compensation may not

be justified’.

Rhode argues that in America discrimination

against unattractive women and short men ‘is

as pernicious and widespread as bias based on

race, sex, age, ethnicity, religion and disability’.

She cites research finding:

• 11% of surveyed couples said they would

‘abort a foetus pre-disposed toward obesity’;

• college students telling a survey they’d rather

have a spouse who is an embezzler, drug

user or shoplifter that one who is obese;

• the less attractive you are in America, the

more likely you are to receive a longer prison

sentence, a lower damages award, a lower

salary, a poorer performance review, less likely

to be married and more likely to be poor.

On the political stage, Rhode reminded

Newsweek readers how Hillary Clinton and

Sonia Sotomayor were savaged by the media

for their looks, and said it’s ‘no surprise that

Sarah Palin paid her makeup artist more than

any member of her staff’ in her run for the US

Vice Presidency.

As Newsweek itself commented: ‘You can’t

succeed in public life if you look old in America’

– noting that (at that time) ‘of the 16 women in

the US Senate between ages 46 and 74, not

one has grey hair.’ AMP




from the


Beauty ‘Winning Weapon’ In Boardroom

In August this year, the London

Daily Telegraph ran headlines noting

‘a retired head teacher at one of

Britain’s most go-getting girls’

schools has stirred up a hornets’

nest by suggesting that beauty is a

winning weapon in the boardroom’.

Clarissa Farr, high mistress of

St Paul’s Girls’ School until 2017,

suggested ‘good looks can give

female bosses an authority they

might otherwise be considered

to lack’.

Farr asserted: ‘There are certain

women whose personal beauty

makes their leadership acceptable

who wouldn’t be able to hold the

sway they do if they didn’t look the

way they do.’

As examples, she cited

Facebook’s Sheryl Sandberg and

British financier Helena Morrissey

and declared: ‘Unfortunately, beauty

is part of successful leadership for

women in a way it shouldn’t be.’

The Daily Telegraph also noted the

research of pioneering sociologist

Dr Catherine Hakim, a former

senior research fellow at the London

School of Economics and author of

‘Honey Money: Why Attractiveness

Is The Key To Success’ who

has published extensively on

labour market topics, women’s

employment and sex discrimination.

Hakim argues that, in addition

to the three recognised personal

assets (economic, cultural and

social capital) each individual has a

fourth asset – erotic capital – that

he or she can, and should, use to

advance within society.

Assessing other research the Daily

Telegraph concluded: ‘Certainly,

when it comes to office politics,

studies have traditionally indicated

that the pretty – male and female

– are beneficiaries of a halo effect,

whereby they tend to be hired

sooner, get promoted more rapidly

and earn more than less comely

colleagues, regardless of IQ.’ AMP


beauty is part of


leadership for

women in a

way it

shouldn’t be.




Est Clinic launch

The new SkinCeuticals EST Clinic in

the prestigious Emporium Melbourne

shopping complex, is the first

boutique retail collaboration of its kind.

Showcasing a partnership between Dr Frank

Lin and SkinCeuticals, the boutique clinic

was recently launched to industry leaders

and key media, including editors from

Vogue, Marie Claire and Beauty Crew with

a glittering cocktail soiree.

The guests were engaged in an insightful

panel discussion hosted by Teresa Love

with Dr Frank Lin and special guest, model

and brand advocate, Rebecca Harding,

to reveal the science of achieving radiant,

healthy-looking skin. The luxurious event

was steeped in ambience and provided

the perfect backdrop to reveal further

opportunities for collaboration in a premium

retail space, offering tailored, bespoke

skincare and aesthetic procedures. AMP




TEOXANE Switzerland

announces the

foRMATIon of

TEOXANE Australia

CEO Valérie Taupin

the formation of TEOXANE Australia will further the global expansion of

the TEOXANE SA innovative and high-end filler range for aesthetic medicine.

TEOXANE SA, Swiss laboratories

specialising in hyaluronic

acid (HA) dermal fillers, has

announced the formation of TEOXANE

Australia. After more than four years of

successful partnership with Mondeal,

the Australian-based Distributing

Partner, TEOXANE will now be setting

up its own operations in Australia as

a wholly-owned subsidiary to further

fuel the development of TEOXANE’s

market share in Australia. TEOXANE

Australia is the ninth subsidiary of the

Swiss hyaluronic acid expert, after

France, Germany, UK, Spain, Poland,

Switzerland, Russia and Italy.

Teoxane Australia will be led by

Krishna Sai, Vice President APAC

(a known aesthetic business leader

in APAC) with Richard Arnott on

his management team, responsible

for the commercial operations. The

current Mondeal staff will transition into

Teoxane team to ensure continuity

of customer support in Australia. With

this latest business transition Teoxane

Australia looks forward to continue to

grow the business through world class

Medical Education and with focused

campaigns to help build on the success

of our customers.


TEOXANE Laboratories was established

in Geneva, Switzerland, in 2003

and is specialised in the design and

manufacture of hyaluronic acid-based


company profile

dermal fillers and cosmetic products.

Since its inception in 2003, the

foundation of the company has been

based on integrated research and

development under its founder and

CEO Valérie Taupin.

TEOXANE’s dedication to

innovation and excellence allows a

strong growth platform in the rapidly

changing Aesthetics environment.

While maintaining the status as an

independently-owned company,

TEOXANE has a significant global

presence in over 90 countries

worldwide with over 12 million syringes

injected to date. The pursuit of

excellence, embedded in the DNA of

TEOXANE, is what has been driving

TEOXANE since the beginning in order

to both reach patients’ satisfaction and

earn partners’ trust.



This is the first HA range designed with

strength and stretch capabilities.

To naturally integrate into facial

structures, a HA filler has to be able to

resist pressure and seamlessly follow

facial movements. 1,2

TEOSYAL RHA ® created by

TEOXANE laboratories is the first* range

of Hyaluronic Acid filler with rheological

properties specifically designed to follow

the expression of the face. It contains

a unique and innovative technology

that preserves the natural chains of the

hyaluronic acid molecules 3 to create a

gel of the highest purity and mimics the

natural hyaluronic acid within our skin.

The award-winning filler works in

synchronisation with facial expressions

to provide a natural looking result, whilst

remaining undetectable 8 .

The TEOSYAL RHA ® portfolio of

dermal fillers provides a selection of four

Dr Joseph


of All Saints Clinic in

Double Bay, Sydney, shares

his experience with TEOXANE

1. How long have you been working with TEOXANE?

Since its launch in Australia which was about 4-6 years ago.

I was one of the first doctors in Australia to use it.

2. Why do you enjoy working with the company

so much?

I find the company to be honest and reputable and it has

been around for years. The product is reliable and delivers

the results it promises – and my patients love the results.

The individuals I deal with at TEOXANE are reliable and

trustworthy, which is so important in our industry. The

company also places a big emphasis on teaching, which

is important.

3. What treatments do you use TEOXANE products for?

Why do you love to work with the products so much?

They have a unique product, Redensity II, that works

wonderfully for hollowing and dark circles under the eyes;

it has a brightening and filling effect. It is a signature

product and my patients love these results. In fact, I use the

entire range; it doesn’t just add volume, it mimics human

expression too.

4. How do you find patient satisfaction with the use


Very high! My patients are so happy. The product integrates

well and, after a few weeks, they can’t detect the filler,

but they can see the results. It isn’t a hard filler, it softens

in the skin.

5. How do you find using TEOXANE enhances your


It adds another dimension to what we have to offer, and

is unique. The under eye and RHA products – no other

company yet has these and I’m pleased we can offer this to

our patients.

The views of the doctors reflect their own views and do not

necessarily reflect the views of the company and should not be

treated as product claims


company profile

hyaluronic acid gels that covers all

aesthetic needs from superficial

wrinkles, through to volume in

extended areas for longer lasting

correction of facial wrinkles and folds.

The clinical efficacy and safety

of the products was highlighted in

an 18-month comparative study.

The study looked at the immediate

and long-term efficacy of the gel as

well as patient satisfaction.100%

of patients stated that they saw an

improvement in the severity of their

wrinkles six months after treatment. 4


For the treatment of superficial

wrinkles of the face, such as

the barcode, crow’s feet, neck

and neckline.

Injection depth: Mid-dermis


For the treatment of moderate

wrinkles such as forehead lines as

well as lip beautification.

Injection depth: Mid to deep dermis/

lip mucosa.


For the treatment of deep wrinkles.

Such as nasolabial folds, marionette

lines and to provide dynamic

lip volume.

Injection depth: Deep dermis/

lip mucosa.


For the treatment of lost volume, in

the extended areas of the cheeks.

RHA ® 2, RHA ® 3 and RHA ® 4 are

class III medical devices approved

by the FDA under PMA P170002

on 19th October 2017 – https://www.


Additionally, TEOXANE offers

a complete dermal fillers range

(16 references, with and without

lidocaine) customised for each

indication. Teosyal ® portfolio is divided

into families, gathering products with

similar treated areas and indications:

The Enhancers, The Essentials, The

Volumisers and The Specifics.


This collection of hyaluronic acidbased

dermal fillers is designed

to compensate for skin plumpness

and volume lost during the

ageing process. 4,5


Designed to deliver volume in

dynamic extended areas like the

cheeks and facial contours. 4


Designed to restore volume in areas

like the cheekbones and chin. 5


includes lidocaine. 6

TEOSYAL ® Ultimate

Designed to restore volume in wider

areas like the cheekbones, chin,

jawline and temples. 7


includes lidocaine. 8


These unique dermal fillers are

specifically created for lip volume

and eye contouring. 9,10


Specifically created for lip

contour and enhancements 9 ,

and available with or without

lidocaine. 11



Designed for under eye correction

and tear trough treatment. 10


This ‘age-prevention’ range

is dedicated to improving the

appearance, hydration and texture

of the skin. 12



Designed for use on the face, neck

and neckline, this rehydrates and

assists in wrinkle prevention. 12


Assists in the treatment of fine lines

on the face, neck and décolletage. 1


Designed for treating either moderate

or deep lines and wrinkles, cutaneous

depressions, folds and furrows. 14



For moderate lines and wrinkles

as well as cutaneous depression,

nasolabial folds and the glabella. 15


For the treatment of deep lines

and wrinkles16, nasolabial folds

and marionette lines. TEOSYAL ®

PURESENSE17 Deep Lines

includes lidocaine.


1. Michaud T, et al. Facial dynamics

and emotional expressions in facial

aging treatments. Journal of Cosmetic

Dermatology. 2014; 0:1-13.

2. Pierre S, et al. Basics of dermal

filler rheology. Dermatol Surg.


3. Report, Rheological characterisations

of hyaluronic acid gels. Rheonovia

(University of Grenoble, France)

4. TEOXANE Laboratories. Quantitative

and comparative safety and effectiveness

analysis of three non-CE approved

injectable dermal fillers in moderate and

severe nasolabial folds treatment versus

CE approved comparators. A randomized

double-blinded within subject clinical trial.

Final 18-months report. Independent CRO

analysis. January 8th, 2016.


Redensity 1& 2, Ultra Deep and Kiss ®

are trademarks of the firm TEOXANE SA.

These products are gels that contain

hyaluronic acid, and 0.3% by weight of

lidocaine hydrochloride (local anaesthetic

can induce a positive reaction to antidoping

tests). In the case of known

hypersensitivity to lidocaine and/or amide

local anaesthetic agents, we recommend

not use lidocaine-containing products

and please refer to products without

lidocaine. Please consult your physician

or pharmacist for more information. These

products are class III medical devices and

are regulated health products bearing the

CE marking (CE0086) under this regulation.

For professional use only. Please refer to

instructions for use. The product availability

depends on registration, please contact

your local distributor. Please inform the

manufacturer TEOXANE of any side effects


company profile

or any claim as soon as possible to the

following address: medical@TEOXANE.


*RHA ® is a trademark of TEOXANE SA.

RHA ® 2, RHA ® 3, RHA ® 4 are products

of TEOXANE SA. They are class III

medical devices and have received FDA

approval but are not yet commercialized

in the United States. The United States

Federal law restricts these devices to

sale by or on the order of a physician or

license practitioner. RHA ® 2, RHA ® 3 and

RHA ® 4 are indicated for the correction

of moderate to severe dynamic facial

wrinkles and folds, such as nasolabial

folds (NLF), in adults aged 22 years or

older. RHA ® 2, RHA ® 3, and RHA ® 4

are sterile gels containing crosslinked

hyaluronic acid in physiological buffer and

0.3% lidocaine hydrochloride to reduce

pain on injection. RHA ® 2, RHA ® 3 and

RHA ® 4 are contraindicated in patients

with previous hypersensitivity to local

anaesthetics of the amide type, such as

lidocaine. Please refer to the Instructions

for Use (

cdrh_docs/pdf17/P170002C.pdf). It is the

practitioner’s full responsibility to read and

inform the patient about contraindications,

warnings, precautions, risks and benefits.

TEOXANE Data on File.Teosyal

RHA ® 1 Notice.

TEOXANE Data on File.Teosyal

RHA ® 2 Notice.

TEOXANE Data on File.Teosyal

RHA ® 3 Notice.

TEOXANE Data on File.Teosyal

RHA ® 4 Notice.














KISS ® Notice




MESO Notice









For more information

call Peta Roberts 1800 633 830

Dr Steven Liew

of SHAPE Clinic in Darlinghurst Sydney,

shares his experience with TEOXANE

1. How long have you been

working with TEOXANE?

I have been working with the

company and its range of products

for the last four years.

2. Why do you enjoy working

with the company so much?

It is a smaller company, with a focus

mainly on fillers, and very shortly,

some anti-wrinkle products. The

charm of a smaller company is that

you don’t have to go through the

levels of bureaucracy to get your

voice heard, and, at the same time,

we are able to work with them to

create great treatment solutions for

our patients’ varying requirements.

It is a symbiotic, mutually beneficial

relationship that is free from the

obstacles you often find with big

pharma. Things get done in a short

and efficient space of time, which is

always fantastic.

3. Have you noticed any changes

and/or improvements since

TEOXANE product distribution

was brought in-house? How has

this made your life easier?

I’ve really welcomed this change,

as we have people directly from

the company on the ground in

Australia and this even better

services our needs.

4. What treatments do you use

TEOXANE products for? Why

do you love to work with the

products so much?

The TEOXANE range itself is fully

comprehensive and it has products

that serve so many purposes,

from sculpting, to projection and

definition. The key thing about

TEOXANE is what they call the

Dynamic Range. After all, our face

is not a static object, it is composed

of hundreds of thousands of very

complex moving parts. This is what

defines a human face. We animate

every single minute of our life, so

this Dynamic Range means that we

can reduce the negative signs of

ageing, without losing the animation

of the face.

6. How do you find patient

satisfaction with the use of


The key demands from my patients

are that they look good and that

no one can tell they have had work

done. Everyone wants that, and

with TEOXANE, patients love the

results – they don’t look stiff or

frozen and it caters to the animation

they wish to keep.

7. How do you find using

TEOXANE enhances your


For me, it fits nicely with all the

demands my patients have. The

greatest thing is not only does it

work, it also has a good safety

profile. There are minimal adverse

effects both short and long-term.

It is great to use and biologically

compatible with human tissue, both

immediately and long-term – three

or 12 months down the track, it still

looks fantastic. It ticks all the boxes

for me. AMP

The views of the doctors reflect their own views and do not necessarily reflect the

views of the company and should not be treated as product claims

















Dr Belinda Welsh founded the

Sunbury Dermatology and

Skin Cancer Clinic in 2002

and Dr Cara McDonald become her

business partner in Complete Skin

Specialists in 2016. The practice is

fl ourishing with fi ve dermatologists,

cosmetic services and the imminent

opening of a satellite clinic with

another dermatologist.

I have been working with Belinda

and Cara in strategic business

planning and implementation for their

growing businesses.

Here I chat with Belinda and Cara

about their experiences as business

women in the medical specialist fi eld.






BW: I decided to do dermatology

while I was in fi nal year of Medicine.

I moved to Sydney after my intern

year and spent several years at

the Royal North Shore Hospital. I

then did a Master of Medicine at

Sydney University and started the

dermatology training program in

Melbourne in 1996. I spent the fi rst

two years as a specialist working

as a locum and started out on my

own in late 2002 one-day-a-week

in Sunbury in a rented suite with

the rather lofty title of Sunbury

Dermatology and Skin Cancer

Clinic. I rebranded as Complete

Skin Specialists and Cara arrived in

2010. I bought a block with an old

house on it in the centre of Sunbury

in 2012 and spent the next two

years designing and building our

current practice. Cara and I became

business partners in 2016 and

she bought the building next door

for our Cosmetic and Laser clinic.

Last year we were joined by four

other dermatologists and that has



represented a big expansion phase

for us, which has been very exciting.

CM: At school my passion was in

fi ne art and I also loved problemsolving,

people and science. I felt

medicine might be a better career

choice. I found that dermatology

allowed me to be practical and

hands-on, creative and peopleoriented

plus it allowed me to use

all my strengths. I met Belinda when

I was a junior doctor and she was

a fantastic role model and mentor,

inspiring me not only to pursue

dermatology, but to prioritise being

a kind and empathetic doctor. After

completing my specialist training,

I joined her already-established

practice and together we grew

the business.





BW: I found the AMA a good

source. They have an annual

‘Setting up in Private Practice’

information day and I also went to

several Private Practice courses

which were extremely useful. This is

where I fi rst heard Hanya speak.

My loyal and supportive but

exasperated husband insisted at

one stage I read a book called ‘The

E Myth: Why most small businesses

don’t work and what to do about it’

by Michael E Gerber.

It took me a few reads to

understand what he was trying

to say, especially with regards to

running a medical practice (in fact

Gerber has a book specifi cally for

doctors – The E Myth Physician) but

ultimately it was this book which

really changed my thinking. The

premise is that we all fall into the

trap of working in the business as

the technician (doing the business

of being the Doctor) but fail to

understand the necessary roles of

manager and entrepreneur. I stopped

just working ‘in’ the business but

started to work ‘on’ the business.

That’s when things changed.

CM: Very little in the way of business

advice or education is off ered in

medical school, nor during specialist

training. Unfortunately, we need to

‘learn on the job’ while also working

as busy specialists. Most doctors

are not necessarily good business

people for this reason.

I have tried to educate myself,

using books and podcasts and have

learnt a lot from my husband and

mother, who have business and

consulting experience. Despite all

this, I still have many weak areas

and realise that it is almost

impossible to dedicate enough

time and energy to optimise the

business side of the practice while

also focusing on providing the best

medical care to patients.





BW: It was an easy decision. She

joined me in 2010 when I was

working out of a small consulting

suite attached to the local private

hospital in Sunbury. We have

very similar values, beliefs and

ambitions, which is critical to the

success of any partnership. Not to

mention a shared sense of humour

on the tougher days. We are both

working mothers and understand

the challenges this presents

and the need to balance all our


Confi dent she was staying for the

longer term, I purchased a property

in the more central part of the town

and designed and built our current

practice. By the time we moved into

this building we had been together

Hanya Oversby

(B.Ed, Dip. Practice

Management) founded

Specialist Consulting to

advise and guide specialists

on medical business

development and strategies.


est practice

I think being fair,

consistent and

understanding are

essential, but at the same

time having a strong set

of values and demanding

accountability of those

around you is key.

for six years with an excellent

working relationship. based on

mutual trust and respect. Cara was

keen to transition to a more secure

position as a business owner and I

was happy to share this with her.

What have been some of

the key advantages from

working with the business


BW: Hanya has bought improved

structure, organisation and

oversight, which has been very


She has improved our lines of

communication and this has been

welcomed by all staff. She has

brought us new ideas and introduced

us to technology to streamline our

business processes.

We also engaged her to find us a

new practice coordinator, which has

proved very successful.

Overall, we feel with Hanya’s

guidance, knowledge and expertise

we can grow the business more

effectively and we have more

confidence in our decision making.

Ultimately, this translates to a better

experience for our patients.

CM: Working with a business

consultant has given us some

clarity around the needs of our

business and enabled us to develop

the business in a more professional

and strategic fashion. Hanya

has provided mentoring for the

management team and created

more harmony and alignment within

the practice. Ultimately, this will

relieve us of some of the

management duties, allowing us to

focus on what we love and do best.

As business owners, how

did you adapt to stepping

into the leadership role?

BW: Having a vision and being able

to communicate this to your team

is very important. Leadership is not

always easy and I’ve never had any

formal training in this area. I’ve really

just grown into it over the years and

no doubt made plenty of mistakes.

I think being fair, consistent and

understanding are essential, but at

the same time having a strong set of

values and demanding accountability

of those around you is key.

CM: Although I was not so aware

of it at the time, my experience

working in large hospitals and

well-run private practices provided

me with a very good foundation,

so the transition was not too

difficult. The intense schedule

required to complete specialist

training and exams gave me a

good understanding of many

issues including goal setting, the

importance of good communication,

clear definition of responsibilities and

risk management.

What is your vision for the

practice moving forward?

BW: At the moment we have

grown quickly with more doctors,

so I’m keen to improve our internal

systems and processes to run as

efficiently and effectively as possible.

CM: Our vision is to exceed

expectations in providing an

exceptional service to our clients.

We strive to put our patients first

and treat everyone with respect.

We are committed to excellence

and we are keen to support and

mentor dermatologists to help meet

the needs of our community. We

look forward to supporting a new

dermatologist in our practice who

consults from satellite locations

(within GP clinics) to make our

services more accessible. AMP









• The first device to harness microwave

frequencies that target deeper layers while

keeping the skin cool and comfortable

• COOLWAVES deliver 80% of energy to target

tissue with only 20% of energy heating the skin

• Complete body contouring - Fat, Cellulite &

Skin Tightening in one user-friendly device

• Effective skin-tightening with greater comfort

than other wavelengths

• Achieves cellulite reduction with absolute

comfort & less treatments

• The latest innovation from DEKA, Europe’s leader

in aesthetic medicine technology for over 30 years



Phone 1300 309 233










Lizzy Boots is the Director of

Boots & All Consulting and

is an experienced human

resources professional

specialising in recruitment,

retention and training

strategies for the medical,

health and beauty industries.

Based in Sydney, Lizzy has

clients throughout Australia.

For more information visit or

call +61 414 644 463

The reception person fulfi ls a

vital and specialist role within

your medical practice, and

unfortunately, all too often they receive

little or no training to set them up for

success in the execution of these

critical tasks.

Often referred to as ‘the essential

gatekeeper’, the ‘bridge between the

patient and the doctor’, the ‘minister

of fi rst impressions’….. the list of

comparisons goes on. With one major

thread, this person is a truly valuable

member of the team.

Progressive and successful

practices acknowledge the reception

person plays a major, highly valued

role, interacting with patients,

working closely with the doctors,

setting the tone of the practice and,

by design, generating the bulk of

the practice income.

It goes without saying that training

our reception staff is a critical concern

in the life of our practices, yet remains

a priority all too often overlooked due

to time constraints or lack of time to

devote to the project.

An analogy often used when

describing your business and your

team is “The Bus”. We all want to

make sure we have the right people

on the bus, the wrong people off the

bus and a clear plan for where the

bus is headed.

Having an untrained person on your

reception team is as dangerous as

allowing Sandra Bullock’s character in

the movie ‘Speed’ to drive your bus:

lots of screaming and shouting, no

clear direction on what to do in a crisis

and a load of very scared passengers

on board, all without a Keanu Reeves

character in sight to save the day!

Following these fi ve simple rules

will help you set up and maintain

a successful relationship with your

reception team and, best of all, reap

the benefi ts for all parties.

1. Recruit for Attitude

and Personality

The old adage ‘hire for attitude, train

for skills and knowledge’ is never more

true than in this situation. A positive

‘can do’ personality is everything and

more in a reception role. Employers will

often list qualities such as ‘attention


Best practice

to detail’, ‘can do’ attitude, ‘kind

and caring nature’; however, thry’ll

then gloss over these if they see a

candidate with ‘on the job’ experience.

To assess if candidates really do have

these essential skills, you can carefully

craft your advertisement to start the

selection process from their first stroke

of the keyboard.

Ask the reception applicants to

‘make you feel special’ by writing a

specific cover letter, addressing it to

you personally and then addressing

the key criteria for the role. Then, if

you get a random CV with no cover

letter or a letter addressed ‘To Whom

It May Concern’ you know you don’t

have a candidate with attention to

detail. Or if they send you a generic

cover letter, they have shown you they

don’t really care about making you

feel special. How will they make your

patients feel special?

Once the specially selected

candidates have been identified for

interview, you can continue the search

for your ideal reception person by

having specific questions ready that

will further help to identify a positive,

happy and ‘can do’ attitude towards

life and others.

2. Have an On

Boarding Plan

– and see it through!

The On Boarding (Induction) process

is a vital link to success and longevity

in the role, yet all too often this is

poorly conducted.

Taking the time to carefully plan what

information the new employee needs,

and in what order this information

should be delivered, will have a

resounding impact on the ongoing

relationship for both parties.

Without going into elaborate detail in

this article, a good On Boarding plan

should include;

• Comprehensive employment

contract – setting out hours of work,

rosters and payment details

• Guided tour of the practice –

including a visit to off-site or ancillary


• Meet the team session – discussion

and supporting material about the

practice history, values and culture

• Workplace health and safety

– clearly defined expectations of


It is important not to overwhelm

the new employee with too much

information delivered too soon.

Remember that first days and even first

weeks are a daunting time for the new

employee; so take it easy and expect

that they may not retain 100% of the

information you provide them.

3. Skills and Knowledge


Once the new employee has shown

signs they are settling in, it is time to set

expectations regarding their acquisition

of knowledge of your practice protocols,

procedures and services.

When training, remember: Stress

Levels Up = Retention Level Down.

Create a calm environment and ask

the new employee to carry a note book

and jot down relevant points throughout

the day. Although they will likely have

a Practice Manual to refer to, having

the notes in their own handwriting is

the first step towards owning the new

processes and information.

Set the reception person up for

success by ensuring they have

proper training on the systems they

will use, especially the patient

management system. It is well worth

the expense to arrange external training

to ensure they pick up all the relevant

aspects of the systems and not just

the basics or shortcuts that may have

evolved over time.

Provide access to information about

the procedures, services and retail

products. Set aside time for reading

during the work day; do not expect

the new employee will go home (often

exhausted) and read for a few hours.

And finally, set an expectation as to a

reasonable timeframe for the employee

to have retained this information, plus

when and how you will be assessing

knowledge and skills.

4. Provide and Ask for

Regular Feedback

All too often I am told by my reception

placements that they felt very unsure

of their job security in the first six

months. Although the practice principals

had given me glowing reports of their

efforts and performance, they had often

failed to give this valuable feedback to

the employee.

It is important to remember that

you have taken the time to recruit

this very special reception person

for their warmth, personality and ‘can

do’ attitude. You have chosen them

because they are passionate about

people and love communication.

So don’t forget to check back in

with them on a regular basis and

tell them you think they are terrific

and reassure them that they are on

the right path.

Remember the reception is at the

coalface of your practice every day

and both sees and hears a lot more

than you about the everyday running

of the practice. Set up regular times

to meet with your reception person to

gain valuable insights into your practice,

patients and wider team.

This is a good opportunity to find

out if they have all the tools they need

to do their job properly of if they need

additional education or training.


Whether you see the reception person

in your practice as the ‘bridge’, the

‘gatekeeper’. the ‘bus driver’ or the

‘director of first impressions’, the

one thing we can all agree on is: the

reception person is a vital component

of a successful practice. Taking the

time to recruit for specific people skills.

and then induct and train for success.

will have a dramatic impact on your

Practice bottom line. AMP








Kerry Bielik

Founder of Insight Patient

Satisfaction Solutions, a

specialist consulting fi rm

delivering bespoke online

customer experience programs

for medical practices.

At Cosmedicon earlier this

year, I had the opportunity

to discuss the impact of

‘Voice of the Customer’ in medical

practice settings with a large

group of business operators. To

get the ball rolling, we pondered

three questions:

1. Has the business of Aesthetic

Medicine become more

competitive over the past 5 years?

2. Is it expected to become even

more competitive over the next

5 years?

3. How do we maintain a

competitive advantage in an

increasingly crowded fi eld?

The answer to Questions 1 and 2

were no-brainers. Obviously – Yes.

Question 3 was where things

became interesting, leading to

a wide-ranging discussion on

topics such as: brand and product

diff erentiation; marketing channels;

service diversifi cation and the like.

Eventually, the conversation worked

around to customer satisfaction

and loyalty. Unsurprisingly,

attendees were unanimously of the

opinion that good service leads to

customer retention and positive

word-of-mouth recommendation.

Strangely, when asked how many

of them proactively sought direct

feedback from their patients, very

few actually did.

A recent study published in the

US Journal of Medical Practice

Management analysed 35,000



online reviews of medical practices.

It revealed 96% of complaints found

fault with the customer service – not

the quality of care.

The study showed that only 1-in-

25 patients rating their healthcare

providers with two stars or fewer

is unhappy with his or her physical

examination, diagnosis, treatment,

surgery or health outcome. The

overwhelming majority of complaints

cite poor communications,

disorganisation and excessive

delays in seeing a physician as the

cause for dissatisfaction.

Our study uncovered a torrent

of patient allegations of doctors

running behind schedule, excessive

waiting time to see a provider,

billing problems, indiff erent staff ,

and doctors’ bedside manners. Yet

hardly anyone had a beef with the

quality of healthcare received. ’

Clearly, fi nding ways to reduce or

eliminate sources of dissatisfaction

results in the twin virtues of patient

loyalty and recommendation; but

the fi rst step is to identify them. Who

better to ask than the customer?

If you are intending to implement a

patient feedback program, take the

time to design it properly. If it gives

the appearance of being inauthentic,

it may actually have the opposite

eff ect to that intended.

Make sure it presents a

professional appearance, is concise

and deals with the touchpoints that

relate to your clients’ experiences.

Things to consider when

designing your questionnaire

and program:

• Simplify survey instructions.

• Consider making it available via

multiple platforms (online, SMS,

social media).

• Ensure it guarantees patient

confi dentiality and privacy.

• Avoid the temptation to ask too

many or irrelevant questions.

• Carefully phrase both the

questions and response options.

• Use quantitative questions

that measure satisfaction

performance scores.

• Provide the opportunity to

include qualitative commentary.

• Place emphasis on personal

interaction aspects of the

patient journey.

• Track satisfaction data over time

to identify trends or anomalies.

• Share results with your team

members, so they engage

with the goal of continuous


One fi nal suggestion: Be prepared

to take valid critical responses

onboard. These can often be the

most valuable learnings and lead to

genuine opportunities to enhance

the overall customer experience of

your practice. AMP





or call +61 414 365 865.


Be Ready

to Evolve








Employ the








Cultur of




Hard to get, easy to lose

Roanne Innes, Business

Coach and Leadership

Consultant, explains the

importance of good

teamwork and maintaining

optimal cohesiveness.

According to Simon Sinek,

a team is not a group of

people who work together;

a team is a group of people who

trust each other.

The best companies are made

up of great teams. However, even

a company full of high performing

employees won’t succeed if those

individuals don’t have the ability to

work well together.

Good teamwork is essential for

high performance in any business,

organisation, sports or any group

working towards a common goal.

Patrick Lencioni tells us it is

teamwork that remains the ultimate

advantage, both because it is so

powerful and so rare.

While we all recognise the value

of teamwork, in most organisations

it continues to remain elusive.

The fact remains that teams are

inherently dysfunctional because

they are made up of imperfect

human beings.

In his book, The Five

Dysfunctions of a Team: A

Leadership Fable, Lencioni

maintains that organisations fail to

achieve teamwork because they

unknowingly fall victim to five natural

pitfalls (illustrated in the pyramid at

the end of this article).


est practice




1. Absence of Trust

Absence of trust is the hardest

dysfunction to overcome and it

really can make or break a team.

In some teams, too much time,

energy and good ideas are wasted

trying to protect reputation.

Employees are often reluctant to

ask for help or to offer assistance to

others, causing lower morale and

unwanted turnover.

In fact the word 'trust' is used

so often and in so many ways, it

has lost its impact. You often hear

people say: 'I trust my co-workers

so I don’t need to question how

they do their job'; 'I trust my boss

so I just do what he/she tells me

to do' – but these stand in contrast

to the type of trust an effective

team needs.

Great teams do not hold back

from one another. They admit their

mistakes, their weaknesses, and

their concerns without fear. Every

effective team needs to have a

substantial level of debate. Teams

must work towards a foundation of

vulnerability-based trust.

Vulnerability-based trust cannot

be achieved overnight as it requires:

• Shared experiences over time

• Multiple instances of following

through and credibility

• An in-depth understanding of

the unique attributes of each

team member

Leaders need to demonstrate

genuine vulnerability first, and create

an environment that does not punish

admissions of weakness or failure.

2. Fear of Conflict

A dysfunctional team may have

tension, but it doesn’t mean the

members have constructive conflict.

If team members don’t trust one

another, they aren’t going to engage

in open, healthy and constructive

conflict – they will just preserve a

sense of artificial harmony.

Members must learn to accept

and engage in passionate, unfiltered

debate about what needs to be

done to succeed.

The primary purpose of productive

conflict is to produce the best

solution in the shortest period of

time. It is important for members to

remember to practice restraint and

allow conflicts to resolve naturally.

It is equally important to set the

expectation that personal attacks

will not be tolerated.

Teams that engage in conflict

put critical topics on the table for

discussion, create opportunities for

everyone’s voice to be heard, solve

real problems quickly with minimal

politics, and have lively, interesting

and productive meetings.

Roanne Innes is a Business

Coach and Leadership

Consultant who helps grow

Medical and Aesthetic

Health businesses and

the people that lead

them. She specialises

in the development and

implementation of business

growth and acquisition

strategies, leadership

coaching and building high

performing teams.


est practice

A leader must be

comfortable with the

prospect of making a

decision that may turn

out to be wrong.








3. Lack of


Is commitment lacking in your

organisation? It may have

resulted from a lack of healthy

debate in meetings, which led

to false consensus and no buyin.

Productive conflict taps into

everyone’s perspectives, which

allows everyone to confidently buyin

and commit to decisions.

The two greatest reasons for

lack of commitment are the desire

for consensus and the need for

certainty. To avoid these:

1. Don’t try and seek consensus,

nor try to please everyone.

It’s rare that everyone agrees

on something naturally and

quickly. Great teams ensure that

everyone’s ideas are heard and

genuinely considered. This creates

a willingness to support the

ultimate decision by the group.

2. Make a decision. A leader must

be comfortable with the prospect

of making a decision that may

turn out to be wrong. and must

also constantly push the group for

closure around issues.

4. Avoidance of


Accountability is a team effort.

Team members need to hold each

other accountable when behaviours

and actions do not support team

goals. Ironically, people hesitate

to hold one another accountable

because they fear jeopardising a

valuable personal relationship, and

this can cause the relationship to

deteriorate as team members begin

to resent one another for not living

up to expectations and for allowing

standards of the group to slip.

Peer pressure is the most effective

means of producing performance.

Encourage accountability by

creating clear standards with

defined indicators that enable each

team member to know that they are

doing their part. The more detailed

the action plans and the more

specific the performance metrics

are, the easier it will be to hold

people accountable.

5. Inattention

to Results

Sometimes ego and selfpreservation

get in the way of

company goals, and this results

in inattention to results. Instead

of focussing on achieving the goals

and results of the team, some

members may focus on other

things, most commonly team

status or individual status.

The key is to define goals for

the team in a simple measureable

way, which leave no room for

interpretation when it comes to

success. Otherwise it only creates

the opportunity for individual ego

to sneak in, and that’s often where

politics can take over.

You can significantly increase

your team results by improving

performance via nipping these

dysfunctions in the bud. It is

difficult and it does take time to

build a cohesive team, but it’s not

complicated. Keep it simple. AMP

For more information call Roanne on 0418 100 748 or

visit or email


est practice

A step

by step

guide to


up a



Alfie Lombardi from Trusted Surgeons explains how to capitalise on

video content by setting up a YouTube channel of your own.

Alfie Lombardi

Chief Enthusiasm Officer

Trusted Surgeons

Video is king when it comes to

content and it doesn’t look

like it’s going to change any

time soon. If you haven’t started

to create video content for your

audience, you are missing a vital

part of your marketing plan. But

what do you do with all that content

once it’s created? Set up your very

own YouTube channel of course.

YouTube is an excellent platform

that if your business is not already

using, it should. While this can be

confusing for some, read on to

find out how to set up a YouTube

channel of your very own.

First things first: go to YouTube

and sign in. You will need a Google

account for this, but most people will

have a Google account, so I won’t

go into setting one up. Once you

have signed in, you will need to go to

the top right-hand corner and select

your profile (a small circle where the

sign in button used to be). (Figure 1.)

In the drop-down box, you will need

to select ‘Your channel’. If this is your

first time signed into YouTube, it will

ask you for your name. This will be

the name that you want displayed on

your channel. (Figure 2.)

Customise your


Once done you will want to find

the button that says, ‘Customise

channel’ and select it. It is here

that you can start to customise

your channel to align with your

brand. It is like a shop display at

the front of your store. Firstly, you

will want to customise your profile

picture. This may be a head shot of


est practice

Figure 4

Figure 2

Figure 2

Figure 3

Figure 5

yourself or your logo or anything else

you want to display. It is simply a matter

of selecting ‘edit’ and then uploading

the image of choice. Your next job is

a little more challenging and requires

you to change your channel art (like

the banner in Facebook). Select ‘add

channel art’. From here you can load a

photo or a banner that you may have

already created previously, like adding

your profile picture. This can really be

anything, but it should be ‘on brand’.

Your users should be able to easily

identify your business and your channel

art should incorporate your logo, your

brand’s colours and even the font you

use across your other channels. Any

messaging or taglines you normally

promote would also go here. Don’t

forget to use high resolution images;

you do not want your channel opened

by a customer on a TV and have your

picture come up blurry.

Channel Art

Spending some time on fine-tuning your

banner can be a little tricky. You need to

remember that your YouTube channel

will be viewed on multiple devices: from

TV screens to laptops, all the way down

to a phone screen, with your image

optimised for each screen. This means

that the image displayed will be different

for each device and it is important to

take that into account when designing

your banner. (Figure 3.) There are many

programs available to help design and

build your channel art, which some of

you may already be using for your other

content. YouTube recommend a banner

size of 2560 pixels x 1440 pixels. This

is effectively what you will see on a TV

screen but there are other sizes that

you need to be aware of when creating

your art. YouTube has what is called a

safe area and this is where your logo

and text should be. Any of the elements

in your safe area will be displayed even

on the smallest of devices, like a phone.

The minimum safe area is listed as 1546

x 423 pixels. While this may all sound

complicated, with a little trial and error

you will eventually find the design you


est practice

want. When you load your design to

YouTube, you will be given the option

to preview the design to see what it

will look like on the various devices

(TV, Desktop and Mobile). If it doesn’t

look quite right, then you can go back

and adjust the original image. Once

you are happy, you will need to save

your work.

Once your YouTube art is saved it is

not set in concrete. That means you

can change it as necessary to help

promote any events coming up or new

treatments you are offering. As with all

platforms on social media, you should

try to maintain consistency and return

to the original art after the event.


You will want to go into settings next

to adapt them to your preferences.

Just under your new banner to the

right-hand side, select the little grey

cog wheel (universal sign for settings)

to reveal your channel settings. Most

of these are self-explanatory and

you just toggle the on/off switch

beside each setting to change them.

You will want to make sure that the

‘customise the layout of your channel’

is switched on, as this will allow

you to arrange the look and feel of

your YouTube channel. Once you

are happy with each of the settings,

press ‘save’.

Who are you and

what are you


Next, select the ‘about’ tab.

(Figure 4.)

Here you will be able to give your

audience some information about

you or your business. If you already

have a website and have a description

there, simply copy and paste into

the channel description box. You

can modify what you put here to

also describe what you are trying to

achieve with your YouTube channel.

You also have the ability to add a

location so your viewers know where

you are. This could be generalised, like

Australia or can zero in on a city like

Sydney. It all depends on what you

want to portray to your audience.

You are not just defined by your

YouTube channel. If you are setting

up a YouTube channel, it is highly

likely that you already have a welldeveloped

Instagram and Facebook

platform. This is the area you can add

those links so that your visitors can

also check out your other platforms.

You will need to hover over the ‘links’

and then click ‘edit’. Click on the ‘add’

button and add your title (what you

want to call the link) and then the web

address or URL. If you want to add

more links, just keep clicking the ‘add’

button. YouTube allows up to 5 links

being displayed. Press ‘done’ when

you are finished to save your changes.

Adding videos

If you have made it this far, well done.

You are now ready to add videos to

your channel. Select the picture of a

video camera with the plus sign on it

and select ‘add video’. (Figure 5.)

Here you will be given some options

to either drag a file onto the page

or navigate to somewhere on your

computer to upload a file. Once you

have selected your file, it will begin

to upload and may take some time

based on your internet connection.

While this is loading, you can give your

video a title and a description. You

only have 100 characters to utilise for

your title, but you should stick to 70

or below as that is what is displayed

on Google. Your title needs to be

descriptive, creative and enticing.

Use the description to give your

audience an understanding of what to

expect in the video. YouTube allows up

to 1000 characters but remember that

your viewers are here to watch a video

and not to read your thesis on the

video. Make sure to include relevant

keywords. Next you need to add

‘tags’ to your video so that YouTube

knows how to categorise and match

your video with similar content. Ideally

your tags need to match the video

and you shouldn’t add tags that you

think will get you better views if they

are not relevant. You will be penalised

for irrelevant tags. Start with the key

search terms for the topic you are

portraying and anything else that is

related to the video.

The final step to adding a video, is

to choose the cover photo or video

thumbnail. This is the static image

that will be displayed to showcase

your video. For those starting out, you

will only be able to select an image

from the video to use as a cover shot

but as you get a little more advanced

(and meet YouTube’s criteria), you

can customise your thumbnail. Your

thumbnail needs to be attractive and

stand out from the millions of other

videos on YouTube.

Once you have completed this

section and your video has finished

uploading, you are ready to publish.

Make sure your video is set to ‘public’,

as you want your audience to see

it. You can also start to build your

playlists but that is for another article.

Click ‘publish’ in the top right-hand

corner and your video will be live.

Congratulations. Your first video on

your own YouTube channel.

There is a lot more to YouTube than

what I have explained above, but you

are well on your way to becoming a

YouTube sensation. I will write a follow

up article in the next issue which

will go through some of the more

advanced features and add some tips

and tricks to help boost your profile

and your videos. In the meantime,

keep creating videos and loading them

to your YouTube channel so that you

start to build a library of content for

your viewers. AMP

For more information call Alfie

on 0416 180 917 or email



A match

made in



Many couples would find being in business

together trying, But not husband and wife

aesthetic practitioners, Dr Peter Muzikants and

Dr Lesley Wild of Ada Aesthetic Medicine in

Glebe, Sydney.

The Secret to

Aesthetic Success

After 30 years in the business,

there’s no denying that Ada

Aesthetic Medicine has more than

stood the test of time, largely due

to an astute business model and

above industry standard approach

to patient care, administered only by

highly qualified and skilled doctors.

'Our business model from

the very start was having a

clinic that was doctors-only for

consultations and treatments,'

explains Dr Peter Muzikants, who

owns and operates the clinic with

his wife Dr Lesley Wild.

'We learned early on that what

attracted many patients to us,

was that we, the doctors, would

be performing the treatments.

Despite the explosion of competition

in Sydney (there are more than

20 cosmetic clinics within a

10km radius), the majority of our

competitors have a work model

where nurses and therapists are

delegated to perform treatments.

This point of difference created a

niche that still serves us well.'

Lesley adds: 'Our clinic is a nonsurgical

practice, focusing on the

skin to improve blemishes, scars,

birthmarks and skin quality using

lasers and injectables. We bought

our current premises in 2000 and

we have been gradually adding new

lasers and equipment ever since.

The word 'Ada' is derived from

Peter’s Latvian heritage and simply

means 'skin.'

Indeed, patients come to Ada

for firstly great skin, but also for the

personal touch, friendly ‘bedside



manner’ and the guarantee they

are being treated by the best in the

business from the greeting they

receive upon entry, to the treatments


'We have two wonderful

colleagues, Dr Margot Campion and

Dr Mandy Hu,' says Lesley. 'They

have worked with us for over 10

years. All the doctors have different

personalities and areas of interest

and expertise; so between us we can

cater to the needs of a large range of

patient issues. We have a fabulous

and friendly reception staff and many

of our patients appreciate the casual

atmosphere of our reception area.'

For the Love of the Job

Both Lesley and Peter receive

enormous satisfaction from their

practice, on a daily basis, and they

see it as more than simply a job.

'The most rewarding thing about

being a cosmetic physician is the

ability to improve people’s selfesteem,'

comments Lesley. 'Some

procedures can be ‘life-changing,’

which truly makes it worthwhile.

Challenges can be unrealistic

patient expectations, so educating a

patient is of vital importance before

embarking on a treatment.'

Peter adds: 'Being an aesthetic

physician has been better than I

had imagined. Apart from the

sensible hours we work, the type

of people we see are on the whole

enormously grateful and satisfied

with the work we can do. It still gives

me great pleasure and satisfaction to

be able to say to patients, 'yes I can

help you', when often they have been

told there is not a treatment for them,

or they have had bad experiences in

the past.

'Aesthetic medicine is dynamic,

with constant innovations and new

treatments that demand constant

vigilance and evaluation of existing

treatments and techniques. I see

this as a positive – keeping up one’s

interest and skills.'

Work Vs Play

When one enjoys their work as

much as Peter and Lesley do, it’s

often tricky to distinguish when

work finishes, and relaxation begins.

However, they seem to have a great

grasp on this.

'Ever since we started medicine,

one of our main goals was to have

good balance of work and family life,'

stresses Peter. 'That’s one reason

this boutique niche area of laser

and aesthetic medicine attracted

us over 30 years ago. We were

quick to establish a full-time career

and business.

'There were at times great

demands to work, but we did

seem to be flexible and adapt our

work hours. One method we found

particularly effective and fun was

combining work and family time

by taking our kids with us on our

conferences, combining them with

holidays. It was a great way to travel

the world with young kids as a family.

We have great memories of these

times. We did continue this until they

were in their late 20s, as they never

said no and, if not for their own jobs,

I think they would still be tagging

along. More recently we have found

'downscaling' our practice as a

great way to increase our desire

to have more time for family and

personal interests.'

Lesley adds, 'We manage to

achieve balance because Peter works

full-time and is largely responsible

for management of the practice. I

work part-time, which enables me to

attend to family and domestic issues.

However, we are always available to

help each other out if pressing work

or family issues arise.'

Getting Away From It All

Travel plays a huge part in the

couple’s work and personal life,

and it’s not something they intend

to give up any time soon. Peter, an

avid runner, takes the opportunity to

compete in marathons around the

world wherever possible.

'I have always been a keen runner

especially distance running,' he

reveals. 'At high school I was able to

reach the NSW state cross country

school competitions. I have been

competing in half marathon and full

marathons for just over 25 years

now. I still do at least one or two

half marathons a year and it’s a nice

feeling to still this year be able to

finish 11th place in my age group 60+

and overall top 15 percent finisher out

of 8,500 runners!

'Highlight of my running has to

be the running the trial Sydney

2000 Olympic Marathon course and

finishing in the main stadium and

watching myself run, as I was actually

running the final full lap of the Olympic

track on the gigantic TV screen set

up in the stadium!

'There have been many great

moments in running the various

marathons around the world, but

running the Boston Marathon

was special, because it has an

unbelievable atmosphere and

community support such as

around the half-way point, we run

through the Wellesley College girls

scream tunnel, with unbelievable

deafening screaming.

'Entry into this prestigious event is

earned by having run a recognised

qualifying time, compared to other big

city marathons were you just enter by



paying. I am very proud I was able to

compete in it twice in 2007 and 2008.

'Travelling overseas to compete in

marathons and attend conferences

in laser and aesthetic medicine has

been a fantastic way to satisfy both

Lesley’s and my other interest, which

is of course travelling. Any destination

in Europe is fine, but in particular I

love visiting any town or city in Italy

especially on the Coast. Favourite cities

are Paris, Berlin and Boston.'

'And of course, it’s not just about

putting on the running shoes and

pounding the pavement!

'I have long been into surfing, board

riding since age 15 years, when I would

wake up at home in western Sydney

and run in the dark with my board

under my arm to catch the early train

to Circular Quay, then catching the first

ferry to Manly in order to be the first in

the waves at Manly beach at sunrise,'

reveals Peter.

'I even designed and made my

own fibreglass surfboard in my dad’s

garage. I continued my passion

though medical school, banding with

other med surfie students to make

‘surfaris’ up to Noosa and down the

South Coast. One highlight has been

surfing incredible waves in the cold,

shark infested waters of Jeffreys Bay,

South Africa. I still regularly check out

the surf at my local break and enjoy

the company of my old Maroubra surf

buddies when the swell is running.'

'Travel is a shared passion,' adds

Lesley, who also cites weekly jazz,

burlesque, hip-hop and Zumba dance

classes, learning other languages and

caring for adopted cats as other fervent

passions. 'We are most fortunate

that, because we work together in the

same industry, we are able to attend

international conferences together, then

add on a short holiday afterwards. My

favourite holiday destinations have, so

far, been Italy, (anywhere in Italy, really!)

the Greek Islands and the South of

France. We have also enjoyed fabulous

adventures in Turkey, Spain, Britain,

USA, Germany, Portugal, Croatia,

Cuba and Morocco. Actually, we

have been visiting Paris for an annual

conference for over 14 years, so ‘we

will always have Paris!’ One indelible

memory is of watching a stunning

sunset in Riomaggiore on the Cinque

Terre, sipping a delicious Prosecco, on

our 25th wedding anniversary.'

Peter pipes in with a memory that

both might rather forget! 'One that still

stands out as a great disappointment

was our big hike in the South of France

from the hilltop village of Sospel to

Menton on the Cote d’Azur. It was

storming, with driving rain and wind for

the whole hike up and down through

rocky ravines and forests. Plans for

relaxing picnic breaks were canned

as we struggled for almost eight

hours without any breaks just to get

to our final destination on the coast.

Our water proof clothing and shoes

lasted about 30 minutes. We were 100

percent wet through with feet sloshing

in pools of water in our shoes; we were

miserable, but the experience was

worth it for the best hot bath ever.'

But it’s these moments that

cement relationships and, after 30-plus

years together, the couple are closer

than ever.

'Love was ‘in the air’ in our second

year of university,' recalls Lesley. 'We

were at UNSW and we were together

for the rest of the course, marrying in

1984. We actually have quite different

personalities, so our ‘secret’ is that

we balance each other. I tend to be

excitable, spendthrift and impulsive,

whereas Peter is the logical, practical

one, helping keep my feet on the

ground. More importantly, however,

is that we have always seen eye-toeye

on the ‘big picture’ – namely

the welfare of our family and the

running of our clinic. We also share a

similar sense of humour and musical

tastes, which are helpful during

stressful times.'

'Our relationship has evolved,'

comments Peter, 'but we still have

those common interests and goals

that keep us together. Being able

to see and respect each other’s

interests and compromise if not both

agreeable, is the key.'

Medpro Finance Success

'Finance and banking stuff have

always been a necessary interest for

us,' reveals Peter, 'especially running

a practice dependent on being up to

date with the latest equipment. It would

have been great if there had been a

Medpro Finance around when we were

getting established and expanding!

'But our association with Medpro

Finance began just a couple of years

ago after hearing a talk they presented

at a CPCA CME meeting in Sydney.

Normally, I don’t take much notice of

these types of finance talks, but they

seemed different and, after doing

our due diligence on Ross and his

partners, I decided to invest with them.

With the excellent returns I receive

each quarter, it was one of my better

decisions in finance and it feels good

to be providing financial backing to our

medical health industry.' AMP

Article sponsored by Medpro Finance.

For more information contact,

or visit



Five Minutes With

Dr Peter Muzikants

My perfect weekend is… early sunrise

surf or, if no surf, a coastal beach run

then a lazy brunch at a local café with

Lesley and our kids if they’re around.

After a sunset walk along beach, settle

in for a round of binge video viewing of

British crime dramas.

My favourite place to eat is … Grotta

Palazzeze, a sea cliff cave restaurant in

Polignano, Puglia Italy.

My favourite car … my old 1973

VW type 3 station wagon, which has

survived over 300,000 klms through

snow fields, beach tracks and everything

I did as a student and in the early days of

starting our family and laser clinic. Lesley

and I both cried when I finally sold that

car. It was truly the end of an era.

My favourite place to travel is…

anywhere in Europe.

My favourite way to let of steam is…

going for a hilly run.

I reward myself by… going out for a

meal or to the movies.

If I had more time I would… travel and

see more of outback Australia

I’m most proud of… just being me,

and also my family.

If I wasn’t a doctor, I would be… an

unhappy mechanical engineer.



Five Minutes with

Dr Lesley Wild

My perfect weekend would be…

a lazy brunch at our favourite nearby

café, a dance class or a seaside walk,

followed by a cosy night-in watching

British crime dramas.

My favourite place to eat is…

Grotta Palazzeze, a romantically lit

seaside cave restaurant in Polignano

in Puglia, Italy. 'Snap', Peter!

My favourite car is… my old faithful

Merc, which I’ve had for over 10 years

and have no plans to upgrade.

My favourite place to travel is… Italy,

anywhere in Italy, you can’t go wrong!

My favourite way to let of steam is…

with a sweaty dance class!

I reward myself with… a sparkly

cocktail dress, or failing that, a stiff G&T!

If I had more time I would… take up

studying languages again.

I’m most proud of… my children, who

have both grown to be kind and caring

adults. Both have achieved academic

success, but their personalities are what

gladden my heart.

If I wasn’t a doctor, I would be…

a linguist. Or else a hoarder, living in a

hovel with 47 cats!


Borrow. invest. refer

we’re here

to help

Welcome to Medpro Finance. Our team of experienced

consultants, specialising in medical finance,

provide fast, flexible solutions.

Medpro Finance will assist you in financing virtually

anything you need, including medical equipment, practice

fit-out, business purchases, debt consolidation, top-up

lending and personal passions such as art and collectibles

Ross Andrews


M: 0488 767 722

Hannah Smith


M: 0467 667 555






In 2010, CoolSculpting ® made

its Australian debut. Today, with

more than seven million treatments

performed worldwide, it is the

world’s number one cryolipolysis

device. CoolSculpting ® is distributed

throughout Australia and New Zealand

by Allergan.

CoolSculpting ® is a non-surgical

body sculpting platform indicated

for use on numerous body areas

including upper and lower abdomen,

fl anks, inner and outer thighs, arms

and the submental. CoolSculpting ®

works by selectively damaging

subcutaneous fat while preserving

the skin and surrounding tissues.

Following treatment, targeted fat

cells enter apoptosis and the body’s

immune system naturally processes

the fat and removes dead cells.

After treatment, patients can

expect some numbness and mild

discomfort. This typically resolves

within a few weeks. Some patients

may experience redness, swelling

and bruising, however this has

been signifi cantly reduced with the

new generation of CoolAdvantage


applicators. There is minimal

downtime after treatment. Results

can be seen from six weeks, with

fi nal results becoming evident at

10 to 12 weeks.

CoolSculpting ® has been found to

reduce fat across multiple treatment

areas by up to 27 per cent. There

are currently over 50 peer-reviewed

publications on the benefi ts of


® .



With the recent addition of the

CoolAdvantage ® applicator family, the

CoolSculpting ® platform can now treat

more areas in a single treatment than

ever before, leading to even better outcomes

and increased patient comfort.

CoolSculpting ® also benefi ts

from a number of patented safety

technologies. CoolControl ® monitors

the patient’s body temperature

during treatment and adjusts the

applicator temperature in real time

to ensure optimal patient treatment

outcomes. Additionally, FreezeDetect ®

is a patented safety technology

that automatically switches the

CoolSculpting machine off if it

detects risk of a skin freeze event.

This helps to prevent the risk of freeze

burns during treatment.

With minimal downtime and high

patient satisfaction, CoolSculpting ®

offers a non-surgical means of refi ning

and sculpting body contours while

delivering an impressive ROI for clinics.

With the support of Allergan’s

dedicated Practice Development

Managers (PDMs), this device is easy

to integrate into new and existing

aesthetic medical practices. It is the

perfect complementary service for

surgical clinics and allows non-invasive

practices to expand their clinical

off erings with a treatment that is both

highly sought-after and eff ective.

Allergan’s training materials and events

allow practitioners to achieve next-level

results with CoolSculpting ® .



products & services

Dr Christopher Lee

One of Australia’s most successful

CoolSculpting ® practitioners

Dr Christopher Lee from Cosmos

Clinic in Canberra was one of

the first practitioners in Australia

to introduce CoolSculpting ® to

his practice. His clinic is now the

#1 CoolSculpting clinic in the

ACT and is in the top 5 for all

Australian-based CoolSculpting ®

clinics, for treatment cycles YTD.

Here, he discusses his experience

with us.

Why did you choose

CoolSculpting ® over other

body contouring devices?

Cosmos Clinic’s expertise is

body sculpting. When we started

12 years ago, we introduced

liquid liposuction to Australia. We

noticed that there was a gap in

the non-invasive body sculpting

market. There was no treatment

on the market that produced

consistent results.

After much research at

international conferences, we

decided on CoolSculpting ® due

to its promising early results.

Initially, we were concerned that

it would divert patients away from

our surgical practice. However,

we realised that it allowed us to

offer a complete body sculpting

service, covering both invasive

and non-invasive. We were able

to offer patients options for body

sculpting and fat removal.

How popular is CoolSculpting ®

with your patients?

At Cosmos Clinic we perform a

large number of CoolSculpting ®

treatments and it is the second

most popular procedure in the

clinic after liposuction. Body

sculpting is one of our most

requested procedures and

awareness among our clientele is

huge thanks to CoolSculpting ® and

VASER liposuction.

How has Allergan supported

your CoolSculpting ® journey?

Allergan has been a great

support and partner in our

CoolSculpting ® experience.

As the key opinion leader for

CoolSculpting ® in Australia, I

have had the privilege of sitting

on the International Medical

Advisory Board and also

to participate in the first

CoolSculpting ® Expert Forum in

Barcelona, Spain. It was great to

see the effort that Allergan has put

into CoolSculpting ® to maintain its

status as the premium cryolipolysis

machine in the world.

CoolNet represents digital

innovation in medical aesthetics.

Resources and the latest training

methods are available at all times

to practitioners, allowing them

to offer the latest and safest

treatment options.

CoolSculpting ® events are a

great marketing tool for promoting

awareness of CoolSculpting ® within

a practice. These events also allow

clinics to understand the dynamics

of the non-invasive market within

their own jurisdiction. It is quite

amazing how geographical, ethnic

and cultural differences can affect

the approach taken by a successful

CoolSculpting ® practice.

Any tips for promoting

CoolSculpting ® in your practice?

1. Customer service: Always

listen to your patient and their

expectations. Understand the

emotional attributes attached to

the desired outcome.

2. Know your limitations: Get to

know what CoolSculpting ®

can and cannot do.

Overpromising a result can

lead to an unhappy outcome,

even if the results are the best

CoolSculpting ® can offer.

3. Be proficient in the body sculpting

consult: Understand the desired

outcomes and 'S' curves. Body

sculpting is not only about

removal of volume; sometimes,

there may be a deficit that may

require volume instead.

Inappropriate or over-treatment

of an area may lead to an

undesirable – and sometimes

irreversible – outcome.


products & services

CoolSculpting ® Technology


The idea of cryolipolysis began in 1970

when researchers discovered that

some children developed dimples due

to sucking on popsicles. 1 The idea that

cold can 'selectively affect fat' inspired

Harvard scientists Dieter Manstein

and R Rox Anderson to develop the

proven Cryolipolysis ® science on which

CoolSculpting ® technology is based.* 2

The patented CoolSculpting ® technology

is exclusively licensed by Allergan. 3–6 AMP

*Data obtained from cryolipolysis investigations using

a pig model.

References: 1. Epstein EH, Jr., Oren ME. N Engl J

Med 1970;282:966; 2. Manstein D, et al. Lasers Surg

Med 2008;40:595–604; 3. Allergan. Patent – Control

unit. US D568,258 S. 2008; 4. Allergan. Patent –

Monitoring the cooling of subcutaneous lipid-rich

cells, such as the cooling of adipose tissue. US

8,285,390 B2. 2012; 5. Allergan. Patent – System for

treating lipid-rich regions. US 8,523,297 B2. 2013;

6. Allergan. Patent – Device, system and method of

removing heat from subcutaneous lipid-rich cells. US

8,702,774,B2. 2014;

CoolSculpting ® reduces excess subcutaneous fat through Cryolipolysis ® * 1

CoolSculpting ® selectively

damages subcutaneous fatty

tissue while preserving the skin

and surrounding tissues* 1

The CoolSculpting ® procedure

targets and cools fat cells to

temperatures that trigger fat

cell apoptosis* 1

Following treatment, fat cells

enter apoptosis and the body’s

immune system naturally

processes the fat and removes

dead cells* 2

CoolSculpting ® has

demonstrated fat layer

reductions across multiple

treatment areas of up to 27%

at 6 months †3

For illustrative purposes only

The process can take up to

~3 months* 2

Fat cells undergoing intracellular

lipid crystallisation ‡4

For more information visit

*Data obtained from cryolipolysis investigations using a pig model.

†Study conducted July 2009 – January 2011 on a total of 112 patients, with n=85 patients available

for follow-up caliper evaluations. The average fat reduction at follow-up was 21.5%. The 27%

reduction refers specifically to the lower abdomen (n=55). Average reductions in other treatment

areas included: brassiere rolls 20% (n=4), lumbar rolls 22% (n=2), hip rolls 25% (n=20), inner thighs

17% (n=3), and medial knees 18% (n=1). Patients were treated at one or more sites for a total of up

to four treatment areas in a single session.

‡Fat cells were exposed to a temperature of –15.1˚C.

References: 1. Zelickson B, et al. Dermatol Surg 2009;35:1462–70; 2. Klein KB, et al. Laser Surg

Med 2009;41:785–90 3. Sasaki GH, et al. Aesthet Surg J 2014;34:420–31;

4. Allergan. Data on File INT/0112/2018.




Unlock the non-invasive fat reduction 1 opportunity with

CoolSculpting®, the World’s number 1 cryolypolisis

device. †2 Available in over 5000 clinics world wide and

with over 7 million treatments performed globally. *3

Based on HCP tracking market research in the US, UK, Germany, Canada, Brazil, China and Australia (N=526),

and global market research of the overall body shaping and skin tightening market.

Backed by Allergan

Allergan is a major pharmaceutical company and a leader in Medical Aesthetics. 4 As a key

Allergan brand, CoolSculpting® receives ongoing brand marketing investment to support

over 5,000 CoolSculpting® clinics worldwide. 3

Strong innovation focus

With 159 global Coolsculpting® patents to date 5 , Allergan has a strong research and

development focus 6 on the brand, with numerous technological advancements including the

CoolAdvantage® applicator family and FreezeDetect® to help reduce the risk of freeze burns. 1

Professional support and training

Enjoy personalised support and training from your Allergan Practice Development Manager.

Combined with exclusive access to our online training and resource portal, and detailed

treatment analytics, you have the tools you need at your fingertips.

To learn more about CoolSculpting® please contact us on either of the following;

PH: 1800 252 224 (option #5) • EMAIL:

* as of September 2018.

1. Allergan, User Manual CoolSculpting ® System, BRZ-101-TUM-EN6-K 2. Allergan, Data on file. INT-CSC-1950062 3. Allergan, Data on file. INT/0484/2018 4. Medical Insight Inc The Global

Aesthetic Market Study: Version XVII. 2019. 5. Allergan, Data on file. INT/0485/2018 6. Allergan, Data on file. INT/0586/2018

During the procedure you may experience sensations of pulling, tugging, mild pinching, intense cold, tingling, stinging, aching and cramping at the treatment site. These sensations may subside

as the area becomes numb. Following the procedure, typical side effects include redness, swelling, blanching, bruising, firmness, tingling, stinging, tenderness, cramping, aching, itching, skin

sensitivity and numbness. Numbness can persist for up to several weeks. A sensation of fullness in the back of the throat may occur after submental treatment. Rare side effects such as paradoxical

hyperplasia, late-onset pain, freeze burn, vasovagal symptoms, subcutaneous induration, hyperpigmentation and hernia may also occur. The CoolSculpting ® procedure is not for everyone. You

should not have the CoolSculpting ® procedure if you suffer from cryoglobulinaemia, cold agglutinin disease or paroxysmal cold haemoglobinuria. The CoolSculpting ® procedure is not a treatment

for obesity. 1

Adverse events should be reported to

CoolSculpting ® and its design are registered trademarks of ZELTIQ Aesthetics, Inc., an Allergan affiliate. Trademark(s) of Allergan, Inc.

© 2019 Allergan. All rights reserved. Allergan Australia Pty Ltd. 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. AN-CSC-1950087 V2.

Date of preparation: September 2019

Images provided by Allergan. For Illustrative purposes only.

products & services



Developed by Italian device manufacturer DEKA, Onda is now making

waves on Australian shores with local distributor High Tech Medical.

Recently released on the

Australian market, Onda by

DEKA is a game-changing

body contouring device, capable of

producing impressive and longlasting

results through a quick and

comfortable treatment.

As the first device to harness

microwave frequencies that target

the skin’s deeper layers, Onda

sculpts the body while reducing

cellulite and tightening skin.

Onda can heat the subcutaneous

fat and connective tissue to around

8-10 degrees hotter than typical RF

devices, while maintaining the same

or lower skin temperature. Research

suggests this can produce a greater

reduction in adipose cell viability in

less treatment time. It also allows

Onda to reach key temperature

thresholds for effective cellulite

reduction and skin tightening in

addition to fat loss.

Onda is the only system that

uses Coolwaves. These are special

microwaves that selectively target

fat cells to reduce localised fat

deposits in a safe, effective and noninvasive

way. These microwaves

are part of the electromagnetic

spectrum (frequency range:

1-300GHz) and are commonly

found in everyday life.

The Onda handpieces generate

microwaves at 2.45GHz, a

frequency that is preferentially

absorbed by fat molecules rather

than by water molecules. The

epidermis and the dermis of the

skin contain a high percentage of

water but little fat. Therefore, when

Coolwaves penetrate the skin, they

pass straight through the top layers

without depositing excessive heat

(about 20 per cent of the thermal

effect from the microwaves). The

majority of the Coolwaves energy

affects the subcutaneous fat, which

is heated far more rapidly that the

skin (approximately 80 per cent of

the thermal effect).

In contrast, traditional radio

frequency (RF) systems, which act

in the frequency range 0.1-40 MHz,

deposit energy mainly on the skin

surface due to high absorption

by water molecules. This means

they not only fail to penetrate deep

into the body to treat fat, but they

also risk patient discomfort and

excessive heating of the skin. This

is not the case with Onda.


Onda has three primary indications:

localised fat deposits, cellulite and

skin tightening.

• Localised fat deposits: Onda’s

deep handpiece enables

Coolwaves to penetrate deeply,

disrupting the membranes of

subcutaneous fat cells. The

lysate is subsequently drained

off by stimulation of physiological

metabolic processes (macrophage

lipolysis). The cooling system

integrated into the handpieces

ensures that the skin remains cool

for maximum patient comfort.

• Cellulite: Histology shows that

Onda can effectively target the

connective septa between the

adipose globules in the more

advanced stages of cellulite.

• Skin tightening: The microwaves

induce immediate shrinkage of

the collagen fibres in the dermis

and stimulate the production of

new collagen, resulting in firmer

and more toned tissues. It takes

about three treatments for lasting

results and is favoured by patients

for price point, comfort and visible


Utilising this unique technology,

which is achieving exceptional

outcomes in a quick and affordable

treatment, you will find Onda is the

ideal way to expand your clinic’s

offerings. AMP


The Onda

experience with

Dr Saras Sundrum

from Dr Saras and Co, NSW

What makes Onda stand

out from other body

contouring devices

you’ve used?

At Dr Saras and Co clinics, we

realised that body contouring

treatments were what the modern

day patient wanted and would

be willing to pay for. So about

10 years ago we began to invest

in body sculpting technology.

Our latest device is the Onda

Coolwave system. There are a

number of key benefits to Onda:

• Onda offers quick treatment

times – it takes 10 minutes to

treat a 15cm by 15cm area.

• It is not painful – it feels like a

warm deep-tissue massage.

• It is non-invasive, so there

are no risks such as those

associated with surgery,

anaesthesia and injectable forms

of treatment.

• It can be used over many body

areas – under arms, bra fat, the

back, the flanks, the abdomen,

the buttocks and the legs.

• There really is no downtime or

aftercare involved.

• The price point for the Onda

treatment is very favourable

compared to other body

contouring devices.

• The treatment only needs to

be performed once a month

and although there need to

be 3-6 treatments per area,

patients can begin to

see results as early as the

second or third treatment.

Who is your typical

Onda patient?

There really is no typical Onda

patient. We see both men and

women seeking this new innovative

treatment. There may be a

woman who really wants the cellulite

on her legs treated, or a man

who is carrying a little too much

fat on his abdomen, or there may

be an individual who has lost a bit

of weight and wants some skin


What kind of results have

you achieved with Onda?

We have now had our Onda

device for three months and

have had some fantastic results,

both in terms of reducing fat

and improving areas of cellulite. I

know a device is going to be very

popular in our clinics when my

staff love the results they achieve

on their own bodies. Another

thing that we have noticed is that

each happy patient is eager to

recommend Onda to their family

and friends.

How has High Tech Medical

supported your Onda


I am very grateful to High Tech

Medical for their ongoing support.

Their trainers have provided indepth

training for my staff. They

also had a recent workshop with

overseas experts sharing their

knowledge and experience of the

Onda device.

Call High Tech Medical for more

information on 1300 309 233

or visit




bodies and



As the latest body

sculpting technology

to arrive on Australian

shores, TESLAFormer

delivers next-level FAt

burning and muscle

building results.

Body contouring is one of

the most sought-after

treatments of 2019. But

what if you could offer patients fat

loss and muscle building in a single

non-invasive treatment? Well, with

TESLAFormer, you can.

TESLAFormer is a new body

forming device that uses the latest

Functional Magnetic Stimulation

(FMS) technology to burn fat and

strengthen muscle in the glutes,

abdomen, hamstrings, arms and

pelvic floor.

This innovative platform is the

only system capable of operating

all muscle groups. It comes with

set programmes for different parts

of the body, but can also be used

manually by trained therapists.

TESLAFormer can induce more

than 50,000 muscle contractions

in a single session, making it a

powerful and effective way to sculpt

and tone the body.

Developed in Europe by Iskra

Medical, TESLAFormer is now

available throughout Australia

through local distributor

Cryomed Aesthetics.

How it works

TESLAFormer is a highly

concentrated, targeted and effective

device for body forming. Like

exercise, TESLAFormer triggers

motoric nerves and excites muscle

contraction. Studies show that

repeated exposure to FMS results in

increased muscle mass.

The FMS magnetic field generated

by TESLAFormer propagates

through clothes, skin and bone.

Once it has reached the deep

tissue, this field is transformed via

induction into a local electrical field,

which depolarises the motor nerves.

Signals then travel along the nerves

to the muscles and force them to

contract. Muscle contraction is then

induced repeatedly, without the

muscles becoming fatigued.


Butt lifting

Assist posture

products & services

30 m


No o

No p





• Strengthens muscle

• Reduces fat

• Non-invasive

• No downtime

• Delivers more than

50,000 contractions per

30 minute session

• Electromagnetic energy

• No operator required

• No preparation required

• Dual sculpting

The energy required to support

this process is sourced from local

fat deposits. During treatment,

local fat tissue in the target area

quickly depletes. The continuous

intense muscle contractions also

force the muscle to increase in

strength and volume. In this way,

TESLAFormer treatments create

natural looking results.

With applicators built into the

seat and backrest of the chair, the

magnetic field can reach structures

inside the pelvic floor and back. Just

by sitting on the chair, FMS works

the deep pelvic floor muscles that

even people who train regularly

tend to neglect.

In addition to muscle

development, core therapy, physical

therapy, posture improvement

and rehabilitation, TESLAFormer

can be used to treat stress urinary

incontinence in women and some of

the symptoms of prostate in men.


in practice

TESLAFormer treatments are a great

option for patients who want to look

fit and healthy, not just reduce excess

fat. FMS is also suitable for patients

who are not candidates for FMS.

No preparation is required before

the TESLAFormer treatment and a

typical treatment lasts 30 minutes.

During this time, the device can

deliver more than 50,000 muscle

contractions, with the TESLAFormer

reaching a magnetic field strength of

up to three Tesla.

A total of eight sessions

carried out every other day are

recommended for best results.

There are no negative side effects

of TESLAFormer treatments,

once all contraindications are

taken BUTTOCKS into account.

TESLAFormer boasts a large,

easy to operate user interface.

Applicators can be positioned

manually to find target motor units

and enable effective stimulation.

TESLAFormer also comes with a

set of pre-prepared protocols for

performing therapies based on

diagnosis or tissue type. Additionally,

users can create custom protocols

when required.

TESLAFormer treatments can be


performed manually by a trained

therapist or in the absence of a

therapist by attaching the applicator

to the body or fixing it to the stand

or trolley. In this way, the device

is easy to integrate into aesthetic

medical practices and can quickly

deliver a healthy ROI.

FMS is changing the way

we approach body sculpting by

giving patients the aesthetic

they desire, while delivering a

workout in the process. This

innovative platform is a gamechanger

in the field of aesthetic

medicine, offering truly desirable

outcomes without discomfort,

surgery or downtime. AMP

For enquiries, call 1300 346 448 or












products & services

H Y A L U R O N I C A C I D + A N T I O X I D A N T S

Mannitol matters


STYLAGE by VIVACY, formulated with mannitol, is a breakthrough range

of dermal fillers thAT uses powerful antioxidants to transform the

patient experience and achieve optimal resuLTS.

When it comes to delivering

exceptional outcomes

with hyaluronic acid (ha)-

based dermal fillers, STYLAGE by

VIVACY should be at the forefront of

every practitioner’s mind.

Now available across Australia

through EnVogue Skin, this fiveproduct

range of HA gels uses

antioxidants and IPN-like technology

to achieve impressive results across

a variety of in-demand aesthetic

treatments, including wrinkle

reduction, lip enhancement, facial

remodelling, volume restoration,

skin hydration and elasticity


STYLAGE stands out from

other HA fillers on the market

today as it uses patented IPN-like

technology to optimise gel

elasticity and viscosity. The

physico-chemical properties of

HA are preserved during storage

and upon injection with mannitol,

while Bi-SOFT Injection Technology

supports the precise delivery of

STYLAGE products.

Made with


When a needle is inserted into

the skin tissue, the inflammatory

response includes the activation

of free radical-generating enzymes

at the injection site. These reactive

molecules – known as hydroxyls

radicals – attack the injected HA

and try to break down its overall

structure. Because antioxidants can

neutralise a radical without forming

another, the inclusion of antioxidants

in HA gels can reduce and prevent

damage from free radical reactions.

The entire STYLAGE range has

been formulated with mannitol.

Mannitol is a chemically inert polyol

found naturally in fruit, vegetables

and plants. It is widely used in the

pharmaceutical industry and has

been incorporated into STYLAGE

gels to preserve the physicochemical

properties of HA.

Mannitol is antioxidant specific

to the most aggressive hydroxyl

radicals. It minimises degradation of

the HA once injected, prolonging the

duration of HA in the skin tissues.

Mannitol also acts as a thermal

stabiliser, guaranteeing the stability

of STYLAGE products even at high

temperatures. This ensures effective

and consistent correction after long

periods of storage.

Mannitol can reduce the duration

and severity of the inflammatory

response after injection, allowing the

HA gel to settle more quickly and

integrate into the tissue, facilitating

a better patient experience and

optimising the final outcome.

Mannitol is well tolerated by the

body, even at high doses.

IPN-like technology

The IPN-like technology used by

Laboratoires VIVACY is an advanced

HA cross-linking process that

involves combining two monophasic

HA networks that have already

been purified and cross-linked but

are mechanically independent by

inserting one network into the other.

This technique allows each

product’s viscoelastic properties


products & services

The physico-chemical properties of

HA are preserved during storage and

upon injection with mannitol.

to be accurately defined. It

optimises the product rheology to

guarantee good injectability. IPN-like

technology also preserves the partial

independence of the interpenetrated

networks, while increasing the

density of chemical nodes. It

supports the cohesion of the HA gel

and its monophasic properties.

The elasticity of each STYLAGE

product is optimised according to

the target indication: lower for fine

lines and superficial wrinkles; higher

for deep wrinkles or thicker skin.

The viscosity of every STYLAGE gel

is also adapted to match the density

of the tissue for which it is intended.

Backed by research

A prospective, multi-centre, open

study on STYLAGE products

conducted on 96 patients over

a one-year period confirmed

STYLAGE gels are well tolerated

by the skin.

Effects like oedema, redness and

haematomas typically observed with

this type of injection resolved, on

average, within seven days, with no

delayed adverse effects found at the

one-year follow-up. The study also

showed that 97 per cent of patients

treated with one of the STYLAGE

products were satisfied with the

treatment at 12 months.

In a separate report, Laboratoires

VIVACY performed a five-year

satisfaction survey in eight countries

involving 80 practitioners. According

to the study:

• 87 per cent of practitioners

considered the volumising effect

of STYLAGE more convincing

than what they usually saw in their

general practice.

• 85 per cent of physicians

indicated that patients treated

with STYLAGE had better than

average skin quality (hydration,

suppleness and appearance).

• Regarding the lifting capacities

(which are directly linked to

product elasticity), 87 per cent

of physicians declared that

STYLAGE product capabilities

were notable, compared to

what they usually saw in their

general practice.

• 91 per cent of physicians

were totally satisfied with

the post-treatment appearance


Offering predictable, longlasting

results at a competitive

price point, the STYLAGE range is

helping practitioners to improve the

patient experience and produce

desirable outcomes that clients

will return for again and again. In

this way, STYLAGE helps new

and established medical practices

to enhance their clinical offerings

and become thriving aesthetic

businesses. AMP

For more information call

Ian Carroll 0452 104 365 or email


An expert’s view

Denis Couchourel, Scientific and

Medical Director at VIVACY Paris,

explains the vital role mannitol plays in

the STYLAGE range.

During intradermal injection, the invasive

movement of the needle or cannula

through the epidermal, dermal and

hypodermal layers provokes the early

stages of inflammation. In the tissue, this

process is characterised by an ‘oxidative

burst’, which means the cells produce

a lot of deleterious molecules known as

Reactive Oxygen Species (ROS). ROS,

among other properties, can accelerate the

degradation of injected HA gels.

Since the mechanical behaviours of

STYLAGE gels are carefully fine-tuned to

adapt to the injected target tissue, it was

mandatory to protect the products during at

least the 48-hour period following injection.

This period is clearly critical in terms of the

safety and efficacy of the treatment.

To ensure the rheology set in the syringe

will remain in the tissue upon injection,

even when the product is ‘attacked’ by

ROS, we decided to add mannitol. This

polyol has a higher affinity than HA for ROS.

This means mannitol will scavenge those

molecules before they can start to degrade

the gel. There are many scientific papers

demonstrating mannitol anti-radical activity,

including in association with HA.

The conclusion here is not to say

that STYLAGE duration after injection is

higher than competitors. Indeed, mannitol

acts only during the 48-hour period

after injection, then the gel enters its

normal degradation process. Our aim

was to keep the gel as close as possible

to the rheology defined in the syringe

during the ‘bio-integration’ period that

begins just after injection.

Additionally, the presence of mannitol

brings an evident thermal stability to

STYLAGE products. The most obvious

consequence of this is that the shelflife

of STYLAGE is 29 months, whereas

competitors generally have a 24-month















As we know, facial ageing

doesn’t appear in one fell

swoop. There’s nothing

uniform about it. Likewise, there

is no one-size-fi ts-all solution to

concerns as varied as volume loss

in the cheeks and mid-face, heavy

jowls, hollow temples or thinning

lips. Juvéderm ® does, however,

off er you a one-stop-shop when it

comes to the various fi llers required

to create natural looking anti-ageing

results across the board.

And it’s not just mature faces that

Juvéderm ® lends itself beautifully

to. For younger patients seeking a

fuller pout, more sculpted cheeks or

better-defi ned jawline, Juvéderm ®

off ers a common-sense stable

of products that allows you to

deliver bespoke and individualised

treatment plans.

The various fi llers in the

Juvéderm ® line-up can be used

alone, or to complement each

other, producing eff ective, naturallooking

results across a vast patient

population. In short, whether your

patient is seeking subtle volume,

clever contouring or elevation plus

elasticity, the Juvéderm ® family

of technologically advanced fi llers

can enable you to deliver the

ultimate results.

HA for Facial Restoring

and Recontouring

Few today would argue that

Hyaluronic Acid (HA) is the

most viable and eff ective option

for rejuvenating, restoring and

recontouring volume in the face.

In fact, a 2012 study and report

by Muhn C et al stated that

optimal results using HA fi llers are

dependent on correcting volume

defi ciencies in the facial envelope

and 'should include creating a

foundation for deep structural

support in the supraperiosteal

or submuscular plane; volume

repletion of subcutaneous

fat compartments; and the

reestablishment of dermal and

sub-dermal support to minimise

cutaneous rhytids, grooves

and furrows.'

With superior quality HA products

across its entire family of fi llers,

each using diff erent concentrations

and compositions of HA chains,

Juvéderm ® is able to achieve

unrivalled results in a number of

treatment areas.


products & services

Dr Steven Liew

on the Juvéderm ®

Family of Fillers

Vycross ® vs Hylacross ®


Where traditional Hylacross

technology uses only highmolecular-weight

HA, which boosts

cohesivity following injection,

Vycross ® technology combines both

low-molecular- weight and highmolecular-weight

HA to increase

elasticity and aid in diffusion after

injection. Vycross ® technology

has been touted to produce more

natural looking results, as a direct

result of this diffusion.

The latest generation of

Juvéderm ® fillers – Volbella ® , Volift ® ,

Voluma ® and Volite ® has been

formulated with Vycross ® to deliver

exceptional results.

The Juvéderm ® Vycross ® range –

in particular Volbella ® – is a hugely

popular choice in lip enhancement.

Indeed, a 2014 Phillip- Dormston

W G et al. study found that of 62

subjects injected with Volbella for

enhancement and correction of

asymmetry of the lips, 83.6 per

cent were Extremely Satisfied,

Very Satisfied or Satisfied with the

aesthetic improvement, immediately

after injection.

At four-weeks post-injection,

1. What is your favourite

Juvéderm ® sub-brand for

cheeks and why?

It has to be Juvéderm ® Voluma ® . It is

an extremely versatile product, able

to provide projection, reflation and

volumisation, based on the patient’s

requirements. It is soft and has great

product integration into the patient

tissue. What this means is that a

patient can come in and have this

done non-traumatically, or gently, and

is able to walk out looking great, with

no tell-tale sign of the procedures

that have been done. It looks so

smooth, softly contoured and when

you feel it, it just feels like a normal

cheek tissue. That is why to me, this

is the number one, overall Juvéderm ®

sub-brand that I prefer.

2. What is your favourite

Juvéderm ® sub-brand for lips

and why?

Juvéderm ® Ultra ® , for a number of

reasons. It is versatile enough for

every type of lip that I like to create.

For instance, I can use it for a nice

lip enhancement for a younger

patient who likes a fuller lip. It

has the power of creating a nice

pout, creates hydration and a

beautiful shape.

In a more mature patient, we can

use less product and create a very

conservative rejuvenation to the lip,

as well as also improve the corner

of the lip. That is why if I were to

choose something for the lip, this is

what I would use for young and older

patients. We just need to vary the

injection technique and obviously be

very conservative with the amount in

the older patient. And it lasts around

12 months, which is very important

to our patients.

3. What do you think is

the most versatile Juvéderm ®

sub-brand for the total face

and why?

Juvéderm ® Voluma ® , based on

the fact that it has a very good

lifting capacity and we are able to

recontour the cheek, jawline and

chin, as well as other parts of the

face such as the temple and the


Obviously in areas such as the

forehead, which doesn’t have a

lot of soft tissue, we would place

it in a deeper plane in a smaller

amount. That is why I find this the

most versatile. We can actually use

it to create a lot of projection, or we

can limit the amount of product and

placement in a different plane to

gently recontour and soften up.

4. If there is one Juvéderm ®

sub-brand you couldn’t

live without, which would

it be and why?

Again, it would be Juvéderm ®

Voluma ® , for all the reasons I have

outlined above. Voluma ® is an

all-rounder and out of the range, it

is my favourite.


products & services

this increased to 94.1 per cent

in patients who received top-up

treatment, and 93.0 per cent

in patients who didn’t receive

top-up treatment.

Furthermore, 61.7 per cent of

patients in the rated the look and

feel of their lips as Extremely Natural

or Very Natural immediately after

injection, a number which increased

to 75.0 per cent and 93.0 per cent

in subjects with/ without top-up

treatment at follow up, respectively.

Sustained Efficacy

and Longevity

HA fillers using Vycross ®

technology are intended – and used

successfully for – deeper injections

and volume re-contouring. Enter,

Voluma ® , a thicker, deeper filler,

commonly used for correcting

volume deficiency in the mid

face and cheek. Once injected,

it assimilates well, emulating the

natural tissue present, and achieving

remarkable results. And its efficacy,

longevity and safety profile has

stood up to rigorous study.

Callan P et al. examined the

efficacy, longevity and safety of

Voluma ® filler over a 24-month

period, enrolling 103 subjects

with mid-face volume deficiency

and using Voluma ® HA to correct

each case. Injections were

performed into the malar area

and were administered with one

or two sessions over an initial

four-week period.

The first post-treatment evaluation

was at week eights, with 96 per

cent of patients displaying at a least

a one-point improvement on the

six-point Mid-Face Volume Deficit

Scale (MFVDS). Notably, 81.7 per

cent of patients were still MFVDS

responders at week 78.

In total, 72 subjects completed

the 24-month study. At the end of

the study 66 out of 72 subjects were

either Satisfied or Very Satisfied with

Voluma ® , with 70 out of 72 patients

indicating they would recommend

the product to others. The study

concluded that Voluma ® is safe and

effective in the correction of mild to

severe facial volume.

HA with Lidocaine

Each of the fillers in the Juvéderm ®

Vycross ® range use HA with

Lidocaine to ensure smooth

results and minimal discomfort

in a comfortable treatment. This

also helps to minimise swelling

immediately following treatment.

Long Term


Treatment Plan

Facial rejuvenation patients are

increasingly looking for subtle

but effective solutions. The

complementary properties of

the Juvéderm ® from Allergan ®

range means the fillers can be

used in conjunction with each

other to achieve just this – subtle

but effective results. This affords

practitioners time to adjust

treatments gradually, according

to how filler from the previous

treatment has settled and use

different products for various facial

areas to create the most natural,

effective long-term results over time.

With a recorded history of

effective, durable and widely

applicable results, Juvéderm ® from

Allergan is a positive investment in

any cosmetic practice. AMP

For more information visit

The Juvéderm

Family of Fillers

Juvéderm ® Volite ® with

Lidocaine is injected into the middle

layers of the dermis across many sites,

nourishing the skin from the inside out,

improving skin quality and hydration

for up to nine months of more. This

product has the lowest concentration

of HA in the Juvéderm ® portfolio,

making hydration its primary focus,

not volume.

Juvéderm ® VOLBELLA ® with

Lidocaine is an injectable gel implant

formulated to effectively treat fine lines

and medium-sized skin furrows due

to premature ageing, scarring or other

conditions. It can also be used to

enhance the lips or create a fuller pout.

It is intended to be used via superficial

or mid-dermis injection or lips mucosa.

Juvéderm ® VOLIFT ® with Lidocaine

is an injectable gel implant formulated

to treat deep skin depressions due

to premature aging, scarring or other

similar conditions. It can also be used

to contour the face and/or restore

volume. Juvéderm ® VOLIFT ® with

Lidocaine is formulated to be used via

deep dermis or lips mucosa injection.

Juvéderm ® VOLUMA ® with

Lidocaine is an injectable implant

intended to restore volume of the face.

Juvéderm ® ULTRA TM XC is an

injectable implant used for filling any

medium-sized depressions of the skin

via mid-dermis injection, as well as

to create or restore lip definition and

improve/enhance pouting of lips.

Juvéderm ® ULTRA PLUS TM XC is

an injectable implant used for filling

mid and/or deep depressions of the

skin via mid and/or deep dermis

injection, as well as for lip definition

and enhancement.


PBS Information: BOTOX ® injection is not listed on the PBS for glabellar lines,

crow’s feet lines or forehead lines

Before prescribing, please review Approved Product Information available on request

from Allergan by phoning 1800 252 224 or from

Australian Minimum Product Information

BOTOX ® (botulinum toxin type A) purified neurotoxin complex is a prescription medicine containing 50 units (U), 100 units (U) or 200 units (U) of botulinum toxin type A for injection.

Indications: Overactive bladder with symptoms of urinary incontinence, urgency and frequency, in adult patients who have an inadequate response to or are intolerant of an anticholinergic

medication; urinary incontinence due to neurogenic detrusor overactivity resulting from a defined neurological illness (such as spinal cord injury or multiple sclerosis) and not controlled adequately

by anticholinergic agents; prophylaxis of headaches in adults with chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine); strabismus;

blepharospasm associated with dystonia, including benign blepharospasm & VIIth nerve disorders (hemifacial spasm) in patients 12 years & over; cervical dystonia (spasmodic torticollis); focal

spasticity of the upper & lower limbs, including dynamic equinus foot deformity due to spasticity in juvenile cerebral palsy patients 2 years & older; severe primary hyperhidrosis of the axillae;

focal spasticity in adults; spasmodic dysphonia; upper facial rhytides (glabellar lines, crow’s feet and forehead lines) in adults. Contraindications: Intradetrusor injection - acute urinary tract

infection, acute urinary retention in patients who are not routinely catheterising or who are not willing and/or able to initiate catheterisation post-treatment, if required; Hypersensitivity to

ingredients; Myasthenia gravis or Eaton Lambert Syndrome; Infection at injection site(s). Precautions: Different botulinum preparations are not therapeutically equivalent. Exercise extreme

caution should substitution with another botulinum preparation be necessary. Botulinum toxin effects may be observed beyond site of local injection with symptoms consistent with mechanism

of action and reported hours to weeks after injection. Symptoms may include muscular weakness, ptosis, diplopia, blurred vision, facial weakness, swallowing and speech disorders, constipation,

aspiration pneumonia, difficulty breathing and respiratory depression. Risk of symptoms is greatest in children with spasticity but can also occur in adults particularly those on high doses.

Swallowing/ breathing difficulties can be life threatening and there have been reports of death (relationship to BOTOX ® not established). Serious adverse events including fatal outcomes have

been reported in patients who had received BOTOX ® injected directly into salivary glands, the oro-lingual-pharyngeal region, oesophagus and stomach. Hypersensitivity reactions such as

anaphylaxis and serum sickness, as well as urticaria, soft tissue oedema and dyspnoea; inflammation at injection sites; excessive weakness in target muscle; pregnancy & lactation. Generalised

weakness & myalgia may be related to systemic absorption. Blepharospasm: Reduced blinking following injection of the orbicularis muscle can lead to corneal pathology. Caution with patients

at risk of angle closure glaucoma, including anatomically narrow angles. Strabismus: Inducing paralysis in extraocular muscles may produce spatial disorientation, double vision or past pointing.

Use in chronic paralytic strabismus only in conjunction with surgical repair to reduce antagonist contracture. Spasticity: Not likely to be effective at a joint affected by a known fixed contracture.

Not for treatment of focal lower limb spasticity in adult post-stroke patients if muscle tone reduction is not expected to result in improved function, improved symptoms or to facilitate care. To be

used with caution in patients at risk of fall. Cervical Dystonia (spasmodic torticollis): Possibility of dysphagia or dyspnoea. May be decreased by limiting dose injected into the sternocleidomastoid

muscle to

Aptos Thread






With over 30 diff erent

threads available in

51 countries, Aptos

is recognised as the leader in

international thread lifting products

and methods. To date over

11,000 Doctors have been trained

internationally in Aptos thread lifting

methods and Aptos has been the

recipient of numerous international

awards for thread lifting excellence.





A signifi cant development in

thread lifting technology was

the introduction by Aptos of a

long lasting absorbable material

consisting of polylactic acid (PLA)

and polycapralactone (PCL). This

unique combination of materials

ensures long lasting thread lifting

results as the thread is absorbed

over a period of one and half to two

years. During this long absorption

time collagen type 1 and collagen

type 3 is developed.

The development of collagen

types 1 and 3 results in the

formation of a fi brous capsule that

continues to hold soft tissues even

after the thread is fully absorbed.

This prolonged tissue reaction

(neocollagenesis) guarantees stable

and long lasting results with the

Aptos thread material. By contrast

polydioxanone threads demonstrate

an average absorption period of

between 60 and 90 days. This

short absorption time off ers minimal

collagenesis and a limited duration

of thread lift eff ect. For this reason

polydiaxanone threads are best

indicated for skin rejuvenation rather

than long term lift eff ect.




Excellence Visage has multiple

applications and can be successfully

applied for both lifting and

reinforcement of almost all areas

of the face and neck. A signifi cant

advantage of the Excellence

Visage thread is that the thread is

preinstalled in a special atraumatic

cannula with a rounded tip. The

rounded tip assists the practitioner

to remain in the correct plane and is

designed to separate and reposition

tissue without any breaks thereby

reducing the risk of perforation

and making damage to the deeper

structures practically impossible.

Aptos Excellence Visage is

available in a pack of 10 threads.

Each multidirectional thread is

190mm long and is preloaded in

a 20G x 150mm non-traumatic

rounded tip cannula with a hole

on the side. The long 190mm

thread off ers the practitioner the

opportunity to insert each thread

multiple times making this choice

of thread both eff ective and

economical. (Figure 1)




Excellence Body Threads can

be used for rejuvenation and

lifting of various parts of the body

including arms, breast, abdomen,




AFTER liposuction and Aptos threads to the neck area.

buttocks, inner thighs, knees and to

address atrophy or slight excesses

of skin in other areas of the body.

The procedure not only strengthens

the tissue but also makes the skin

more elastic as a result of sustained

neocollagenesis resulting from the

long absorption time (18-24 months)

of the Aptos Body Thread. Typically

the skin improves in quality and

skin colour, texture and hydration is

signifi cantly improved.

The Excellence Body thread

is an absorbable thread with

multidirectional barbs to enforce body

tissue holding. The multidirectional

barb can distribute stress and

eff ectively hold soft tissues strongly

after insertion. There are four

multidirectional barbs per centimetre

along the entire length of the thread

to ensure strong tissue fi xation and

maximum lift and rejuvenation eff ect.

Each pack of Excellence Body

Threads contains 15 threads each

240mm in length with a cannula 19G

x 200mm (2 pieces) and a lancet point

injection needle 18G x 40mm. The

correct layer for thread implantation

is in the subcutaneous tissue. Once

the cannula is inserted into the

subcutaneous tissue the cannula will

move easily encountering only slight

resistance. (Figures 2 & 3)




It is not just the thread that

produces the best result, equally

important is the method and the

skills applied. Mara Aesthetics

conducts regular Aptos training

workshops at its training centre –

South Pacifi c Cosmetic Academy

– to ensure all doctors are profi cient

with Aptos methods.

Workshops are conducted by

accredited Aptos trainers and include

Initial and Advanced courses. On

completion of the Initial course

doctors have access to the extensive

Aptos on-line video library with over

400 videos available in English.

Training is conducted on a doctorto-doctor

basis. AMP

To fi nd out about Mara Aesthetics

training workshops visit www. under the

heading South Pacifi c Cosmetic

Academy or phone 02 9056 5036.

TGA COMPLIANCE.. All Aptos threads

comply with TGA Regulations and are listed

on the Australian Register of Therapeutic

Goods (ARTG).

Figure 1. Facial Lifting with Excellence Visage

Figure 2. Excellence Body threads

Figure 3. Body marking









After months of research

and collaboration, the

mesoestetic Pharma

Group laboratory has released a

complete range of next generation

sunscreens for all skin types, with

fi ve unique products that utilise the

most innovative technology in sun

protection. With this pioneering

range, mesoprotech ® raises the

bar for sun protection through its

focus on the unique requirements of

individual skin types and concerns.

mesoprotech ®


All products in the new range

feature mesoprotech ® complex,

a broad-spectrum sun protection

formula that combines physical,

biological and/or chemical fi lters for

maximum protection against UVB

and UVA radiation. This combination

protects the skin on all fronts

from the harmful eff ects of sun

exposure including actinic damage,

oxidation and premature ageing. All

fi ve products are very high factor

sunscreens (SPF 50+) and tested for

water resistance.

Innovative ingredients

This new range features a number

of core components that place it

a cut above other sun-protection

alternatives on the market.

• Mattifying particles eliminate

excess oil and shine and leave the

skin with a velvety matt fi nish.

• Chia seed oil, rich in omega

3 and 6, provides elasticity and

nutrition while strengthening the

skin’s barrier function.

• Hyaluronic acid and silicon

provides hydrating action at the

epidermal level and enhances

elasticity and fi rmness.

• Pigment system helps prevent






the appearance of sunspots and

produces a more even skin tone.

• Rosa canina fruit essential oil

helps boost epidermal repair


Collagen pro shield

mesoprotech ® ’s fi ve innovative

sunscreens are formulated with

‘collagen pro shield’ which

provides antioxidant protection that

neutralises free radicals. collagen pro

shield helps prevent photo-ageing

and improves fi rmness of the skin.



1. mineral matt anti-ageing fluid

is specifi cally for combination,

oily and sensitive skin types.

The formula includes mattifying

particles and mineral fi lters that

eliminate excess shine and leave

the skin with a velvety matt fi nish.

It has an innovative non-greasy

fl uid texture that turns into a

powdery emulsion on the skin.

2. light water anti-ageing veil

is designed for normal and

combination skin types. It is

formulated with hyaluronic acid

and silicon to provide hydrating

action, enhancing elasticity and

fi rmness. Its ultra-light emulsion

texture is rapidly absorbed to

create an invisible protective veil.

3. nourishing anti-ageing oil

is intended for dry, mature skin.

It is formulated with chia seed oil

and therefore rich in omega 3 and

6. This innovative protective oil

provides elasticity and nutrition to

the skin while strengthening the

skin’s barrier function. It has a light

oil gel texture that melts into the

skin leaving a dry fi nish.



melan 130 pigment control is for

skin with pigmentation concerns,

including skin undergoing cosmetic

treatment, skin aff ected by hormonal

changes, photosensitive skin and

more. Its pigment system helps to

prevent the appearance of sunspots

and promotes a more even and

brighter tone. The ultra-fl uid texture

contains pigments to avoid leaving

a white residue on the skin, while

minimising imperfections and

providing a lightweight, natural tone.

Maximum protection

for sensitive areas

sun stick 100 is specifi cally for

sensitive areas such as the lips, eye

contour, scars, etc. It incorporates

rosehip oil to boost skin regeneration

and comes in a practical, solid

stick form that enables application

anytime with comfort and ease.

Clinically tested

Scientists conducted in vivo tests

for UVB protection where a subject’s

back was exposed to rays and

treated with the product. The test

measured the additional time during

which the sunscreen provides

protection before erythema occurs.

Water resistance was also tested

in vivo where the subject was

immersed in water for 20 minutes

with a 15 minute interim. The

subject’s skin retained more than

50% of the protection applied.

In vitro tests were conducted

for UVA protection where a dish

treated with the product is exposed

to UVA radiation to evaluate its

absorption capacity. The effi cacy

of collagen pro shield was also

tested with studies on human

fi broblast cultures.

It is essential to match the correct

mesprotech ® product to the skin

type as an unsuitable sunscreen

can result in insuffi cient application

through lack of adherence.

mesoprotech ® products have been

evaluated in accordance with ISO

24444 standards in compliance with

European regulations.

With its dermatologically tested

formulas and innovative textures

designed to suit the needs and

demands of each skin type,

mesoprotech ® is at the forefront

of next-generation sun protection

against UVA and UVB. AMP

For more information call 1800 242 011, email or



products & services


& est clinic Collaboration

collaboration is considered essential for brand development and growth

and A new alliance between SkinCeuticals and Dr Frank Lin at EST Clinic in

Victoria proves how beneficial such strategic alliances can be.

Already ranked as the

Number One US medical

aesthetic skincare brand

worldwide, SkinCeuticals (owned

by parent company L’Oréal),

is renowned for its critical antiageing

breakthroughs and

with its cornerstone pillars of

Prevent, Protect and Correct, it is

considered to be at the forefront of

antioxidant technology.

The Antioxidant


SkinCeuticals, an industry leader in

antioxidant formulations, is trusted

by skincare professionals and

leading media figures globally. Since

its inception in 1989, the company

has forged new paths and now

boasts over 30 years of research,

40-plus clinical studies and more

than 25 international dermatological


Its founding scientist and chief

medical advisor Dr Sheldon Pinnell

established SkinCeuticals as the

industry’s antioxidant authority.

Dr Pinnell’s groundbreaking, peer

reviewed research and comprehensive

dermatological knowledge resulted

in the Duke University Antioxidant

patent, which is now the gold

standard for topical antioxidant

formulations and licensed exclusively

to SkinCeuticals.

Indeed, hero product C E Ferulic,

a potent elixir of stabilised vitamin C

known to address and prevent the

concerns of ageing, is a worldwide

best seller and has been widely

showcased in leading international

consumer and trade publications

and platforms.

With a brand pillar of results-based

skincare backed by science, the

entire SkinCeuticals product line-up

has become the go-to for skincare

professionals around the world.

It is used in over 30 countries by

over 8000 dermatologists, plastic

surgeons, medispas and professional

retail establishments to complement

aesthetic procedures and for daily

home skincare. These 'backed by

science' formulas have been proven

to complement procedures well and

work to correct signs of ageing,

protect healthy skin, prevent future

damage, and promote a visibly,

radiant-looking complexion.

Forging the Future

Now, SkinCeuticals has launched

a new era in skincare and antiageing,

with SkinCeuticals EST

Clinic, a collaboration with esteemed

specialist plastic, reconstructive and

aesthetic surgeon, Dr Frank Lin of

EST Clinic.

Dr Lin and SkinCeuticals have

opened a new boutique clinic at

Emporium Melbourne – SkinCeuticals

EST Clinic. This destination retail clinic

in Emporium in the luxurious heart of

Melbourne, showcases the brand’s

Integrated Skincare Approach, which

places emphasises on prescribed

home skincare to complement

clinical aesthetic procedures and

professional treatments.

SkinCeuticals' high potency

formulas are concentrated in pure

actives and proven to penetrate

optimally into skin, which makes them

the ideal product to complement any

aesthetic procedure. These formulas

will be sold in the retail space and

customers can also enjoy diagnostic

skin consultations, bespoke services

and expert advice, with ease of

access in the elegant CBD.


products & services


world class boutique clinic.

The clinic features an extensive range

of SkinCeuticals products and services

provided by EST’s specialist therapists

and nurses under the direction of our

doctors and myself. From the 'express'

treatment for our clients on the go,

to an in-depth consultation utilising

the SkinScope, we aim to tailor our

treatments to each patient’s individual

needs. Beyond skin treatments, we

also offer medical consultation and

treatments such as cosmetic injections

and Ultherapy in conjunction with the

main EST city clinic on Collins St.

Q: Could you tell us about your

area of expertise and what EST

Clinic specialises in?

A: I am a Melbourne based plastic

surgeon specialising in facial plastic

surgery. I founded Eastern Plastic

Surgery in 2012, and as my interest

evolved towards facial aesthetics, EST

clinic became a natural extension of my

surgical practice.

EST Clinic specialises in a range

of minimally invasive skin treatments,

ranging from skincare and facials, to

injectables, energy based treatments

such as lasers, non-invasive skin

tightening and body contouring

treatments. We have a strong following

amongst Asian patients and have

become a leading authority in the

aesthetic treatment of Asian skin in


Q: A global first, the stunning

co-owned boutique clinic at

Emporium Melbourne represents

an exciting new avenue for

SkinCeuticals. Why did you decide

to partner with SkinCeuticals?

A: SkinCeuticals has been our partner

since the day EST Clinic first opened its

doors. Our collaboration is founded on

the shared belief that the highest quality

product and services can only come

from a rigorous pursuit of science.

Like EST Clinic, SkinCeuticals traces

its origins to a specialist medical

practice. Over the years, it has

evolved to become the world leading

'Antioxidant Authority' in skincare. It is

the number one US medical aesthetic

skincare brand worldwide, and is

renowned as an innovator of critical

anti-ageing breakthroughs at the

forefront of antioxidant technology.

SkinCeuticals’ clinically proven

formulas, and its renowned products

such as C E Ferulic, Phyto Corrective

Gel, H.A. Intensifier, amongst many

others, are used all over the world by

dermatologists, plastic surgeons, and

cosmetic physicians.

Q: Together, SkinCeuticals and

EST Clinic provide a doctorendorsed

clinic in a prime retail

location. Why did you decide to

base the boutique in Emporium

Melbourne and what’s on the

Treatment Menu? How does the

SkinScope diagnostic device fit

into the consultations?

A: Emporium is the heart of

Melbourne’s high-end retail space,

surrounded by global luxury names.

Its location is central and provides a

recognisable and convenient location

for our international clients. To me, it is

the premier location for the launch of a

Q: SkinCeuticals’ Integrated

Skincare Model is a pivotal part

of the brand’s offering. Could you

explain the idealogy and benefits of

this model?

A: The concept of integrating skincare

with clinic treatments is not new. It is

acknowledged by clinicians worldwide

that having healthy skin compliments

and enhances all non-invasive and also

surgical procedures. Having skin that

is healthy and prepped, coupled with

appropriate post procedural home care,

allows each patient to get the most out

of their treatment, and often improves

the recovery and longevity of the results.

At EST Clinic, we are constantly

educating our patients on the

importance of achieving this solid

foundation with high quality skincare

products. Our partnership with

SkinCeuticals has allowed us to come

full circle in providing the best overall

treatment for our patients.

By providing clinicians with a high

quality, scientifically proven, range

of professional skincare products,

along with a willingness to work

with us to constantly improve and

evolve, SkinCeuticals have positioned

themselves at the forefront of integrated,

medical grade skincare. AMP

For more information contact

SkinCeuticals EST Clinic

Emporium Melbourne












step up from the budgetfriendly

'White Label'

line targeting millennials,

Dermaenergy 'Black Label' will

cater to a more mature, luxuryseeking

audience. This is phase

two of Dermaenergy’s plan to off er

medical-grade products for every

step of a customer’s skincare

journey. The formulas are highly

concentrated, catering for skins

requiring advanced stimulation.

'Targeting everyone aged 35 and

up, Black Label aims to resolve skin

conditions, rather than manage skin

types,' says Dermaenergy Founder,

Sean Abel. Black Label is formulated

with powerful active ingredients,

alongside signature energising

ingredient adenosine triphosphate

(ATP) to address skin conditions

including ageing, fi ne lines,

wrinkles, pigmentation, congestion,

dehydration and roughness.

Combining ATP with actives

helps deliver prolonged stimulation

for results that are not only fast,

but enduring.

Eschewing the playful White

Label names targeting a younger

customer ('Dissolve And Solve',

'Hydrate And Infl ate', 'Solution

From Pollution'), Dermaenergy

Black Label is serious skincare

with serious results. Strictly a 'skin

clinic only' brand, Black Label will

not be sold online or through other

retail avenues.

How does Black

Label differ from

White Label?

The Black Label products are

suitable for an older target market,

over 35 years. It has stronger

formulas, containing four times

the concentration of ATP. ATP

is featured at 1% in White Label

and comes at 4% in most Black

Label products. The concentration

of the main active ingredient in

each product (e.g. niacinamide) is

doubled, making it eff ective for more

mature skins. Hence the range is

strictly sold in skin clinics only.



by Dermaenergy

What type of products

can customers expect?

Sulphate-free cleansers

Fragrance-free (on all serums and


3 series ' A3, B3, C3 and HA3

Serums – contain three main actives

in each product

A3 Serum – includes three diff erent

vitamin As

B3 Serum – includes three diff erent

vitamin Bs

C3 Serum – includes three diff erent

vitamin Cs

HA3 Serum – includes three diff erent

hyaluronic acids

LQD Serum – hydroxy acid liquid


Serums formulated with

encapsulated Retinol, Vitamin C,

Peptides and more

Pre and Probiotic moisturisers with

blue light protection

Mineral (chemical-free) sun protection

Sun protection – SPF50+ with ATP

Signature ingredient adenosine

triphosphate (ATP) at 4x

concentration of White Label in

all products

Prescription-only, Dermaenergy

Black Label will dramatically reignite

a more mature skin, increasing

energy and vitality and reducing

visible signs of ageing.

For enquiries call 1300 799 709 or





The Eyes Have It




Plasmage ®

Connect Lab

The fi rst of its kind, the

Plasmage ® Connect Lab

smartphone application links

to a medical device that

connects the practitioner to a

network of medical peers. This

innovative technology allows

the practitioner to take ‘before

and after’ photos and edit

them into a useful format for

easy sharing.

It off ers an immediate

platform for keeping up-todate

with patients, colleagues

and scientifi c committees

from around the world and

provides updates on signifi cant

protocols and events.

While it undoubtedly

delivers incredible results,

surgical blepharoplasty

does come with extended

downtime, which for time-poor

patients, may not be ideal. And

for those patients who are in need

of a gentler lift or tweak, going in

for the full surgical procedure may

not always be necessary. Enter,

Blefaroplasma ® Plasmage ® by Brera

Medical Technologies.

This innovative new technology

allows for non-invasive, nonablative

treatment of sensitive,

hard-to-treat areas in as little as one

session. The secret is a patented

Fractional Plasma System known

as Plasmage ® , which allows for

fast and convenient treatment, less

aggressive techniques, improved

patient comfort and considerably

less downtime.

Signature to this technology is the

Blefaroplasma ® , a minimally invasive

alternative to a surgical eyelift, or

blepharoplasty. Effi cient and easy for

a practitioner to perform, it delivers

quick results at a fraction of the

price of surgical options.

Addressing issues including

wrinkles, xanthelasma, acne

scarring, lentigo, fi broma and

verrucas, the device is as versatile

as it is effi cient. It also works well on

treating milia cysts, fatty eye lumps,

acne, scars and warts.

Patented, Controlled


Plasmage ® is the fi rst and

only fractional energy delivery

system that aff ords practitioners

greater control over the energy

used, rather than the standard

form of continuous energy.

This delivers advanced results

while minimising risk, injury and

recovery time.

A class IIb device, its features

include a ‘user friendly’ interface

that sublimates tissue without

ablation or other adverse side

eff ects to the skin.

The plasma energy delivered

can be provided in 30 modulations

of energy, continuous mode,

fractional mode, four levels of

fractionation, and six scales

of intensity. Such a varied and

comprehensive selection allows

the practitioner to adapt the

energy to the treatment protocol

and precisely control the treatment

area, all while providing a high

degree of safety.

This versatility of variable energy

power also means that practitioners

may treat patients from a wider

variety of ethnic backgrounds.






Eyes Right

When treating eyelids, Plasmage ®

can be used to reduce excess

skin, producing a localised and

precise retraction of the eyelids,

without the need for general

anaesthetic. In fact, patient

comfort can be ensured simply

by using topical or injectable


Reduced Downtime

Post treatment, patients may

experience some redness and

swelling around the treatment

area, as well as some crusting

of the aff ected skin, the latter of

which is necessary to protect the

new skin forming underneath.

Typically, these post-treatment

signs last between 10-14 days,

depending on the intensity of the

treatment and condition of the

patient’s skin.


Holistic Treatments

Plasmage ® can be used alongside

other techniques, including

ultrasound eyelift or muscle

relaxants, to produce ideal results,

minimising fi ne lines, reducing

puffi ness and creating overall

rejuvenation and a youthful,

blemish-free appearance.

Why Choose

Plasmage ®

• Smart Software: A selection

of pre-set, ‘indication specifi c’

programs allow ease of use

with optimal energy supply for

each procedure.

• Intuitive Technology: The smart

software allows the operator

to choose from 30 diff erent

treatment protocols and to

manually adjust as desired.

• Needle Tip: The applicator

consists of an ergonomic and

lightweight handpiece, as well

as various sized and shaped


• Lightweight and Portable:

Weighing only 2kg, Plasmage ®

comes equipped with its own

carry case.


products & services

Q&A with

Dr Richard Hogben

Dr Richard Hogben of Allure Laser

& Skin Studio in Mackay, QLD, has

been using Plasmage ® in his busy

practice for the past 12 months

and says it has become an integral

part of his practice for a number of

different conditions.

‘I find the Plasmage ® is the

go-to device now, because of

the minimal preparation needed,

less downtime and fewer

adverse effects, plus improved

patient comfort.’

Here, we speak to Dr Hogben

about his experience with

the device.

Q: Aside from the eye area,

what conditions are you using

it to treat most?

A: Around the eyes is extremely

popular and we do see excellent

results with tightening of the

loose skin, particularly under

the eye. Apart from this, the

Plasmage ® is used extensively for

removal of skin tags, small benign

lesions, for example seborrheic

keratoses, cysts and even milia

which are very hard to extract.

Fine perioral lip lines can also

benefit from the Plasmage ® .

Q: How do you find the results?

A: The results are excellent.

For the benign lesions, usually

only one treatment is required

and most of the time there is no

hypopigmentation, scarring or

any adverse effect seen. In most

cases on review you cannot

see where the lesion was

removed. Around the eye with

the Blefaroplasma ® mode we see

tightening of the loose skin in both

the upper and lower eyelids and

reduction of fine lines.

Q: Which modality is your

preferred? Or rather, the most


A: The Plasmage ® has become

an integral tool in our clinic,

used multiple times on a daily

basis, whether for the popular

tightening around the eye with

the Blefaroplasma ® mode or an

‘add on’ to a consultation

to remove skin tags or other

benign lesions on the face or

other parts of the body. It is a

very quick, straightforward

procedure with minimal to no

preparation and downtime.

Q: Typically, how many

treatments are required for

best results in any given


A: For a majority of indications

only one treatment is needed.

For tightening of loose skin in

the upper and lower eyelids and

reduction of fine perioral lines,

the patient may benefit from two

procedures spread over three

to six months.

Q: What would you say patient

satisfaction is like?

A: Patient satisfaction is excellent.

When removing the cysts, skin

tags and other benign lesions

patients often state ‘that was

so much easier than I thought

it would be. I should have done

this years ago.’

Q: Is downtime and patient

comfort improved?

A: I find with the removal of

small lesion, no preparation is

needed. Comfort is helped with

cooling only. For larger lesions,

either local anaesthetic topical

gel or minimal local anaesthetic

injections is all that is required.

For the Blefaroplasma ® we

prepare our patients by getting

them to come 30 minutes before

the procedure to apply local

anaesthetic gel.

Q: Would you recommend

other practitioners get

Plasmage ® for their


A: I have found the Plasmage ®

to be an excellent and reliable

tool in our practice with

reproducible results time and

time again. I would recommend

the Plasmage ® to practitioners

as they will find it becomes an

integral part of their practice,

whether that be larger

procedures for the loose skin

of the upper and lower eyelids

or the multiple times a day

that they would like to remove

benign lesions with minimal to

no preparation, downtime and

adverse effects. AMP

For more information call 1800 242 011 or email

or visit



The first patented

Fractional Plasma® for

treatments of delicate areas



• Blefaroplasma®



• Wrinkles

• Xanthelasma

• Acne

• Lentigo

• Scars

• Fibroma

• Verrucas


Advanced Cosmeceuticals | 1800 242 011

products & services

Step Into the Future

Propel your practice into the future with Candela’s Nordlys platform, with

its three foundational technologies to treat both the face and body.

Candela is renowned for

engineering the systems

that deliver reliable solutions

for myriad conditions on the

full spectrum of skin types. The

company has been trusted

for decades by dermatologists,

plastic surgeons and medical

practicioners alike. From hair

removal to body contouring, tattoo

removal to cellulite smoothing,

there is a solution to almost every

patient’s problem.

Now, with Candela’s Nordlys

platform, a wider array of innovative

solutions becomes available for the

face and body, simply by switching

between three foundational


These foundational technologies

– Ellipse IPL ,Frax 1550 and

Nd:YAG 1064, propel your

practice into the future of cosmetic

medicine by offering a vast array

of treatments for both the face

and body.

Ellipse IPL

This unique IPL boasts narrowband

technology, defined by dual filters

and sub-millisecond pulses for

exceptional photo-rejuvenation

and vascular treatments. It is also

effective for hair removal.

FRAX 1550

A non-ablative fractional treatment

for skin resurfacing and treatment for

acne scars, surgical scars and striae,

FRAX500 comes with SoftCool to

minimise disco fort during treatment.

Nd: YAG 064

A wide range of vascular lesions can

effectively be treated with minimal

discomfort both during and after,

thanks to the integrated SoftCool.

Clinically Proven

With 21 indications for use, the

Nordlys system is configured with

pre-set aesthetic and dermatologic

treatments that have been

developed and designed for over 20

years to meet your needs.

Nordlys has been clinically

proven to effectively treat rosacea,

vascular lesions/reticular vessels,

telangiectasia and hair removal. It is

also shown to provide exceptional

results in photo-rejuvenation and the

improvement of skin texture.


products & services


products are


proven, with

over 700 clinical

papers published.

Did you


• Over 30, 000 leading

physicians globally treat

patients with Candela


• Over 10 million treatments

are performed annually

with Candela products

• Candela products are

scientifically proven,

with over 700 clinical

papers published

• Candela boasts over

40 year’s experience in

the medical aesthetic

device market.

Ease of Use

The Nordlys system’s clinical

intelligence is designed to facilitate

a quick learning curve. It is available

for three levels of user: Guided,

Expert and optional Pulse Definition

mode,* enabling users to completely

customise treatments as they

become more adept.

Features include:

• An adjustable arm that easily

moves the screen and tray into

the desired position;

• Switch sttings or accessories

without moving a step;

• Applicators with flexible cables

to reduce the risk of repetitive

strain injury;

• An accessories tray to keep

glasses and gel close at hand;

• A quiet mode of operation to

ensure a comfortable treatment

for both physician and patient;

• Aclear view of the treatment area

for the user;

• Secure, Wi-Fi-enabled remote


• The ability to diagnose and

update your device (during or

after working hours) for effective

service support;

• A patient database that allows

you to build a patient record and

review treatment history.

The Candela Promise

When you purchase a Candela

product, you are assured of a

three-year warranty on all devices,

plus full manufacturer and clinical

training by factory trained qualified

technicians. Your purchase includes

all servicing and customer support

and comprehensive marketing

resources, Flexible finance packages

are also available.

For further information call

1300 (CANDELA) 226 335


Dr John Sullivan

Dr John Sullivan from Kingsway

Dermatology and Aesthetics

has been using Candela Nordlys

for over five years. Here he

discusses its myriad benefits.

Q: What conditions are you

treating most frequently

with Nordlys?

A: As a dermatologist, vascular skin

conditions are the most common

indication I treat. This includes

telangiectasia and broken capillaries,

diffusing redness, rosacea and

flushing, along with cherry angiomas

and campbell de morgan spots, and

spider naevi. Vascular skin changes

have a high impact on patients and

are very satisfying to treat.

The Nordlys excels for treating

such vascular lesions due to multiple

handpieces designed for this

indication, including the long pulse

Nd:Yag for deeper and larger or IPL

resistant vessel treatment, the 555-

950nm handpiece for deeper and

blue vessels, and the 530-720nm

for surface red vessels and diffuse

redness. The flexibility of settings

and the option of sub-millisecond

pulses has been extremely useful for

treating flushing and rosacea that

includes diffuse redness.

Photodamage is our second

main indication and is a major

problem for Australians, resulting in

accelerated skin changes of ageing.

This includes pigmented skin lesions


products & services

Q&A continued

with candela’s

Nordlys platform,

a wider array of



becomes available

for the face and

body, simply by


between three



(solar lentigo, dyschromia) and

telagiectasia, skin redness,

irregular sized pores and textural

skin changes.

The vascular options as above

are useful in this group and the IPL

handpieces handle these vascular

and pigment changes well with the

option of combining with 1550nm

fractionated laser enhances benefits

further. The special pigment lesion

(400-720nm handpiece) can be

useful to spot treat treatment

resistant pigmented lesions.

The photodynamic therapy

option (PL handpiece) has also

proved a well-tolerated way to

deliver photodynamic therapy

light activation more comfortably

over traditional LED light for

treating actinic keratosis,

superficial basal cell carcinoma

and Bowen’s disease.

We also use the Nordlys regularly

to improve our patients’ surgical

and other skin scars either targeting

redness of younger scars using

the vascular IPL settings and/or

in combination with the 1550nm

handpiece to also further and safely

blend textural differences.

The 1550nm handpiece is

also useful for acne scarring

when not severe.

The Nordlys flexibility and smart

filtering also makes its unwanted

hair treatment options effective and

well tolerated.

Q: How do you find the results?

A: The Nordlys is the type of multiplatform

device that has

good default settings to achieve

good outcomes right from the

start, but also allows with time

and experience the ability to tailor

and alter treatment parameters

with great flexibility to allow a

more targeted pulse duration for

different targets, such as vessel

size variation for better results and

outcomes over time.

Having several handpieces to

choose from also allows the ability

to alter what you can achieve with

each treatment session, such as

mainly targeting pigment lesions and

larger vessels on the first photorejuvenation

treatment session

then focusing on smaller blood

vessels and diffuse redness on a

subsequent treatment, and targeting

of any resistant pigmented lesions.

Q: Which modality is your

preferred? Or rather, the most


A: Vascular (redness, capillaries and

rosacea) skin conditions have the

greatest patient impact in our clinic

and are our number one indication.

Q: Typically, how many

treatments are required for

best results?

A: Although a single treatment

session can address many lesions

/individual blood vessels, I find

typically two-to-three sessions at

four-to-six weekly intervals can

achieve good clinical results for

vascular skin problems.

Similarly, for photodamage twoto-three

sessions at four-to-six

weekly intervals will have benefits

over a single treatment session.

Mixing IPL and Frax (1550nm) can

produce added benefits.

Q: What would you say patient

satisfaction is like?

A: The Nordlys offers an effective

and flexible combination of

handpieces, which has allowed

us to better meet the increasing

expectations of our patients

safely. This makes follow up

review appointments comparing

pre-treatment imaging a usually

rewarding time.


products & services

Q: Are ‘downtime’ and patient

comfort improved?

A: The dual filtering of the

Nordlys IPL system also removes

unnecessary heat from light pulses

to improve patient tolerance

(reducing unnecessary skin heating).

This allows the use of lower fluences

multi-platform devices, there is often

significant compromise in many

handpieces; this is not the case with

the Nordlys, with all handpieces

cleverly and ergonomically

designed. This has been a very well

researched, thought through and

carefully built reliable device. I can

compared to many other systems

enationwithout 3

highly recommend

compromising clinical

Photorejuvenation Rosacea 4 the Nordlys. AMP


Rosacea 4

outcome and improving safety.

The flexibility of being able to, for

example, lengthen pulse duration for

patient tolerance also assists in the

enation 3

treatment of individuals with reduced

Rosacea 4

pain tolerance.

The cooling system of the Nd:Yag

and 1550nm laser using moistened

cooled air directed over treatment


enationsites 3



has also been well designed

Rosacea Before Before


AFTER two treatments After* After* with VL 555 and one

treatment with PR 530. Photos courtesy of


two treatments for both with VL treatment 555 and one safety treatment and better



Patient received

treated with two PR treatments 530. Dr Guillermo Simón, Spain.

with VL 555 and one treatment with

Patient treated with PR 530.

courtesy of

patient Guillermo

tolerance Simón, M.D.,

compared Spain.



Photos 530. courtesy Photos courtesy of Michael of Drosner, Guillermo M.D., Simón, Germany.

M.D., Spain.

Photos courtesy of Michael Drosner, M

many other similar devices.


For photodamage After*

downtime and



comfort it compares favourably


sion/Reticular Vessel Vascular Telangiectasia Lesion/Reticular 5

Vessel Telangiectasia 3

two treatments with VL 555 and one treatment with

Patient treated with PR 530.

to other similar devices. For

courtesy of Guillermo Simón, M.D., Spain.

Photos courtesy of Michael Drosner, M.D., Germany.

challenging vascular skin conditions

(e.g. severe redness due to rosacea)

unfortunately better outcomes 5 with


all devices Vessel

does result in significant




AFTER treatment with PR 530. Photos courtesy of




Dr Michael Drosner, After*


two treatments downtime with VL 555 such and as one purpuric treatment changes


courtesy of which Guillermo can Simón, take M.D., a week Spain. or so to

Patient treated with PR 530.

Photos courtesy of Michael Drosner, M.D., Germany.

resolve but will usually signify a

good ultimate result. Studies have


sion/Reticular however shown Vessel this After* 5

to be at least

Telangiectasia Before Before


After* After*


ith Nd:YAG as 1064. well or better tolerated when


Patient treated

received with two Nd:YAG treatments 1064.

with VL 555 and one treatment with

Patient received two treatments with VL

of Ellipse A/S. treating this challenging type of


PR 530. courtesy Photos courtesy of Ellipse of A/S.

Guillermo Simón, M.D., Spain.

PR 530. Photos courtesy of Guillermo S

rosacea/flushing than alternative

treatment options.

ore After* Before Hair Removal 6


val 6


Skin Texture 7

AFTER two treatments with VL 555 and one

treatment with PR 530. Photos courtesy of Dr

Guillermo Simón, Spain.

ith Nd:YAG Q: 1064. Would you recommend other

Patient received two treatments with VL 555 and one treatment with

of Ellipse A/S.

PR 530. Photos courtesy of Guillermo Simón, M.D., Spain.

practitioners introduce Nordlys

Skin Texture 7

val ore 6

for their practices?

A: The Nordlys is a good multiplatform

device and After* the most

Skin Texture Before 7


ith Nd:YAG utilised 1064. and flexible laser/light/

of Ellipse A/S. energy-based device in our practice.

Patient received two treatments with VL 555 and one treatment with

PR 530. Photos courtesy of Guillermo Simón, M.D., Spain.

Its broad range of indications make

it a great option when choosing your


val 6


first such practice device. After* With many

Skin Texture Before Before


AFTER treatment with Frax 1550. Photos

courtesy of Dr E Victor After* After*

Ross, USA.


ith HRD 645.


Patient treated

treated with

with HRD

Frax 1550.


Patient treated with Frax 1550.

of Agneta Troilius AESTHETIC Rubin, M.D., PhD, Sweden. MEDICAL PRACTITIONER Photos

Photos courtesy

courtesy of

of Agneta

E. Victor Troilius Ross, Rubin, M.D., USA.

M.D., PhD, Sweden.

Photos courtesy of E. 99

Victor Ross, M.D







In partnering with Venus Concept,

aesthetic professionals gain

access to never-before-seen

business features such as the most

comprehensive warranty program,

unmatched marketing support,

continuous clinical education and

more. The subscription model is

unique and includes: a three-year

warranty, in-house fi nance (interest

free) with 36-month terms, expert

clinical education, tailored marketing

support, plus easy upgrade options

are available.

Here we speak with leading

US dermatologist Dr Sonia Batra

about two of Venus Concept’s vast

range of devices, Venus Viva and

Venus Versa.

Venus Viva

A versatile and customisable

device, Venus Viva is powered by

NanoFractional Radio Frequency

with SmartScan technology.

It’s the fi rst and only fractional

radio frequency (RF) system that

allows operator control of ablation,

coagulation and resurfacing for

enhanced effi cacy in resolving mild

to severe skin damage.

Q: Dr Batra, what are you

typically using Venus Viva for

in your practice?

A: I use it for improvement in

texture and tone. This includes

acne scarring, stretch marks,

and ageing skin.







Q: What kinds of results are

you seeing and in what time

frame? Do patients need to

have a series of treatments for

optimal results?

A: I see a smoothing and fi rming

eff ect on the skin that is noticeable

about one month after treatment.

I usually encourage patients to

have a series of three treatments

spaced 4-6 weeks apart for

optimal results.

Q: How much downtime is

involved with this device?

What are the post-treatment


A: Our post-treatment protocol is

to have the patient use a cold roller

or ice packs, take a non-sedating

antihistamine, and use hydrating

skin care products that we provide

at the treatment.

This usually limits swelling to

1-2 days and redness to no more

than three days. The tiny, black

grid pattern from the microneedle

insertion is usually subtle and

sloughs within a week. Posttreatment,

we caution patients

about strict sun protection and a

gentle, non-irritating regimen for

one week.

Q: How long do results

typically last?

A: The results are more of a rewind,

so they do not wear off suddenly.

I am seeing patients about once a

year for maintenance treatments.

Venus Versa

Available in 580, 690HR, 690HR

XL, each of which Dr Batra uses

in her practice, the Venus Versa

off ers the practitioner myriad

combinations when it comes to

patient treatment, whether it be for

hair removal or skin rejuvenation.

Ten handpieces make it a multiapplication

platform that is able to

provide the most popular, noninvasive

aesthetic procedures.

From photo-rejuvenation/

photo-facials, acne treatments,

hair removal, skin resurfacing,

body contouring, cellulite reduction,

skin tightening and wrinkle

reduction, there’s very little Venus

Versa can’t tackle.

And, it does this with

leading technologies, including

Intense Pulsed Light (IPL) with

SmartPulse, NanoFractional

radio with SmartScan and Venus

Concept’s Proprietary (MP)

technology (Multi-Polar Radio

Frequency + Pulsed Electro

Magnetic Fields.

Q: Dr Batra, what are you

typically using Venus Versa for

in your practice?

A: I use the IPL handpieces to

improve colour, such as lentigines

and telangiectases, and improve

tone. I use the NanoFractional

Radio Frequency handpiece for

texture and fi rming. The hair removal

handpieces are very eff ective in

phototypes I-IV. The MP handpieces

are popular to fi rm and tighten the

skin since they have no down time

and the treatments are relaxing.

Q: What kinds of results are

you seeing and in what time

frame? Do patients need to

have a series of treatments for

optimal results?

Dr Sonia Batra

Dr Sonia Batra is a co-host on the

Emmy ® Award-winning talk show

The Doctors and a board-certifi ed


Dr Sonia Batra graduated Magna

Cum Laude from Harvard University

as a member of Phi Beta Kappa and

earned her MD with honours from

Harvard Medical School, where she was

president of the Student Council.


products & services

The Venus

Diamond Polar

provides both an

immediate glow

and more delayed

lifting effect to

the skin.

A: For all of the handpieces, a series

of treatments usually provides the

best results.

With the IPL, patients are very

satisfied with the reduction in brown

spots and overall evening out of

skin colour that improves with each

successive treatment.

With the NanoFractional RF,

patients see smoother, more firm

skin about one month after treatment.

For hair removal, patients often

consider their series complete by six

treatments. With the MP handpieces,

I see a significant firming effect on

the skin after about 3-4 treatments,

and with this handpiece, I often see

patients continue treatments electively

before events.

Q: How much downtime is involved

with this device? What are the

post-treatment precautions?

A: With the IPL, the lentigines darken

and look like coffee grounds for 3-5

days. For NanoFractional RF, there

is some swelling and redness for

up to three days, and 3-4 additional

days before the grid pattern of the

handpiece fades completely. The hair

removal and MP handpieces have

minimal down time. After treatments

with any of the Versa handpieces, I

recommend strict sun protection and

treating the skin gently for one week.

Q: How long do results

typically last?

A: After a series of successful

treatments with any of the handpieces,

patients often come in once a year for

a treatment to maintain their results.

Venus Diamond Polar

This fast and non-invasive skin

tightening treatment is highly effective

in firming the skin, as well as reducing

the appearance of fine lines and folds.

It relies on Pulsed Electro Magnetic

Fields, which support increased blood

flow and oxygenation to the skin cells,

resulting in a lit-from-within glow.

The Radio Frequency causes a

thermal reaction within the skin, which

then stimulates the body’s natural

healing response, thereby triggering

fresh collagen formation and new

elastin fibres. This in turn supports

firmer skin with a softening of lines

and wrinkles.

Q: Dr Batra, what are you typically

using Venus Diamond Polar for in

your practice?

A: I am using the Diamond Polar for

patients who cannot accommodate

any down time and want to improve

the tone and firmness of their face,

jawline or neck.

Q: What kinds of results are

you seeing and in what time frame?

Do patients need to have a series

of treatments for optimal results?

A: This device provides both an

immediate glow and more delayed

lifting effect to the skin. I usually

recommend at least 3-4 treatments

about 1-2 weeks apart to see

optimal results.

Q: How much downtime is involved

with this device? What are the

post-treatment precautions?

A: There is no downtime with this

device. I usually advocate strict sun

protection, but patients can resume

their usual regimen immediately.

Q: How long do results

typically last?

A: I often see patients return about

a year after a successful series for a

maintenance treatment.

Venus Octipolar

A body-shaping and contouring

device, this relies on Multi-Polar

Radio Frequency and Pulsed Electro

Magnetic Fields to naturally boost

collagen production and break

down fat cells, diminishes fine lines

and wrinkles, tighten sagging skin,

reduce the appearance of cellulite,

and promote a slimmer, more

sculpted silhouette.

Q: Dr Batra, what are you

typically using Venus OctiPolar

for in your practice?

A: I’m using the OctiPolar for firming

and fat reduction on the body. The

most popular treatment areas are

thighs and abdomen.

Q: What kinds of results are

you seeing and in what time frame?

Do patients need to have a series

of treatments for optimal results?

A: We’re seeing a firming and

tightening effect after a series of

3-4 treatments spaced about two

weeks apart.

Q: How much downtime is involved

with this device? What are the

post-treatment precautions?

A: There is no down time and patients

can typically return to their usual

routine immediately.

Q: How long do results

typically last?

A: Most of our patients are happy

with how long the results last and will

return once a year for maintenance

treatments. AMP

For more information contact

Venus Concept on 0423 505 931




WE are the experts in your industy

so we know what works!

• content marketing

• graphic design

• Event management

• clinic brochures

• newsletters

• website design & content

• social media

Contact Michelle Kearney now for a no-obligation quote

on 0419 624 246 or email




Dr Robin Chok has been using Spectra XT for

the past 18 months in his busy Adelaide practice,

Regenesis Cosmetic Surgery. He is extremely

happy with the results he has been achieving,

particularly when treating Melasma.

Spectra XT is among the

few lasers FDA approved

for the treatment of melasma,’

Dr Chok says, adding that he

has performed over 5,000

treatments using the device. ‘It

allows me to treat pigmentation

with minimal discomfort and a

high degree of safety in all skin

types, without compromising on

pulse fluence energies.’

A feature of the device Dr Chok is

particularly impressed with, is that it

produces real, effective results within

a short treatment time, which is

attributed to its unique beam profile.

‘Spectra XT Q-Switched Top

Hat beam profile creates a highenergy

spatially confined injury to

the epidermis, which is referred to

as an area of Laser Induced Optical

Breakdown (LIOB),’ he explains.

‘This results in skin lightening and

rapid rejuvenation by a unique

mechanism of epidermal-driven

collagen remodelling and fibroblast


products & services

stimulation, caused by the very short

duration laser photo acoustic effect.’

Another benefit of this beam

profile is the reduced risk of posttreatment


‘With its large spot size of

10mm, we can treat melasma

and general pigmentation with

minimal risk of post-inflammatory

hyperpigmentation (PIH),’ he reveals.

‘This is due to the build-up of

thermal injury. Our in-house protocol

for rejuvenation consists of high

fluence QS 1064nm Revital mode

of at least 7,000 –10,000 shots for

the face, neck and décolletage. To

reduce or eliminate the appearance

of melasma, Spectra XT Q-Switched

fast 1064 and 532nm pulsed

laser energy gently targets and

destroys melanin in the skin, and the

scattered pigments are absorbed by

the immune system.’


Spectra XT also affords a shortened

downtime and provides a better

treatment experience for patients

with high sensitivity.

‘Laser Toning is the perfect choice

for melasma treatment because

it delivers long-term results with

no downtime,’ says Dr Chok.

‘Gold Toning plays a significant

role in controlling the abnormal

micro-vasculature, so the redness

disappears, allowing the skin colour

to return back to normal.

‘Specifically, Spectra XT offers a

new additional melasma treatment

mode that is applicable to thin and

dry or pain-sensitive skin with its

new unique PTP Mode. Optimal

treatment of inflammatory skin is

best combined with Spectra XT

proprietary Gold Toning with a new

enhanced frequency of 595nm. The

Gold Toning spectrum is by far the

most useful in treating rosacea, acne

and sun damaged skin, especially

on the face and décolletage.

‘Another special talent of Spectra

XT is the 660nm RuVY Touch, a

new pigment removal treatment that

significantly reduces the possibility of

having post-treatment side effects.

Current laser treatments can cause

more crusting, are associated with

longer downtime, and frequently

result in side effects like postinflammatory


Most pigmentation laser treatments

often irritate the vasculature

underneath pigmented skin, causing

the irritated blood vessels to trigger

an inflammatory cascade.

‘However, 660nm RuVY Touch

laser treatment does not irritate

the vasculature, yet still removes

pigmented lesions efficiently and

carefully. Therefore, RuVY Touch

minimises the potential side effects

such as PIH that usually occur as a

result of inflammation. RuVY Touch

can be used to treat freckles and

other epidermal pigmented lesions.’



With its many modalities, the results

Spectra XT delivers are enhanced

and elevated.

‘These quick and effective

rejuvenative Laser Toning and

Revital treatments can be further

augmented with Spectra XT’s

proprietary Carbon Enhanced

‘Hollywood Laser Peel’, which

improves pores and epidermal

tightness,’ explains Dr Chok.

‘Proprietary Carbon Enhanced

Hollywood Peel Mode allows for

better interaction with each pore,

enabling better pore size reduction

with no downtime, giving that

glamorous Hollywood Peel glow –

great for events!’

In my opinion,

laser Toning is

the perfect

choice for



because it

delivers longterm


with no


Similarly, Spectra Mode allows for

effective results on areas of arms,

hands and neck with minimal to

no risk of hyperpigmentation. ‘I am

especially impressed by the unique

Spectra quasi-long pulse mode of

300ms duration at 1064nm, which

penetrates deeper for collagen

remodelling and deep tissue

refirming,’ says Dr Chok.


products & services

Spectra XT

A New Era in Laser Technology

With its increased range of clinical indications, This Extended Platform

is ushering in a new wave of laser treatments.

Skin rejuvenation, texture

smoothing and refining,

pigmentation clearing and

even tattoo removal – the versatility

of Spectra XT will exceed patient

expectations and elevate your practice

to the next level.

Distributed by Advanced

Cosmeceuticals, Spectra XT from

Lutronic comes with a Zoom Collimated

Handpiece, while the Spectra XT

EX features the Zoom Collimated

Handpiece, plus RuVY Touch and

Gold Toning Handpieces.

These state-of-the-art extended

handpieces allow for a vast array of

treatment choices for both doctor

and patient, without the need for

your practice to invest in separate

additional devices.

RuVY TOUCH – 660nm

Perfect for pigment removal, this

new handpiece can be used to

treat freckles and other pigmented

lesions. While current laser treatments

may result in more crusting, longer

downtime and post-inflammatory

hyper-pigmentation, RuVY Touch

significantly reduces the possibility

of post-treatment side-effects

and affords a less intense treatment

with shorter downtime.

Unlike other laser treatments,

which often irritate the vasculature

underneath the pigmented skin and

cause the irritated blood vessels to

trigger inflammation, RuVY Touch

removes pigmented lesions carefully

and effectively, without irritation to the

blood vessels. This means that RuVY

Touch minimises potential side effects

like PIH that typically occur as a result

of inflammation.


Ideal for acne suffers, or those in postacne

stages left with redness, Gold

Toning 595nm laser targets redness

left after acne has cleared up. This

can often last a long time, leaving the

sufferer feeling stressed and lacking in

confidence. It can also be used to help

calm inflamed acne – even without the

help of acne medication. It is a onestop

solution to acne-prone skin, in

both its advanced and inflamed stages

as well as once lesions have subsided.

Gold Toning laser is absorbed

by the haemoglobin in the dilated

microvasculature, helping to control

redness and allow the skin to settle

back to its normal tone.

Gold Toning can also target

melasma associated with abnormal

dermal vascular activity and post

treatment erythema.


Perfect for patients with melasma – a

skin condition typically seen in females

that is characterised by irregular darker

patches of skin, Laser Toning gently

and effectively targets irregular melanin,

destroying it and leaving the scattered

pigments to be controlled by the body’s

natural responses. Skin is left more

uniform, with long term results, and little

downtime. For patients with thin, dry

or pain-sensitive skin, Spectra XT

offers a new additional melasma

treatment mode.


Offering high-performance collagen

remodelling for skin rejuvenation,

Revital Treatment is a high-powered

quasi-long pulsed 1064nm that is

capable of delivering a maximum of

45J in one second.

It effectively treats enlarged pores,

fine lines and wrinkles, particularly

stubborn ones that have not responded

to a myriad of other treatments, as it

is able to target deeper skin layers to

refine pores, tighten slackness and

soften the appearance of folds.

Revital is also effective on seborrhoea

with enlarged facial pores and inflammatory

acne lesions with seborrhoea.

Treatment time is also reduced,

improving patient comfort, yet results

are unparalleled.




With over 35 percent of tattooed

Australians regretting their decision

to get inked up*, there’s never been a

better time to invest in additional tattoo

removal handpieces.

As with most long-term decisions

made impulsively, reversing them

takes time, so you want to ensure your

practice offers the most advanced

technology in this area. With its Dual

Mode Q-Switched ND:Yag Laser that

features four different wavelengths,

Spectra XT targets all types of coloured

tattoos to significantly lighten them,

or completely remove the ink from the

skin. AMP

*source: CHOICE

For more information call 1800 242 011


products & services


Post-Acne Erythema

Post-Acne BEFORE Erythema

AFTER Spectra XT Laser tattoo removal

AFTER treatment with Spectra XT

the versatility

of Spectra XT

will exceed



and elevate

your practice

to the next


Courtesy of of Ratchathorn Panchaprateep, MD, MD, Thailand


Large Pores

AFTER treatment with Spectra XT.

Courtesy of Ratchathorn Panchaprateep, MD, Thailand

Courtesy of of Ratchathorn Panchaprateep, MD, Thailand

Large Pores


Courtesy of of G.S. G.S. Lee, Lee, MD, MD, South Korea

AFTER treatment with Spectra XT.

Courtesy of G.S. Lee, MD, South Korea















Cutera’s excel V+ is a bestin-class

laser platform,

recognised among

dermatologists and aesthetic

doctors for its engineering and

performance excellence.

A technological advancement

that off ers 50 percent more

power and treatment speed

in half the time of any device

in its class, excel V+ also

features optimised delivery

systems and unparallel precision

in treating vascular lesions and

pigmentation concerns.

San Diego dermatologist, Dr E

Vic Ross from Scripps Clinic, says:

‘excel V+ off ers a greater range of

spot sizes and versatility. These

advances allow for a speedier and

more comfortable experience for

our patients. The pencil-sized tip

allows for more precise beam

delivery for smaller lesions.’

Dermatologist Dr Omar A

Ibrahimi, of Connecticut Skin

Institute, adds: ‘excel V+ from

Cutera is more powerful, which

actually allows me to treat

patients in a kinder, gentler yet

more eff ective manner. I can

use larger spot sizes that were

previously not possible and thus,

use less actual energy, which

means less patient discomfort.

‘I can treat rosacea quite

eff ectively, particularly stubborn

little red blood vessels on the

face as well as red facial lesions

including birthmarks.’









With increasing numbers of people

presenting with rosacea, spider

veins and pigmentation concerns,

as well as seeking skin rejuvenation,

excel V+ presents a multi-pronged

solution for a varying range of

patient demands.




An excel V+ treatment takes

between 10-15 minutes, with

a series of sessions potentially

required for optimal results.

Excel V+ features a built-in cooling

mechanism, which eff ectively

manages patient discomfort.

And, because excel V+ safely

zeros in on the blood vessels that

are a hallmark of rosacea and

spider veins, destroying them

while leaving the surrounding skin

undamaged, downtime is minimal,

with mild to moderate redness,

swelling or bruising lasting between

24 to 48 hours.

Patients will begin to notice results

in two-to-six weeks, with fi nal results

becoming evident within six months.



In the past, this type of laser

therapy was not advised for

people with darker skin. But excel

V+ laser is considered suitable and

eff ective for all skin types including

dark, light or tanned skin. ‘Another

advantage of the excel V+ is to

reduce redness and brown spots,

which is very popular among

millennials as a minimal-to-no

downtime procedure,’ says

Dr Ibrahimi. AMP

excel V+

• Fully-integrated 532/+ 1064

nm wavelengths, with the

addition of ‘Green Genesis’

a micro-pulsed 532 nm


• Fifty percent more power with

the 532 nm wavelength;

• Large spot sizes up to 16 mm

for doubly fast treatments; and

• New ‘Dermastat’ tracing

handpiece to quickly treat

small vascular and pigmented

lesions on the face and body.

For more information,

contact us on 1800 288 372 or

visit us on


Products & services

The team at Cutera is

fully committed to

supporting its

customers in choosing

the best investment in

technology for their

patients and for their


About Cutera

Cutera is a leading provider of laser

and other energy-based aesthetic

systems for practitioners worldwide.

Since 1998, Cutera has been

developing innovative, easy-to-use

products that enable physicians

and other qualified practitioners to

offer suitable and effective aesthetic

treatments to their patients.

With more than 20 product

introductions in 20 years, Cutera

continuously develops and

provides scientifically advanced

laser systems.

Cutera was founded with a simple

goal: to offer industry-leading laser

and light-based solutions that

provide a compelling and lasting

investment, uniquely designed for

specific market segments. These

products redefine functionality and

offer Cutera’s physician partners the

widest range of clinical applications

for the face and body. The

company is justifiably proud of its

accomplishments and looks forward

to paving the way for the next 20

years of aesthetic innovation.

In addition to its commitment to

innovation, it is equally committed

to supporting causes that reflect its

core beliefs and values. To

that end, Cutera has partnered

with the National Rosacea Society

in support of National Rosacea

Awareness Month.

Since rosacea affects more than

16 million Americans, Cutera is

pleased to offer a solution like excel

V+, that can address rosacea, and

other vascular skin conditions.

Cutera Australia & New

Zealand has undergone many

positive changes in recent times,

as it has continued to invest in

the right people to support its

customers who invest in Cutera’s

advanced technology.

The Cutera family of products - a

suite of cutting edge technology

such as xeo, excel V+, excel

HR, truSculpt iD, enlighten 3 and

enlighten SR - is designed to

offer patients the best possible

outcomes, regardless of their

condition or skin type.

The team at Cutera is fully

committed to supporting its

customers in choosing the best

investment in technology for

their patients and for their

business. AMP



Get ready for



5-8 march 2020

intercontinental double bay











Boasting the latest

ACCUREP technology

and four interchangeable

handpieces, Thermage FLX by Solta

Medical is enabling practitioners

to achieve patient satisfaction like

never before.

A proven track and safety record

– over two million treatments have

been successfully performed

globally – stands Thermage apart

from its peers in the non-invasive

skin-tightening technology category.

Thermage FXL, the fourth

generation Thermage system,

takes this further, by employing a

unique handpiece tip and teaming

it with real-time impedance tuning

to reduce treatment times, improve

patient comfort and deliver better

results than practitioners have

previously seen.

Versatility Plus

Thermage FXL’s handpiece features

four interchangeable tips, which

makes this patented radiofrequency

(RF) device to treat the face, eyes

and body. Its Total Tip 4.0 covers 33

percent more surface area than the

Total 3.0, which enables treatment

time to be shortened by 25 percent.

What’s more, the handpiece is

light and ergonomically designed

and features a multi-directional

vibration and a large touchscreen

with user-friendly interface for

practitioner comfort and ease of

navigation. Patient comfort is also

improved thanks to enhanced face

and body vibration.

Treatment Time

Thermage FLX delivers monopolar

RF energy to the skin’s surface via

the handpiece’s cryogen-cooled

tips, which keep the superfi cial

layers of the skin protected as

deeper dermal tissue is heated.

Treatment time varies from 30-90

minutes, depending on the area

being treated.

Instant Satisfaction

Both practitioners and patients are

delighted with the instant results

provided by Thermage FLX. Unlike

other treatments in its class,

Thermage FLX provides an instantly

noticeable lift that improves with



time, which continues to gradually

improve over the next two to six

months after treatment. These

results may last years, depending

on the condition of the skin and the

post-treatment care and protection

employed by the patient. Indeed,

the results are impressive and easy

to predict, and thus far Thermage

FLX has been found to improve

facial and skin laxity in 96 percent

of patients.


This remarkable technology allows

the Thermage FLX system to

integrate tuning pulses into each

individual REP. These tuning pulses

automatically and accurately

measure local impedance values and

adjust energy output parameters to

deliver consistent energy both in the

individual site treatment and from

one treatment site to the next.

This allows for more consistent

and accurate results overall and

ensures that within one treatment,

all levels of laxity are correctly

addressed and remedied as much

as is possible.


Bare Laser and Skin was the fi rst clinic

in Melbourne to purchase Thermage

FLX and has seen incredible results

in the six months since acquiring it.

Here, we speak with Alishia Boot, clinic

founder and Principal Dermal Therapist,

on her experience with the device.

Q: What do you love about the

Thermage FLX?

A: I really enjoy seeing the clients’

reactions when they see their instant lift

after treatment. While we do wait 4-6

months before we see full results, for

clients to see this initial transformation

instantly is really gratifying.

Q: What areas of the body are you

mostly using it on?

A: We use it over the full face, as well

as the neck, décolletage and body. For

the body, the most popular treatment

is post-pregnancy tummy and the top

of the knees – the tightening and lifting

there is quite satisfying.

Q: How many treatments are

required and what kind of full-term

results are seen?

A: In most cases just one single

treatment is required to achieve

desired results.

Results can be seen after just one

treatment and continue to improve for

up to 24 months. Thermage FLX can

be performed yearly, to improve results

and add to the collagen bank.

Everyone is different, of course – it

depends on the amount of collagen

content the client has to begin with,

if they are sun damaged or not, the

degree of laxity and so on.

The treatment offers lift and

tightening, and it also triggers new

collagen formation. This combination

adds such a beautiful result. Also, if

someone was having a facelift this

would be a great complementary

treatment to consider.

Q: What is the downtime like? Is

it reduced in comparison to other

devices of this kind?

A: There is no downtime. Clients can

leave and go to dinner or back to work.

Q: How is patient comfort during

the procedure?

A: It is variable. I would explain it by

saying it is uncomfortable, but the entire

treatment is bearable.

Q: How has having the device

improved your practice?

A: Signifi cantly. I wanted to introduce

a technology that was able to take my

clients to that next level. The treatments

I offer for general skin tightening,

pigmentation, pore size and fi ne lines

are great, but it was important for me to

also be able to offer my clients the next

step and this has provided it.

I have absolute confi dence in the

technology and adding that to my skill

set, client satisfaction is through the

roof. It is a really popular treatment in

the clinic.


products & services

Thermage FLX


monopolar RF

energy to

the skin’s

surface via the




Babyface Cosmetics

Skin and Spa Clinic

Emmy Yang from Babyface

Cosmetics Skin and Spa Clinic in

Haymarket, Sydney, has been using

Solta’s Thermage FLX for 10 months.

Here, we chat to her about how it

has enhanced both her clinic and her

client satisfaction.

Q: What do you love about the

Thermage FLX?

A: It is an effective new technology

for skin tightening and anti-ageing

and collagen production. It is very

popular in our clinic right now,

especially for the Asian clients. Most

of my client base is from China,

Korea or other parts of Asia and like

anyone, they wish to maintain their

youthful appearance. So far client

satisfaction has been amazing.

Q: What areas of the body are

you mostly using it on?

A: We use it predominantly on the

face and the tummy. Some clients

have even had treatment on the

arms and thighs for skin tightening.

The technology is great as you can

use it on the eye area, too.

Q: How many treatments are

required and what kind of fullterm

results are seen?

A: We only need one treatment to

see results and these last up to two

years, depending on the patient

and their skin condition to begin

with. We see a slight but noticeable

improvement immediately after

treatment, but within 2-3 months,

there is a really great result of lifting,

firming and improved skin tone.

Q: How is patient comfort during

the procedure?

A: We have used it a lot on the upper

eyelids, which is a really sensitive

area. We have been treating this area

and finding the patient is tolerating it

well and enjoying comfort throughout

the procedure.

Q: How has having the device

improved your practice?

A: We have noticed a wider range

of client ages coming for the

treatment, from 25 to 55 or even 60

to 75 years old. They are looking

for age prevention in younger

demographic as well as improving

the skin at a more mature age. It has

really increased our customer age

demographic. AMP

For more information call 1800 251

150 or visit

Q: What is the downtime like? Is

it reduced in comparison to other

devices of this kind?

A: There is next to no downtime.

Some patients might experience

a little bit of swelling. Any tell-tale

signs of slight redness can be easily

covered with make-up.



products & services

† †





Softened lines lines the the lines

lines lines around

around the


on on the mouth,

mouth, and eyes,

eyes, and forehead;



improved Softened Softened

lines the the definition

definition lines

around around chin.


on the


on jawline

jawline the

mouth, mouth, and

and eyes, and under

under eyes,





the chin.


improved improved

definition definition


on on

jawline jawline


and and

under under


the the



B efore B efore Thermage





B efore B efore



B efore B efore




After After Thermage

AFTER Thermage




After After


After After Thermage


Reduced wrinkles

wrinkles and

and and

and decreased

decreased "hooding"

"hooding" for

for for

for a



more Reduced Reduced more awakened

awakened wrinkles wrinkles look.

look. and

and and look. and decreased decreased "hooding" "hooding" for

for for

for a a

more more awakened awakened look.



Thermage FLX


With its non-invasive profile,

this radiofrequency cosmetic

procedure has been proven to help

smooth, tighten and contour the

skin, delivering an overall refreshed

and younger looking appearance.

Its combination of heat energy

to treat deep tissue and cooling

effects allow for patient comfort

throughout the treatment, which is

tailored to tighten existing collagen

and trigger new collagen growth.

A walk-in, walk-out treatment,

with little to no downtime or

recovery, Thermage FLX shows

immediate results that continue to

develop in the two to six months

after treatment.

Patients, no matter what

skin type or tone, can expect

natural looking results both on

the face and body, from a single

procedure. This includes areas of

the eyes, face, stomach, upper

knees and thighs.

B efore

B efore



efore Thermage


B efore B efore



efore Thermage







After After Thermage

AFTER Thermage

After After


After After Thermage

and and of of Improved











crepey skin;

skin; skin;


skin skin the the and and smoother

smoother Improved Improved


skin contours contours the

the and

and and


abdomen appearance appearance



and legs.

legs. of

of of legs. of legs. crepey crepey skin;



smoother smoother skin

skin skin

skin on

on on

on the

the the

the abdomen abdomen and

and and

and legs.



B efore B efore Thermage

After After Thermage

B efore B efore Thermage

After After Thermage



efore Thermage

AFTER Thermage

After After Thermage

BAll efore B All before before Thermage

and and after after photos photos have have not not been been retouched.

After After


efore Thermage

After After Thermage

All Individual All

All before and results and

and after after

after may photos may vary. vary. have have not not been been retouched.

All before and after photos have have not not been been retouched.

Individual All All before results and and after after may may photos vary. vary. have have not not been been retouched.

Individual All All before results and and after after may photos may vary. vary. have have not not been been retouched.

Individual results may may vary. vary.

Individual results may may vary. vary.













PICOCARE 450 is a second

generation Picosecond

Nd:YAG laser indicated

for use on epidermal and dermal

pigment, tattoo removal, skin

rejuvenation and scarring.

Now available throughout

Australia through Cryomed

Aesthetics, this innovative

platform combines ultra-short

picosecond laser and HEXA

Laser Induced Optical Breakdown

(LIOB) to deliver best-in-class

results across a range of common

indications with less discomfort

and downtime than competing


PICOCARE 450 is in a class

of its own in terms of speed

(450 picosecond pulse duration)

and power (peak power of

1.33GW). This unique platform

shatters pigment into infi nitely

small particles that can be more

readily eliminated by the body,

making treatments more effi cient,

comfortable and eff ective.

The new 450 picosecond pulse

is a signifi cant upgrade compared

to previous models. By increasing

the power and shortening the

pulses, treatments produce better

results with less downtime and

higher safety.

While most systems off er one

or two wavelengths in picosecond

mode, PICOCARE 450 has four

(1064nm, 532nm, 595nm and

660nm). This allows PICOCARE

450 to support the removal of all

coloured tattoos, including diffi cult

to treat green and blue pigments.

Ultra-precise irradiation means

minimal risk of damage to the

surrounding tissue and faster patient

recovery times.

Created by Wontech in Korea,

PICOCARE 450 is the fastest, most

powerful second generation laser on

the market today.

Enhanced precision

PICOCARE 450 can come with a

total of six handpieces, including

a zoom handpiece with spot sizes

from 2mm to 10mm, a collimated

7mm handpiece for pico-toning

procedures, and two fractional

handpieces to address pigment and

textural conditions. There is also the

option to add two additional fi lter


Skin rejuvenation remains

popular among patients seeking

laser treatments. Treatments using

picosecond lasers with fractional

handpieces have become especially

attractive due to the higher


products & services

efficiency with decreased risk of

photothermal damage, compared

with conventional fractional lasers.

PICOCARE 450 uses the latest

HEXA Microlens Array (MLA)

technology handpiece to optimise

precision and power.

Compared to conventional

fractional ablative techniques,

the use of PICOCARE 450 with a

HEXA MLA handpiece has been

found to induce LIOB, thereby

offering the advantages of lower

risk of side effects and higher

efficacy. Moreover, by limiting

damage to the stratum corneum

and basal membrane, treatment is

fast and effective.

The HEXA MLA handpiece allows

PICOCARE 450 to have maximum

impact on the target area while

causing minimal disturbance to

the surrounding tissues. Because

LIOB shatters only the target

pigment, risk of Post-Inflammatory

Hyperpigmentation (PIH) after

treatment with PICOCARE 450 is

also reduced.

The HEXA MLA handpiece

can focus up to 15 times more

energy into each dot, thanks to its

exceptional quality and refractive

properties. PICOCARE 450 with

the HEXA MLA handpiece can

replace aggressive scar treatments

such as subcision, as scar

tissues in the deep dermis can be

destroyed without causing severe

pain for the patient.


in practice

As a dynamic platform designed to

treat some of the most common

skin concerns, PICOCARE 450

makes an attractive addition to

new and existing aesthetic medical

practices, particularly those

interested in utilising the latest


With a peak power of 1.33GW,

PICOCARE 450 allows practitioners

to treat more patients more

effectively and efficiently. By

shortening treatment times and

delivering more power in fewer

shots, this device also enhances the

patient experience.

PICOCARE 450’s ultra-short

pulse and high peak power photo

mechanical effect cause particles

to react more predictably, therefore

therapeutic reliability is increased. Its

easy-to-use touchscreen interface

comes with preset protocols for

greater efficiency.

With no consumables and low

ownership costs, PICOCARE 450

can deliver an impressive ROI.

With the support of Cryomed

Aesthetics, you can easily integrate

this fast, effective and innovative

platform into your practice, while

improving your clinic’s performance

outcomes. AMP

For enquiries, call 1300 346 448 or





Second generation

picosecond laser

Peak power of 1.33GW for

greater efficacy

450 picosecond pulse duration

shatters targeted pigment into

infinitely small particles that

can be more readily removed

by the body

Multi-wavelength treatment

(1064nm, 532nm, 595nm and

660nm) supports the removal

of colour tattoos, including

green and blue pigments

Ultra-precise irradiation for

minimal risk of damage to

surrounding tissue and faster

patient recovery time

Higher peak power combined

with shorter pulse duration

provides better efficacy in

treatment of pigments,

tattoos, epidermal lesions

and dermal lesions.


Epidermal pigment Dermal pigment Tattoos Skin rejuvenation Scars

Becker’s nevus ABNOM Multi colours Wrinkles Acne scars

Café-Au-Lait Ito nevus Dull skin Chicken pox scars

Freckles Ota nevus Dry & rough texture Ice pick

Lentigines Lentigines Dyschromia Boxcar

Melasma Post-Inflammatory Rolling




LDM Technology



LThe innovative LDM (Local

Dynamic Micro-massage)

technology is currently the

most sold aesthetic device in

South Korea, the beauty capital

of the world. Made by Wellcomet

Germany, it was specially developed

to treat diff erent aesthetic and

dermatological conditions.

The LDM technology is based

on dual-frequency ultrasound

waves at 10MHz and is able to

modulate dynamic processes

of production and destruction

within connective tissue. More

than 800 experiments in vitro

(some of which are published)

provided the impetus for the LDM

system, which was then tested in

diff erent clinical applications.

Ultrasound has various

mechanical, thermal and chemical

eff ects on cells and tissues, and

has had diff erent applications in

medicine and aesthetics for a long

time. Conventional ultrasound

systems use the frequencies of

1MHz and 3MHz. Ultrasound

waves of these frequencies can

eff ectively penetrate into the body

to depths of several centimetres,

which are clearly below epidermal

and dermal layers where the main

ageing processes take place. LDM

technology applies an ultrasound

wave of 10MHz frequency with a



• Wrinkle reduction

• Skin tightening (face and body)

• Skin rejuvenation

• Anti-ageing

• Cellulite reduction

• Stretch marks

• Sonophoresis

• Acne

• Atopic/perioral dermatitis

• Skin ulcers

• Hypertrophic scars/keloids

• Eczema

• Psoriasis

penetration depth of 0.3cm which is

consequently almost fully absorbed

in upper skin layers where ageing

and most skin diseases manifest.

The wave of this frequency

also has a very small amplitude

of 0.018µm,which is much smaller

than the size of the single cell

(10µm) and the cell membrane

(0.005µm) and therefore can directly

infl uence cells or small cell groups

within tissue.

This property is responsible for

some very specifi c reactions of

diff erent cells to ultrasound waves

of 10MHz frequency.

Clinical studies have shown that

LDM treatments can modulate Extra





• Immediate results with longer

lasting outcomes as new

collagen forms

• No discomfort or downtime

• Additional revenue with a new

customer group

• Can be treated year-round on any

skin type and age group

• Can be combined with laser and

injectables to enhance treatment

• Wound healing capabilities,

including on burns, scars

and redness

• No consumables = cost eff ective

• Unique technology – 10MHz and

dual frequency ultrasound skin

treatment system is only available

with Wellcomet

• 22 preset applications, including

aesthetic and dermatological

treatment modes

Cellular Matrix (ECM) components

and that they can increase Heat

Shock Protein (HSP) by 1800%

without damage to normal cells or

infl ammation. Stimulation of collagen

production through fi broblasts

shows the best results if supported

by simultaneous modulation of

MMPs that can stimulate new

collagen. HSP molecules account

for correct protein folding – a

process which is extremely

diminished in aged skin. Production

of hyaluronic Acid is essentially

important for skin moisturisation

and elasticity. Specifi c modulation

of all these components can lead

to signifi cant improvement of skin

appearance and consequently

reduce signs of ageing. So, if

you are looking to provide a

treatment to improve skin quality,

not just its appearance, the LDM

treatment is ideal.



BalaBala Laser Clinic was

established in 2016. We are opening

a franchise in Melbourne’s CBD

with plans to open more franchise

clinics in other states. The clinic’s

success and growing reputation

have been founded in the provision

of the highest quality services and

treatments. Our company’s vision

is to provide the most effi cacious

solutions for our clients’ needs. It

is underscored by the core values

of customer focus, accountability,

respect and excellence. In order

to create a clinical environment

that encourages client trust and

loyalty, we have installed the latest

technologies and the best machines

in the world, such as the LDM.



We searched for the most

advanced, proven, non-invasive and

cutting-edge medical technology

to provide our clients with the most

cost-eff ective, high-quality services.

LDM’s proven results from clinical

studies and its multifunctionality

captured our attention. LDM is

extremely versatile – suitable for

all skin types and any age group –

thus all our clients can benefi t from

the LDM system. It is our go-to

machine for a variety of treatments.

We have spoken to overseas clinics

that have used LDM for many

years and the feedback has been

excellent. More than 1,300 systems

have been sold in Korea. LDM has

become a must have system for

clinics there and I have only heard

positive feedback.



We are the fi rst clinic in South

Australia to launch LDM-MED.

Since we introduced LDM-MED to

our clients, they have enjoyed a far

more favourable clinical experience

with their skin treatments. They

feel less pain, report fewer side

eff ects and see better results.

LDM-MED has defi nitely increased

our business, both through

attracting new clients and

encouraging current clients to

return for multiple treatments.



Q&A continued


For our clinic, LDM is very profi table as

the services it provides can respond

to the needs of most clients and it

requires no consumables. For the client,

as a stand-alone treatment, there is

no pain, no downtime, and no side

eff ects. When combined with other

treatments or procedures it can be

used to treat side eff ects and burns.

Due to its outstanding performance,

our clients keep returning to our clinics

for successive treatments. Additionally,

whereas we can only off er limited

numbers of sessions with certain

lasers, LDM can be off ered weekly, so

we are able to treat our clients more

frequently, which has led to increased

revenue. Therefore, as soon as we

purchased an LDM-MED from Quantum

Health Group, we purchased a second

machine. Quantum Health Group has

provided excellent support and we will

be purchasing third and fourth systems

for our next franchise clinics.



Our clients love LDM. Clients with

sensitive skin have been particularly

pleased as LDM increases the skin’s

tolerance to external factors and

reduces redness. For sagging skin,

after only one treatment, the clients

see visible results and are happy to buy

more sessions. In the case of pre-and

post- care (injections, lasers, HIFU, RF

etc), LDM speeds up the skin’s healing

process and encourages regeneration

of new tissue. For our clients LDM is the

must-have treatment to improve skin

quality, not just its appearance.



We ensure that the price of one

session is aff ordable for most clients.

Also, at our clinic, LDM can be

combined with laser treatments (like

pigmentation removal, acne treatment,

and skin rejuvenation), medical

procedures (thread lifting, RF, and

HIFU), and injections.

Not only do we provide the

opportunity for clients to refresh their

looks with no pain, no side eff ects and

no downtime, but LDM can be used all

year round, enabling our clinic to off er

top-level services to our clients. AMP


are exclusively distributed in Australia

by Quantum Health Group, a leading

medical equipment distribution,

solutions provider and manufacturer in

SE Asia. For more information, call 1800

228118, email

au or visit












LDM-MED is the latest form of ultrasound treatment. The 10MHz and

dual frequency targets the diff erent layers of the skin at the same time.

In this way, the LDM-MED off ers an eff ective non-invasive treatment for

skin tightening, wrinkle reduction, improvement of the skin structure

and stimulation of collagen.

Dynamic pressure



Quick visible aesthetic results

All skin types and age groups

No discomfort or downtime

Can be combined with laser and injectables

to enhance treatment

No consumables

Immediate ROI

Improves the quality of the skin not just the appearance

Acne - Rosacea during pregnancy Complication after Filler Injection Skin Tightening

Before Before Before

After After After

LDM - Quantum Health Group


1800 228 118













Perfect for your female patients

who wish to maintain intimate

wellness without hormones,

invasive procedures and/or

downtime, TempSure Vitalia probe

is specifi cally designed for smaller,

hard to reach areas.

The 300 watt, 4 MHz expandable

RF platform provides safe, consistent

and reliable RF treatments, thanks to

revolutionary time and temperature

control monitoring, dual temperature

sensing, built-in temperature

sensing for ease of use and two

thermistors coupled with impedance

monitoring to prevent arching. In

fact, the treatment timer will only

activate when the target tissue is at

a therapeutic temperature, delivering

repeatable results every time.

TempSure Vitalia’s delivery of

precise heating for smaller, hard-toreach

areas temporarily increases

local circulation as it decreases pain

and muscle spasms. This means it is

gentle and assures patient comfort

– the treatment is well-tolerated,

non-invasive and non-ablative,

and it doesn’t require anaesthesia.

With little to no downtime, most

patients can resume normal activity

immediately following treatment.

Alongside women’s intimate

wellness, other applications of

TempSure Vitalia include wrinkle

reduction, skin tightening through

soft tissue coagulation and

cellulite reduction.



Dr Josh Wall, of Contour Clinics

in Five Dock, Sydney, has been

using Vitalia for six months. We

spoke to him about his experience

with the device.

Q: Approximately how many

women have you treated using

TempSure Vitalia?

A: We have probably treated around

15 women so far, with nothing but

good feedback.

Q: What are the major concerns

they are looking to remedy?

A: A lot of women are interested

in the treatment for its vaginal

tightening features. We also have

seen patients seeking increased

lubrication and improved pleasure

during intercourse.

We have treated women who

suff er mild incontinence and have

had to wear panty liners after having

kids. We have also treated some

women who are concerned with the

external appearance of the vulva

and are seeking a tightening, lifting

and shrinking eff ect. These women

are nearly at the point where they

are considering a labiaplasty. They

may have developed laxity post

menopause, or something similar

and we have been able to address

this with Vitalia.

Q: What is patient comfort

typically like throughout the



Dr Josh Wall


A: The feedback we have received

is that the treatment is very

comfortable. The device has a

heat sensor, so it is possible to tell

exactly what temperature the deep

dermal tissues we are treating are

at, which contributes to the comfort

level. The inbuilt technology driving

the treatment reduces the risk of

overtreating any area. The probe is

quite narrow, which seems to be

tolerated well in patients.

Q: Is there any downtime?

A: There is virtually no downtime.

Patients can resume normal daily

activity immediately.

Q: What value do you think

TempSure Vitalia has brought

both to your clinic and to

your patients?

A: In the past, there has been a lack

of information on what treatments

are available to women who are

experiencing laxity or decreased

sensitivity and/or pain during

intercourse. Vitalia gives women a

vialble choice and also provides a

cosmetic option, which many are

seeking. The testimonials I have been

receiving are very positive; in one

recently the treatment was refered to

as ‘life changing’, as my patient said

she no longer had to worry about

urinary incontinence or wearing a

pantyliner after just one treatment.



Dr Keturah Hoff man from

Restoration Clinic in Perth has

been using TempSure Vitalia in

her practice for six months. Here,

she shares her experience.

Q: How many women

have you treated using

TempSure Vitalia?

A: To date, we have treated 16

women with Vitalia.

Q: What are the major

concerns they are looking

to remedy by having the


A: We are treating menopausal

women and post-childbirth

patients. Some have Vaginal

Relaxation Syndrome, and they

report a ‘loose’ feeling and air

might move in and out of

the vagina. We have performed

the treatment successfully in

these cases.

Another concern patients have

is Vulvo Vaginal Atrophy, where

the mucosa becomes thin and

this results in painful intercourse.

Depending on the severity, the

patient might experience pain in

the area all the time; there are

some women who simply can’t

sit comfortably, because they feel

a burning sensation in this area

due to the condition. Sometimes

people will have little cuts and

ulcers on the vulva from this



Dr Keturah Hoffman

thinning. For instance, if they wipe

too hard after going to the toilet,

it can break the skin. We can

improve the quality of the mucosa

to prevent this.

The treatment actually

shrinks the labia minora; so this

is a positive for those wanting a

cosmetic result as well. We have

also treated women with urinary

incontinence, and it has been

very successful.

Q: What kinds of results are

you achieving and in what

length of time?

A: The results depend on the

severity of the problem. We

have noticed women can

experience results after one

treatment and sometimes it is

immediate. Within days many

notice they no longer have

problems with urinary leakage.

As far as intercourse becoming

less painful, it requires longer;

but laxity is usually remedied

quickly. If the problem is

signifi cant, patients would need

some follow-up treatments,

generally at monthly intervals.

Q: What is patient comfort

typically like throughout

the treatment?

A: Patients fi nd the treatment

very comfortable and the

probe is very thin, which is a

contributing factor.

Many patients say it is less

embarrassing than a pap

smear or vaginal exam from a


Q: How long does

treatment take?

A: It only takes about 20 minutes

to treat the inside of the vagina

and 15 minutes on the vulva, if

treatment is required there.

Q: Is there any downtime?

A: Patients can go straight

back to work; they can have

intercourse the same day;

they can even use tampons

straight away, should they

begin to menstruate following

a treatment. We wouldn’t do

it during a ‘period’, as if there

is blood in the vagina it would

interfere with the probe.

Q: What value do you think

TempSure Vitalia has brought

both to your clinic and to

your patients?

A: The Vitalia has defi nitely

added value and the potential is

enormous. At least 50 percent

of menopausal women will have

some symptoms and they no

longer need to accept them as

this device is versatile and suitable

for most patients who present

seeking treatment.

For enquiries contact Cynosure at


Dr Shang-Li Lin

Sydney, NSW

Saturday, 14 September 2019

The 80 attendees at

Cynosure’s 2019 Aesthetic

Exchange were treated to

a day of informative presentations

and live demonstrations at the

InterContinental Hotel in Double

Bay, Sydney. Dermatologist

Dr Shang-Li Lin, the guest

speaker from Taiwan, gave

two lectures: one on PicoSure

Clinical Applications, an Asian

Experience and the other on his

own personal experience with

Cynosure devices in his clinic,

Marketing and Practice Success

– A Doctors Perspective. National

presenters included Dr Gina

Messiha, Dr Shobhna Singh, Dr

Varun Sharma, Natalie Song,

Michelle Kearney, Dr Josh Wall

and Dr Keturah Hoff man.

Indications such as skin

tightening, acne scarring,

pigmentation, hair removal,

women’s wellness as well as

minor surgical applications

were covered.

Cynosure’s Aesthetic

Exchange is designed to help

industry professionals engage

with likeminded peers and

industry experts to grow

their network and information

base, whilst diving into the

detail on how to implement

the latest marketing strategies

to keep growing their aesthetic

business. AMP

Dr Keturah Hoffman

Dr Josh Wall






Key benefits

• Innovative FMS technology

• Deep stimulation of muscular


• More eff ective than


• Totally non-invasive – eff ectively

stimulates muscle tissue without

direct skin contact

• Patients can remain fully clothed

during treatment

• Suitable for patients where

electrotherapy cannot be used

• Hands-free operation

Powered by Functional

Magnetic Stimulation (FMS)

technology, the TESLAChair

is a revolutionary new treatment for

urge, mixed and stress incontinence

in men and women. This innovative

device stimulates deep muscle

tissue without coming in direct

contact with the skin.

Backed by clinical trials, the

TESLAChair is redefi ning the

intimate health and wellness space,

with studies showing that up to 90

per cent of women suff ering from

post-natal urinary incontinence

were relieved of their symptoms

after the TESLAChair treatment.

The remaining 10 per cent saw a

signifi cant improvement.

As TESLAChair treatments

are totally non-invasive, they are

particularly attractive to patients

who are keen to avoid the risks and

downtime associated with surgery.

TESLAChair treatments are also

suitable for patients who cannot

undergo electrotherapy.

FMS technology

The TESLAChair uses advanced

FMS technology to treat weakened

pelvic fl oor muscles and all types

of urinary and faecal incontinence,

including urge, mixed and stress

incontinence, and incontinence after

childbirth. This device also helps

to accelerate rehabilitation after

surgeries in the urogenital area.

FMS can benefi t patients with

sexual dysfunction and chronic

pain in the pelvic region and lumbar

spine. Additionally, the TESLAChair

therapy can have a positive eff ect

on sexual performance, erections,

the ability to achieve orgasm, and

the active contraction of groin and

gluteal muscles.

FMS uses a magnetic fi eld to

penetrate the deeper biological

tissues without aff ecting the skin.

During electromagnetic induction,

rapid changes of magnetic fi eld

intensity induce an electrical current

in the neuron. Once the current

reaches a certain value, a so-called

neuron action potential is achieved.

This neuron action potential causes

the neuron cell to depolarise, which

eventually leads to a complete

muscle contraction. By inducing

muscle contractions, and helping

boost circulation and nutrition in the

target area, FMS leads to increased

strength and endurance of the

sphincter and pelvic fl oor muscles.

The TESLAChair


The TESLAChair treatment is totally

non-invasive. Because FMS can

pass through clothes, tissue and

bone, patients can remain fully


products & services

clothed while being treated. This

makes the TESLAChair a great

option for people who are not

comfortable getting undressed in

front of others. Prior to treatment,

patients are asked to complete a

questionnaire. They should also

undergo a physical examination.

The TESLAChair is a four-channel

device comprising of a chair with

seat and back applicators, as

well as two additional handheld

applicators. Treatment parameters

can be set to meet each patient’s

needs. The TESLAChair can reach

a magnetic field strength of up to

three Tesla.

The TESLAChair’s unique seatlike

design allows patients to sit

in a comfortable position for the

duration of their treatment. While

seated on the TESLAChair, patients

are encouraged to concentrate on

muscle contraction during periods

of stimulation. This facilitates the

implementation of active learning

exercises. Stimulation occurs in

bursts of six seconds, followed by

six seconds of rest.

Each treatment typically lasts 30

minutes. For best results, patients

should undergo two to three

treatments a week until they have

had between six and 10 treatments

in total. Improvements can be seen

after the first couple of treatments.

There are no known side

effects to TESLAChair treatments.

TESLAChair therapy has been found

to be a more effective treatment for

incontinence than electrostimulation.

Practice benefits

By providing those suffering from

incontinence with a completely

non-invasive treatment option, this

unique technology is changing the

lives of incontinence sufferers both

in Australia and around the world.

Globally, more than 200

million people are believed to

be suffering from incontinence.

Effective non-surgical solutions

for all types incontinence are

therefore in high demand.

The TESLAChair’s hands-free

operation system makes it easy

to introduce to new and existing

medical practices. TESLAChair

treatments can be delegated to

trained staff and offer a significant

return on investment. AMP


• Urge urinary incontinence

• Stress urinary incontinence

• Mixed urinary incontinence

• Incontinence after radical


• Faecal incontinence

• Regeneration after childbirth

• Milder forms of drooping

uterus and bladder (cistokela,

descensus uterusa)

• Rehabilitation after pelvic

floor surgery

• Chronic prostate inflammation

• Erectile dysfunction

For enquiries, call 1300 346 448 or


Scientific support

The graph shows the results of

therapy using the TESLAChair.

The results were collected across

three independent centres with

160 female patients:

36 women were treated for urge

urinary incontinence;

42 women were treated for mixed

urinary incontinence;

61 women were treated for stress

urinary incontinence; and

21 women were treated for urinary

incontinence after childbirth.










after childbirth

Urinary incontinence

Fully dry

Significant improvement

No improvement or insignificant improvement



A series of sensational

performances by

Australian females

grabbed the sporting

spotlight across

2019’s northern

hemisphere summer.





Hannah Green, 22

West Australian Hannah Green

produced the performance of a

lifetime to stun the international

golfing world in June with her ‘wireto-wire’

victory in the Women’s PGA

Championship (one of the world’s four

annual Major Titles) at Hazeltine in

Minnesota in the USA.

She became only the third player in

history to lead all-the-way (from startto-finish)

in the PGA Championship.

Green also became only the third

Australian to win a LGPA Major event:

following in the footsteps of Jan

Stephenson (3 Majors) and Karrie

Webb (7 Majors and 41 LGPA events).

In just the last 12 months she has

seen her World Ranking jump from

147 (earlier this year) to 85 prior

to Hazeltine and up to 29 after her

dramatic win.

Ashleigh Barty, 23

Only four Australians had been ranked World Number 1

tennis player since the current official rankings system

began in 1973: John Newcombe (1974), Pat Rafter (1999),

Lleyton Hewitt (2001-2003) and among the females

only Evonne Goolagong Cawley 43 years ago in 1976.

With her dominant 6-1 6-3 victory over Czech Marketa

Vondrousova in the final of the French Open (one of

the world’s four annual Grand Slam titles) in June,

Queenslander Ashleigh Barty became Australia’s latest

World Number 1 – as well as collecting a massive $3.7

million prize-money cheque.

Barty’s extraordinary story had seen her win the Junior

Wimbledon title aged just 15; but then as an 18-year-old in

2014 she quit the pressure of the international tennis circuit

and switched to playing cricket in the Women’s Big Bash

League Twenty20 tournament for the Brisbane Heat.

But after taking 21 months away from tennis, Barty has

returned in spectacular fashion: she had been Australia’s

highest earning tennis player over the 12 months prior to

the French Open – collecting $9.1 million prize-money

and $400,000 in endorsements (and, following the French

triumph, those sponsorships will jump massively this year).





Tasmanian teenager Ariarne Titmus, dubbed

by teammates ‘The Terminator’, lived up to her

nickname when stunning all-conquering US champion

Katie Ledecky to win the Gold Medal from Ledecky

in an adrenalin-charged fi nal of the 400m Freestyle

at July’s World Swimming Championships in Gwangju

in South Korea.

International superstar and multiple Olympic champion

Ledecky had been undefeated at all distances since

2013, before Titmus edged her by a second in the fi nal

in 3min 58.76sec.

Titmus had shown her potential with a series of

triumphs during 2018: she broke the 400m Freestyle

world record at the World Short Course Championships

in Hangzhou in China (winning gold medals in both the

200m and 400m); as well as collecting Gold Medals in

both the 200m and 400m Freestyle at last year’s Gold

Coast Commonwealth Games.

Titmus (who also won Silver in the 200m Freestyle and

Bronze in the 800m Freestyle in Gwangju) is now one

of Australia’s premier Gold Medal hopes for next year’s

2020 Olympic Games in Tokyo.




Ellyse Perry completed her latest

series of headline-grabbing

successes in leading the Australian

team to a succession of crushing

victories during the 7-match

Women’s Ashes Cricket series

against England in the UK during


Perry has consistently dominated

the international cricket scene

since making her debut for both the

Australian Cricket and Australian

Women’s National Soccer team,

(the Matildas) at the age of 16: she

played her first Cricket International

in July 2007 (the youngest person,

male or female, to represent Australia

in cricket) before earning her first

soccer cap for Australia just a month

later; she also became the first

Australian to have appeared in both

Cricket and Soccer World Cups).

During her most recent Ashes blitz,

Perry’s extraordinary dominance

included: Game 1 (1st 50-Over One

Day International) won Player-Of-The

Match with bowling 3 wickets for 43

runs; Game 2 (2nd 50-Over One Day

International) top scored with batting

62 runs; Game 3 (3rd 50-Over One

Day International) again won Player-

Of-The Match with all-time best ODI

bowling by an Australian woman of 7

wickets for 22 runs; Game 4 (4-day

Test Match) awarded another Player-

Of-The Match with batting scores

of 116 and 76 not out, plus bowling

of 1 wicket for 44 runs; Game 5 (1st

T20-Over International) key bowling

of 2 wickets for just 11 runs; Game

6 (2nd T20-Over International)

collected yet another Player-Of-The

Match award with top score of 47

not out, plus bowling of 1 wicket for

17 runs; and finally Game 7 (3rd T20-

Over International) top score batting

60 runs not out.



Rhiannan Iffland, 27

Newcastle’s Rhiannan Iffland won each

of the four initial events in this year’s

2019 Red Bull Cliff Diving World Series

(at El Nido in Palawin in the Philippines

in April, Polignano a Mare in Italy in early

June, Sao Miguel in Azores in Portugal in

late June and Beirut in Lebanon in July).

Iffland originally trained at the local

Belmont High School in trampolining,

and then worked as an acrobatic

trampolining and diving entertainer

on cruise ships in the Mediterranean

and Caribbean, before training at a

French theme park in Lyon, where she

eventually attained dive heights of 20

metres (66 feet).

In 2016 she turned professional

and was granted a wildcard entry to

compete in the opening event of that

year’s Red Bull Cliff Diving World Series

(established in 2009 and held annually

over a circuit of 7 events at various daredevil

venues around the globe) where

competitors dive from platforms at

heights ranging from 26-28 metres (85-

92 feet) and reach speeds of 85 km/h.

She won the championship in her debut

year (the first-ever rookie to do so).

Iffland followed up her initial 2016

series victory with repeat series wins in

both 2017 and 2018, and by August this

year already had an unbeatable lead in

the 2019 championship.



Samantha Kerr, 25

West Australian Samantha Kerr booted 5 goals for the

Australian soccer team to be leading scorer among all

countries in the preliminary rounds at the 8th edition

of the FIFA Women’s Soccer World Cup (52 matches

across 9 cities in France in June-July).

Kerr plays for Perth Glory in the Australian W-League

and Chicago Red Stars in the US National Women’s

Soccer League. She is the current captain of the

Matildas, the Australia women’s national soccer team.

After progressing through preliminary rounds (against

Italy, Brazil and Jamaica), Australian lost a heart-breaking

penalty shoot-out (after a 1-1 draw following extra time)

in the knockout stage against Norway.

But immediately after the World Cup, Kerr (one of 5

international finalists in last year’s FIFA World Player-

Of-The-Year awards) was reported to have received a

$1 million plus offer to continue her career with a top

European club.

That followed The Sydney Morning Herald reporting

in March that Kerr was already ‘on course to become

the first Australian female footballer to earn more than

$1 million in a year now that she is set to be the face of

Nike Australia this year’.














Toulouse,’ la ville rose’ or the

pink city, is the 4th largest city

in France. As the headquarters

of Airbus is in Toulouse, it has

become an international city.

Smaller and less crowded than

Paris, it retains all the charm

one associates with France.

Situated in the south west, in

the summer the beaches of the

Mediterranean Sea, and the

Atlantic Ocean are both within 2

hours of Toulouse; and in winter,

in 2 hours, one can be skiing in

the mountains of the Pyrenees.

In 45 mins one can also be in

‘la France profonde’ the deep

countryside, such as the Gers,

famous for duck and foie gras.

Recreational activities like golf,

cycling and bushwalking are all

easily accessible.



The city hall and square

Purple sunset at Toulouse city

The Cathedral of St Etienne of Bourges

City of Toulouse



Toulouse is best to see ‘a pied’, by

foot. The historical centre is very

compact, without high rise buildings

and the small streets are fabulous to

wander through, especially looking

upwards to admire the architecture.



The beautiful churches and

cloisters from the 11th to 14th

century of the Jacobins, St Etienne

Cathedral and the stunning Basilica

of St Serin, as well as Place

Capitole, Place Wilson and Place

St George are all ‘must sees’.

Toulousains love sitting ‘en terrace’

with a glass of wine watching the

world go by. The Victor Hugo market

is a gastronomic wonderland.

Be sure to try the local produce:

magret de canard, confi t de canard,

foie gras, cassoulet and sausage

de Toulouse.




Dining out is a national past time, so

there is no shortage of restaurants

in Toulouse.

They range from charming

small locals to Michelin starred

restaurants. The Bibent in Place

Capitole and Chez Emile in Place

St George are quality restaurants.

For oyster and seafood lovers, Chez

Jeannot is excellent. Two special

occasion restaurants are Michel

Sarran and Amphytyron.


global medico

Michel Sarran


And the locals’ best

kept secret?

The locals love cycling or running

along the Canal du midi. Toulouse

is the rugby capital in France, so

watching the local rugby team Stade

Toulousain play a home match is an

incredible experience with a fantastic

atmosphere. A local tip: For great

value, try out the best restaurants

at lunchtime.

What’s the most

unusUAL or unique pLACE

to visit there?

As the headquarters of Airbus,

Toulouse is the epicentre of the

aeronautical industry. A visit to the

Airbus plant and its final assembly

line is amazing.

Anything else YOU

would like TO add about


Toulouse airport is only 8km

from the centre of Toulouse, so

easily accessible. Better still, it

is small enough to make flights

throughout Europe and international

connections stress-free compared

to major hubs like Paris, London

and Frankfurt. AMP

Dr Lakhdar Belhaouari



What led YOU TO pursue a

Career in plastic surgery?

Plastic surgery was a new discipline

in Toulouse. With its dependence on

technical expertise coupled with my

love of aesthetics, it was a natural fit.

It is so rewarding to be able to see the

results of your quality work and have

the appreciation of your patients.

What’s been a career

highlight for YOU?

Sharing my experience with

doctors from all over the world by

conducting international masterclasses,

presenting at congresses and

publishing about aesthetic medicine

and surgery techniques has certainly

been a highlight.

What’s your experience of

prACTICINg in Toulouse?

I studied in Toulouse and became chef

de clinique, so have developed long

lasting relationships over many years. I

have setup my clinic and a laser centre

and also an anatomy lab. Teaching

technical expertise in both aesthetic

medicine and surgery, to ensure safe

medical and surgical practice, is a

passion of mine.

The Canal du midi, Toulouse













Source Euromonitor International Limited; Medical Aesthetic Skin Care: includes Skin Care products sold through medical dispensing channels, such as dermatologists and plastic surgeons, and

which may additionally be sold through medical spas and online channels; rankings at global brand name level at MSP; sold in calendar year 2015; brands included ONLY if founded in the United

States of America; based upon research conducted in March and April 2016.







E: T: 1300 346 448 W:

More magazines by this user